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SUMMARY 
On the basis of Fc receptor expression and phagocytic 
activity, approximately 20 -25% of the cells present within 
the highly immunogenic, methylcholanthrene- induced, murine 
fibrosarcoma FSA -R could be classified as macrophages. These 
cells did not express the Mac -1 antigen and were approximately 
50% I -Ak- positive. The expression of I -Ak required the 
presence of mature T cells, and macrophages obtained from tumours 
grown in nu /nu hosts were I -Ak negative. Both the percentage 
of macrophages present within the tumour and I -Ak expression 
by these cells remained constant during the observed period of 
tumour growth and during serial passage of the tumour in vivo. 
Macrophagés were enriched from enzymatically disaggregated 
tumour cell suspensions by virtue of their capacity to adhere 
tightly to glass or plastic surfaces and the accessory cell 
activity of the adherent cell population was investigated in 
various well defined in vitro assay systems. Thus tumour - 
associated macrophages were shown to be fully capable of 
reconstituting the primary anti -CRBC PFC response of Sephadex 
G -10 passed normal spleen cells. This function required the 
presence of I -Ak- positive cells, and tumour- associated macro- 
phages treated with anti -Ia serum plus complement or obtained 
from tumours grown in nu /nu hosts, were inactive. Tumour - 
associated macrophages were also able to supply the essential 
cell activity required for effective cooperation between antigen- 
primed TH cells and normal B cells in the generation of PFC 
responses in vitro. Finally, tumour -associated macrophages 
were found to secrete a soluble factor(s) which considerably 
enhanced the primary anti -CRBC PFC response of whole normal 
spleen cells. Cell separation studies indicated that this 
activity was primarily a function of large macrophages. 
Furthermore, since macrophages treated with anti -Ia serum 
plus complement', or obtained from tumours grown in nu /nu hosts 
were as efficient as normal tumour -associated macrophages at 
enhancing the response, it would seem that I -Ak- positive cells 
were not involved in this function. 
The possible significance of tumour -associated macrophage 
accessory cell activity is discussed. 
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CHAPTER I - INTRODUCTION 
2 
1.0 IN SITU TUMOUR IMMUNITY 
Pathologists have long been aware that most human and 
animal tumours are infiltrated by significant numbers of 
normal host cells. Indeed the first reports documenting 
the presence of such cells appeared during the latter half 
of the 19th century (reviewed by Underwood, 1974). Subsequent 
careful histological examination of tumour sections by conven- 
tional light microscopy -has produced a wealth of data confirm- 
ing these early findings (reviewed by Underwood, 1974; Ioachim, 
1976). However, it is only recently that extensive efforts 
have been made toward understanding the in vitro and potential 
in vivo significance of tumour -associated host cells. Interest 
in this area has developed following increasing evidence that 
systemic tumour immunity neither reliably reflects the clinical 
status of cancer patients nor necessarily correlates with their 
prognosis. Moreover, most immunotherapy trials based on an 
evaluation of systemic tumour immunity have been conspicuously 
unsuccessful (reviewed by Currie, 1980). 
A large number of studies have demonstrated that cells 
isolated from the lymph nodes,spleen, peritoneal cavity or 
circulation of tumour -bearing animals can effectively destroy 
autologous tumour cells in vivo and in vitro (reviewed by 
Baldwin, 1981). A variety of different cell types have been 
implicated in such anti -tumour reactivity including activated 
macrophages, cytotoxic T lymphocytes (Tc), natural killer cells 
(NK) and granulocytes. However, there was no experimental 
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proof for the assumption which was made consciously or by 
implication in many of these studies, that the same effector 
mechanisms were operational at the site of primary tumour growth. 
Indeed, when comparisons were made between systemic and local 
or in situ tumour immunity, both quantitative and qualitative 
differences were usually found (Haskill et al., 1978). 
It is clear therefore that in situ tumour immunity 
constitutes a crucial variable in the equation describing the 
tumour -host relationship and it is not unlikely that any con- 
clusion regarding this relationship based exclusively on an 
evaluation of systemic tumour immunity may be partially or 
completely incorrect. Moreover, without an understanding 
of the trafficking of cells into tumours and their potential 
anti - tumour influences, there is little hope that immunotherapy 
can ever play an effective role in the treatment of cancer. 
Virtually every type of anti -tumour effector cell which 
has been detected systemically has also been found in situ 
in at least one tumour system (reviewed by Haskill, 1982). 
However, of the cells which are commonly found within tumours, 
the macrophage has perhaps stimulated most interest. Macro- 
phages have been shown to play a pivotal role in the induction, 
regulation and expression of both humoral and cell mediated 
immune responses and their presence within the tumour mass 
suggests various ways in which they may interact with the 
neoplasm. 
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2.0 MACROPHAGE HETEROGENEITY 
Macrophages perform a large number of diverse and on 
occasion mutually antagonistic functions. They do for instance 
on one hand constitute a major line of host defence against the 
establishment and spread of microbial (Mackaness, 1964; Ruskin 
et al., 1969; Steigbigel et al., 1974) and neoplastic (Adams 
and Snyderman, 1979; Adams, 1982; Adams et al., 1982; Zoler, 
1983) disease, while on the other hand they may support the 
growth of certain microorganisms (Mackaness, 1971) and tumour 
cells (Noar, 1979; Gablzon et al., 1980; Gorelik et al., 1982; 
Prehn, 1982). Similarly, macrophages act as accessory cells in 
the induction of humoral and cell mediated immune responses 
(Unanue, 1972, 1981; Howie and McBride, 1982a)but may also 
inhibit the proliferation and differentiation of lymphocytes 
(Kirchner et al., 1975a; Baird and Kaplan, 1977a,b) and other 
cells (Jones et al., 1975; Keller, 1976). Other functions 
ascribed to macrophages include the secretion of various bio- 
logically active substances (Nathan et al., 1980; Adams, 1982) 
and numerous homeostatic functions unrelated to host defence 
such as the removal of senescent red blood cells, turnover of 
lung surfactant and bone remodelling and resorption (Douglas, 
1980; Silverstein, 1982). The range of capabilities is in fact 
so diverse as to raise the question of whether one cell can 
possibly perform all these functions or whether as is the case 
with the T cell system, distinct subsets of macrophages exist 
each capable of performing only certain functions. 
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2.1 Identification and characterization of macrophage 
heterogeneity 
Although all macrophages show common morphological,bio - 
chemical or functional characteristics they are by no means 
uniform in these respects. As long ago as 1925 Sabin et al. 
using supravital staining techniques described the similarity 
between resident murine macrophages in the spleen, peritoneal 
cavity and liver and pointed out that such cells differ in 
many respects from monocyte- derived exudate macrophages elicited 
by intraperitoneal (i.p.) administration of blood. The develop- 
ment in recent years of various assays of macrophage function, 
the identification of cell surface and intracellular antigens 
using heteroantisera and monoclonal antibodies, and the use 
of assays which identify and quantitate intracellular and extra - 
cellular enzyme activities, has produced a wealth of data 
documenting macrophage heterogeneity (reviewed by Walker, 1976; 
Hopper et al., 1979; Walker, 1982). Thus it seems that for 
almost every characteristic which has been examined macrophages 
show diversity of expression. 
Two major types of macrophage heterogeneity have been 
described. The first is termed "Interpopulation" heterogeneity 
and refers to differences between macrophage populations obtained 
from different tissue sites. The second is termed "Intrapopulatior 
heterogenetiy and refers to differences between subpopulations of 
macrophages obtained from within a particular site (Walker, 1982). 
It is relatively easy to speculate on the possible mechanisms 
G 
by which such macrophage heterogeneity could be generated 
but somewhat more difficult to find good experimental evidence 
to support proposed mechanisms. What little evidence there is 
available suggests that macrophage heterogeneity results 
largely from two main mechanisms - differentiation and modulation 
- although the issue is further complicated by the proposed 
existence of macrophage sublineages derived from distinct 
bone marrow precursors. 
2.2 Differentiation 
It is now generally accepted on the basis of a large 
body of experimental evidence, that under normal steady state 
conditions, tissue macrophages originate mainly from multi - 
potential haematopoietic stem cells located in the bone marrow 
(reviewed by van Furth, 1981). These cells divide and differ- 
entiate giving rise to a population of cells which are hetero- 
geneous in nature and variably committed to produce cells of 
both the granulocyte and macrophage series (GM -CFC) (Metcalf 
and McDonald, 1975; Byrne et al., 1977; Bol and Williams, 
1980). The most immature cell so far recognized which is 
entirely committed to macrophage production is the monoblast 
(Goud and van Furth, 1975; Goud et al., 1975). Murine mono - 
blasts have a cell cycle time of about 12 hours (van Furth, 1981) 
and division of one cell produces two promonocytes which in turn 
divide after approximately 16 hours to give two monocytes 
(van Furth, 1981). These proliferation and differentiation 
7 
events are absolutely dependent, at least in vitro, upon 
the presence of a colony stimulating factor (CSF) known as 
CSF -1 (Metcalf et al., 1980; Watson and Prestidge, 1983). 
CSF -1 appears to be a largely proliferative signal and 
distinct differentiation signals (D factors) are probably 
also involved in the sequence of events (Onozaki, et al., 
1983). Monocytes do not remain in the bone marrow for long 
and are rapidly liberated into the circulation (van Furth, 
1981). Their half -life in the blood is about 17 hours 
(van Furth, 1981) and they are thought to migrate into the 
tissues where they further differentiate to form tissue macro- 
phages (Blusse and van Furth, 1979). 
However, the generation of macrophages may be more com- 
plex than this. A number of studies have demonstrated that 
a small proportion of macrophages isolated from sites, in 
addition to the bone marrow, such as the peritoneal cavity, 
blood, lung, liver, thymus and lymph nodes are capable of 
generating colonies in vitro in the presence of colony stim- 
ulating factors (Lin, 1977; MacVittie and McCarthy, 1977; 
McCarthy and MacVittie, 1978; MacVittie and Provaznik, 1978; 
Chen et al., 1979). Unlike GM -CFC such cells can survive 
the initial absence of CSF, only proliferate in vitro after a 
delay of one to two weeks, and generate small colonies composed 
solely of macrophages (Metcalf, 1982). These macrophage colony 
forming cells (M -CFC) are more mature than bone marrow GM -CFC 
a 
in that they are already committed entirely to macrophage 
production. 
The quantitative significance of local proliferation in 
the generation of tissue macrophages in vivo is the subject of 
considerable debate (van Furth, 1981; De Bakker and Daems, 
1981). The percentage of macrophages which incorporate 
3H- thymidine in vivo varies from one tissue to another. For 
example, only approximately 5% of peritoneal macrophages incor- 
porate the label (van Furth, 1978), while in the lung, this 
figure may be as high as 20% (Lin et al., 1975; Chen and Lin, 
1982). Consequently, it seems likely that the extent to 
which local proliferation contributes to the macrophage pool 
will depend largely on which tissue is being examined. The 
nature and origin of these proliferating cells remains to be 
established although they are probably local M -CFC. 
The macrophages which accumulate at inflammatory sites 
are also derived mainly from blood monocytes (Bursuker et al., 
1982). However, depending on the nature of the inflammatory 
stimulus used, a variable proportion of such cells may prolif- 
erate in situ (Dienstman and Defendi, 1978). Nevertheless, 
it seems unlikely given the magnitude of the monocyte influx 
that local proliferation could contribute much numerically to 
the total macrophage content of inflammatory sites at least 
early in the response. 
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While certain macrophage characteristics are stably 
expressed during differentiation from bone marrow precursors, 
the expression of others depends upon differentiation stage 
and may vary in both a qualitative and quantitative manner. 
For example, during the differentiation of macrophages from 
bone marrow precursors in vitro, the expression of receptors for 
C3b, the ability to pinocytose horse radish peroxidase and lyso- 
zyme activity all increase (Goud and van Furth, 1975; Goud et al., 
1975). Similarly, Bursuker et al._ (1982) have suggested that 
the expression of the lysosomal enzyme(3- galactosidase may be 
used to determine macrophage differentiation stage. It seems 
that the enzyme activity increases during differentiation but 
unlike many other characteristics (e.g. C3b expression) 
F' 
-galactosidase levels are unaltered by various environmental 
stimuli (Bursuker et al., 1982). 
As they differentiate macrophages mayalso express different 
functional characteristics. For example, the cells exhibiting 
natural killer -like activity isolated from a Corynebacterium 
parvum - elicited peritoneal exudate or generated in vitro 
during bone marrow culture were identified as promonocytes 
while more mature cells did not perform this function (Lohmann- 
Matthes et al., 1981). 
Differentiation of monocytes into characteristic tissue 
macrophages in vivo or in vitro is accompanied by a considerable 
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increase in cell size (Lee, 1980). It is possible to exploit 
this fact to separate macrophages into functionally distinct 
subpopulations and thereby demonstrate a correlation between 
differentiation stage and functional capability (Lee et al., 
1979; Lee, 1980). For example, only small, presumably 
poorly differentiated, macrophages expressed Ia determinants 
and presented macrophage -bound antigen to primed T cells in 
an antigen- specific proliferation assay. It was proposed 
that as macrophages differentiate they lose Ia expression 
and accessory cell function (Lee et al., 1979; Lee, 1980). 
These findings suggest that as macrophages differentiate 
they may express a series of functionally distinct phenotypes. 
It is possible therefore that differences in macrophage diff- 
erentiation stage may contribute to interpopulation and intra- 
population heterogeneity. Within a particular macrophage 
population it is likely that some cells are poorly differen- 
tiated having just arrived from the blood stream while others 
may have been resident for some period of time. Inflammatory 
agents produce dramatic alterations in the functional character- 
istics of a macrophage population and it is possible that they 
do this in part by causing an influx of relatively immature 
cells into a site thereby altering the proportion of cells in 
different differentiation stages (Bursuker et al., 1982). 
Proliferation of immature exudate macrophages may further add 
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to the degree of heterogeneity. It has been reported that the 
expression of several cell surface components varies with the 
cell cycle (Bursuker and Goldman, 1982, 1983). The hetero- 
geneity of Fc receptor expression in the macrophage tumour 
cell line P388D1 and other cell lines may be due to cell 
cycle variation (Gandour and Walker, 1983). Neuman and 
Sorg (1981) have suggested that macrophages express distinct 
functions at different stages in the cell cycle and that 
proliferation may contribute to macrophage heterogeneity. 
2.3 Modulation 
The term "modulation" is used to describe those induced 
changes in macrophage morphology, biochemistry or function 
that result from continuous exposure to a particular signal; 
when the signal is removed the changes are reversed and the 
cell rapidly returns to a quiescent state, (Dougherty and 
McBride, 1984). 
Macrophages from different tissues differ considerably 
with respect to a large number of characteristics and modul- 
ation is assumed to be the major source of such interpopulation 
heterogeneity. The implication is that the cells entering 
different tissue sites are essentially identical and that all 
the events which lead to the generation of interpopulation 
heterogeneity occur entirely within a site as a result of 
exposure to modulating signals. For example, alveolar macro- 
1L 
phages function in a high oxygen environment, are largely 
aerobic and generate their energy by oxidative phosphory- 
lation, while peritoneal macrophages function in a low oxygen 
environment, are largely anaerobic and generate their energy 
by glycolysis. Consequently, the two populations differ in 
their expression of key enzymes of the oxidative phosphory- 
lation and glycolysis metabolic pathways (Oren et al., 1963; 
Karnovsky et al., 1970;- Simons et al., 1977). Bar -Eli et al. 
(1981) have shown that the progeny of single bone -marrow macro- 
phage precursors exhibit different metabolic enzyme profiles 
depending upon culture conditions. If cultured in a high 
oxygen environment they expressed the enzymes of oxidative 
phosphorylation and if cultured in a low oxygen environment 
they expressed the enzymes of glycolysis. These environment- 
ally induced changes were reversibly acquired and when cells 
adapted to low oxygen tension were exposed to high oxygen 
conditions there was a time dependent recovery in the expression 
of the enzymes of oxidative phosphorylation. 
In as much as enzyme expression is readily altered by the 
cellular environment it is a modulated characteristic. Many 
other aspects of interpopulation heterogeneity may be the 
result of environmental modulation. Macrophage Ia expression 
(Section 3.3) and activation status (Section 4.1) are two 
obvious examples. Although a feature of modulated changes is 
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that they are reversible, it is possible to imagine a situation 
where modulating signals exert such a profound effect on cell- 
ular physiology that some induced characteristics are more 
permanently acquired. 
In addition to the effect of continuous exposure to normal 
microenvironmental stimuli, the expression of a number of 
important macrophage characteristics may also be altered by 
non -microenvironmental stimuli. For example, the degree of 
macrophage heterogeneity which results from the administration 
of inflammatory stimuli could be explained in terms of the 
nature of the modulating signals generated and the responsive- 
ness of macrophage subpopulations to these signals. Macrophage 
responsiveness is likely to depend upon differentiation stage 
and previous exposure to modulating signals thereby generating 
heterogeneity. 
2.4 Sublineages 
The possible existence of true sublineages of macrophages 
derived from distinct bone marrow precursors provides an addit- 
ional level of complexity to the subject of macrophage hetero- 
geneity. These precursors may produce cells with a preferred 
tissue destination and functional capabilities, and stimuli 
such as those generated by inflammation may lead to the prefer- 
ential involvement of certain sublineages. 
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The evidence in support of the existence of distinct 
macrophage sublineages is not conclusive. However, it appears 
that macrophage precursor cells are inherently heterogeneous 
with respect to physical, biochemical and functional character- 
istics (Metcalf and McDonald, 1975; Byrne et al., 1977; Bol 
and Williams, 1980; Nicola et al., 1980). Moreover, colonies 
of macrophages clonogenically derived from individual bone marrow 
precursors may express different phenotypes. For example, 
Claesson and Olsson (1980) found that only selected colonies 
of mouse bone marrow -derived macrophages, expressed strong 
natural cytotoxicity for tumour targets. The authors did 
not however examine the differentiation stage of the cells in 
each colony. Previously, promonocytes have been identified 
as the cells responsible for natural cytotoxicity (Lohmann- 
Matthes, 1981) and in this connection it is interesting to 
note that colonies consisting exclusively of promonocytes have 
recently been described in cultures of mouse bone marrow 
(Buhles, 1979). 
Bursuker and Goldman (1982) have shown that in cultures 
of bone marrow from normal mice, macrophage clones exclusively 
express either high or low 5'- nucleotidase activity. The 
, 
expression of the ectoenzyme 5 -nucleotidase has proven a use- 
ful marker to distinguish resident and inflammatory peritoneal 
macrophages. The resident population express high 5'-nucleo- 
tidase activity whereas inflammatory macrophages express low 
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activity (Bursuker and Goldman, 1982, 1983). These results 
have been taken to suggest that resident and inflammatory 
macrophages may arise from distinct bone marrow precursors 
(Bursuker and Goldman, 1982). This conclusion was reinforced 
by the finding that in cultures of bone marrow from animals 
undergoing an inflammatory reaction, the percentage of macro- 
phage clones expressing low 51- nucleotidase activity was signi- 
ficantly increased (Bursuker and Goldman, 1983). In this 
instance, there appeared to be no major differences in the 
degree of differentiation between bone marrow -derived macro- 
phages from normal or inflammation bearing animals as determined 
by the expression of ß -galactosidase, although clonal expression 
of this enzyme was not similtaneously examined. 
Thus the progeny of individual macrophage precursors 
appear to retain certain distinctive characteristics during 
differentiation in vitro. Assuming that there is no internal 
regulation within a clone which results in collective expression 
of particular characteristics, then these experiments show the 
existence of distinct macrophage sublineages. The actual 
number of such sublineages remains to be determined, although 
it seems unnecessary to postulate that many will be found and 
heterogeneity is likely to be generated mainly by differentiation 
and /or modulation of one, or at the most, a few highly versatile 
macrophage lineages. 
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3.0 MACROPHAGES AND THE AFFERENT ARM OF THE IMMUNE RESPONSE 
The immune system is a complex collection of cells and 
soluble mediators capable of recognizing and rapidly respond- 
ing to challenge with a large number of different foreign 
molecular configurations (antigens) in one or more of a series 
of specific ways. However, an immune response does not result 
from a simple encounter between immunocompetent lymphocytes 
and antigen. On the contrary, both the nature and the magni- 
tude of the response generated following challenge with 
antigen depends upon a complex cascade of well controlled 
interactions involving many different cell types. The initial 
step in the reaction cascade leading to the generation of an 
effective immune response to most, if not all, antigens 
requires cooperation between immunocompetent helper T lympho- 
cytes (TH cells) and various non -lymphoid accessory cells 
(reviewed by Unanue 1972, 1981). Although our understanding 
of this interaction is far from complete, it is evident that 
the activation of populations of TH cells requires that access- 
ory cells "process" the antigenic material and "present" the 
appropriate epitopes to T cells in association with major 
histocompatibility complex (MHC) encoded class II glycoproteins 
(Ia antigens) (reviewed by Unanue, 1981; Unanue et al., 1984). 
Many diverse cell types have been shown to possess this 
accessory cell activity including macrophages (reviewed by 
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Unanue, 1981), Langerhans cells (Silberberg- Sinakin et al., 
1976; Stingl et al., 1978; Braathen and Thorsbay, 1980), 
dendritic cells (Nussenzweig et al., 1980; Steinman et al., 
1981; Britz et al., 1982; Miyazaki and Osawa, 1983), foll- 
icular dendritic cells (Klaus et al., 1980), veiled cells 
(Knight et al., 1982), interdigitating cells (Humphrey, 1981), 
B lymphocytes (L'Age -Stehr, 1981; Chesnut et al., 1982), 
endothelial cells (Hirschberg et al., 1980), and neutrophils 
(Okuda et al., 1980). The functional cells always expressed 
Ia determinants and their activity was generally held to be 
MHC restricted. What is not clear at present, is whether all 
these different accessory cells present antigen in the same 
way and stimulate the same type of response. In this conn- 
ection it is interesting to note that Ramila et al. (1983) 
have recently reported that while Ia- positive tumour cell 
lines and peritoneal exudate cells were both able to induce 
MHC- restricted antigen- specific T cell proliferation, only 
the peritoneal cells were able to induce functional antigen - 
specific TH cells. Furthermore, the type of Ia molecules 
expressed by the accessory cell may be important. Thus while 
presentation of antigen by an I -A positive accessory cell seems 
to be critical for TH cell activation (reviewed by Unanue, 1981), 
recent data has suggested that I -J positive accessory cells 
are required for the activation of antigen- specific T suppressor 
cells (Ts cells) (Gershon, 1974; Minami et al., 1982; Zembala 
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et al., 1982; Lowy et al., 1983, 1984). It is likely 
therefore that in mixed cell cultures antigen presentation 
may be carried out by more than one cell type (Miyazaki and 
Osawa, 1983) and the overall response generated may depend 
to some extent on the number of different antigen presenting 
cells that are present. 
Although antigen presentation represents the initial 
step in the generation of an effective immune response, the 
subsequent clonal expansion and differentiation of immuno- 
competent lymphocytes requires the involvement of various 
lymphostimulatory factors (reviewed by Howie and McBride, 
1982a)and expression of this function probably varies between 
different accessory cell populations (Miyazaki and Osawa, 1983). 
In addition, although Ia- negative cells cannot present antigen, 
they may nevertheless secrete lymphostimulatory factors 
(Lipsky and Kettman, 1982) and may thus significantly contri- 
bute to the generation of an immune response. 
3.1 Antigen processing by macrophages 
When antigen enters a lymphoid tissue it is taken up by 
macrophages lining the sinuses or dispersed among the lymphoid 
elements. Many studies have demonstrated that antigen 
associated with macrophages plays a key role in the initiation 
of the immune response by lymphoid cells (reviewed by Unanue 
19 
1972, 1981). Most of the antigen internalized by macrophages 
is rapidly catabolised, but a small percentage (10 -20 %) is 
broken down more slowly (Unanue and Askonas, 1968) being 
retained either as a component of the macrophage surface 
(Unanue and Cerrottini,1970) or in an internal pool (Ellner 
and Rosenthal, 1975). Some antigenic components may be 
released from the macrophage as soluble products (Schmidtke 
and Unanue, 1971; Cruchaud et al., 1975). 
For most antigens, a processing step is required before 
TH cells can recognised and respond to them. For example, 
the proliferation of primed T lymphocytes in response to 
Listeria monocytogenes requires that macrophages bind and 
internalize the bacteria, and process the antigen in an acid 
vesicle (Ziegler and Unanue, 1981, 1982). Interference with 
any of these steps blocks presentation. A similar obligitory 
antigen processing step has been described for soluble Listeria 
polypeptides as well as other well- defined proteins (Chesnut 
et al., 1982; Lee et al., 1982). It should be noted however 
that transfer of antigen from one cell to another may occur 
(Ellner et al., 1977) suggesting that processing and presentation 
need not necessarily be carried out by the same cell. In this 
connection,Shimonokevitz et al. (1983) have reported that a 
small tryptic peptide from ovalbumin can be presented by fixed 
macrophages. Thus once a protein is fragmented it is apparently 
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in a form which is able to interact with membrane structures 
on a presenting cell in such a way as to be recognised by 
the T cell. 
The question of which epitopes are displayed by antigen 
presenting cells is an'important one with respect to T and B 
cell repertoires. It has been suggested that T cell reactivity 
can be directed against-the primary sequence of partially 
digested or unfolded proteins while B cells can recognize 
only native confirmational antigenic determinants (Sela, 1969). 
Although this phenomenon requires further examination it is 
possible that such differences in functional T and B cell 
repertoires could in part be a reflection of the form in 
which antigen is presented to the different lymphocyte 
populations. 
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3.2. Antigen presentation by macrophages 
Many early studies indicated the highly immunogenic nature 
of macrophage- associated antigen in vivo and suggested a 
requirement for adherent phagocytic cells in order to generate 
immune responses in vitro (reviewed by Unanue, 1972). However, 
the essential nature of macrophage antigen presentation was 
not fully appreciated until the discovery of the restriction 
imposed on cellular interactions by products of the MHC. 
The first observations on the histocompatibility require- 
ments of macrophage -T lymphocyte interactions were published 
by Alan Rosenthal and Ethan Shevach in 1973 (Rosenthal and 
Shevach, 1973; Shevach and Rosenthal, 1973). Making use of 
two inbred strains of guinea pig which differed at MHC loci, 
strains 2 and 13, they investigated the ability of antigen - 
pulsed macrophages from one strain to stimulate the prolifer- 
ation of antigen -primed T lymphocytes from the other strain. 
It was found that antigen -induced T cell proliferation was only 
obtained when the macrophages and T cells came from the same 
strain. If the macrophages and lymphocytes came from diff- 
erent strains then no proliferation was seen above the control 
values obtained using macrophages that were not pulsed with 
antigen. The possibility that the lack of responsiveness 
found with allogeneic combinations of T cells and macrophages 
was the result of a suppressor effect was ruled out by the 
finding that T cells from an F1 cross ((2x13)F1) could respond 
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perfectly well to antigen in the context of either strain 
2 or strain 13 macrophages. It was concluded from these 
results that identity at MHC loci was required for effective 
macrophage -T lymphocyte interaction in the generation of a 
proliferative response. Subsequent studies indicated that 
the major differences between the MHC of strain 2 and strain 
13 guinea pigs were found within the I- region (Geczy et al., 
1975; Schwartz et aí.,.1976), suggesting that the MHC genes 
restricting macrophage T cell interaction also lie within 
this region. This conclusion is strongly supported by the 
finding that macrophages and T cells from outbred guinea pigs 
could only interact if the two populations were histocom- 
patible at the I- region (Shevach, 1976). 
These initial findings in the guinea pig have been 
confirmed and extended in a wide variety of species including 
man. In murine systems, the availability of genetically well 
defined congenic mouse strains with intra -H -2 recombinations 
has enabled the loci controlling macrophage -T cell interactions 
to be mapped more precisely. For most antigens the histo- 
compatability requirement mapped to the I -A subregion (Yano 
et al., 1977, 1978; Schwartz et al., 1978), although macro- 
phages and T cells having only I -E /C identity were capable 
of generating proliferative responses to some antigens (Richman 
et al., 1980), while for other antigens, the responding T cells 
and macrophages were required to share both I -A and I -E /C 
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subregion homology (Rosenwasser and Rosenthal, 1979; Schwartz 
et al., 1979). 
The requirement for I- region identity between T cells 
and antigen pulsed macrophages does not only apply to pro- 
liferative responses. Transfer of delayed type hypersensitivity 
(DTH) by antigen -primed T cells required that recipient and 
donor share I -A subregion homology, presumably reflecting a 
requirement for antigen presentation at the site of antigenic 
challenge in order to restimulate the primed T cells (Miller 
et al., 1977; Vadas et al., 1977; Smith et al., 1979). Erb 
and Feldmann (1975a) found that the induction of TH cells 
for antibody formation required that the antigen pulsed 
macrophages and T cells were histocompatible at I -A. Inter- 
estingly, TH and B cells also had to share I -A subregion 
identity for successful co- operation (Katz and Benacerraf, 
1975; Sprent, 1978a). The interaction of T cells with 
antigen on macrophages and on specific B cells may thus be 
identical or very similar. Finally, in some experimental 
systems TS cell responses have been shown to be MHC restricted. 
When observed such restrictions map either to the I -J sub- 
region (Tada et al., 1977) or to H -2D (Miller et al., 1978). 
Several theories have been put forward in an attempt 
to explain MHC restriction. Early models envisaged a like - 
like form of interaction in which identical MHC- encoded 
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molecules on the surface of a macrophage and a T cell became 
physically associated (reviewed by Schwartz, 1984). Respond- 
ing T cells were proposed to have an antigen receptor which 
imparted specificity. Presumably both molecular interactions 
had to occur at the same time in order to stimulate the T cell 
to respond. However, several lines of evidence argue against 
the like -like interaction model and suggest instead that MHC 
restriction is an inherent property of T cell recognition of 
specific MHC determinants on the surface of an antigen pre- 
senting cell. For example, although T cell proliferation 
was effectively inhibited by pretreatment of antigen -pulsed 
macrophages with antisera or monoclonal antibodies directed 
against Ia determinants, preincubation of T cells with anti - 
la antibodies had no effect (Schwartz et al., 1978; Thomas 
et al., 1978; Lerner et al., 1980). This finding is con- 
sistent with the observation that in some species, notably 
the mouse, the responding T cells did not bare detectable Ia 
molecules (reviewed by Unanue, 1981). Using a different 
approach, studies on F1 hybrids between two histoincompatible 
stains have shown that these animals contain two populations 
of primed T cells both of which respond to the same antigen 
although each does so only in the context of one set of 
parental class II antigens and not the other (Miller et al., 
1976; Paul et al., 1977; Sprent, 1978b). Since I- region 
genes are co- dominantly expressed it is clear that if a like - 
like interaction occurred then it would have been expected 
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that F1 T cells primed against an antigen in the context of 
one parental class II antigen would be able to respond to 
the same antigen if presented in the context of the other 
parental class II antigen. The possibility that a suppressor 
mechanism may account for these results has recently been 
ruled out by the isolation of T cell clones from F1 animals 
which respond to antigen only if it is presented by macro- 
phages from one parental strain and not the other (Sredni 
and Schwartz, 1981). Since these clones have been purified 
away from other T cells, particular TS cells, it appears no 
longer possible to attribute MHC restriction of the macrophage - 
T cell interaction to any type of suppressor cell effect. 
The conclusion that may be drawn from these results is 
that an explanation of MHC restriction by a like -like inter- 
action model is untenable. Instead the T cell must possess 
a different molecule, presumably a recognition structure 
which is complementary to the Ia molecule expressed on the 
macrophage surface. 
The potent inhibitory effect of anti -Ia antibodies on 
T cell responses contrasts sharply with the lack of inhibition 
usually produced by antibodies against native antigen (Ellner 
and Rosenthal, 1975; Ben -Sasson et al., 1977; Thomas and 
Shevach, 1978; Lerner et al., 1980). However, recently 
Lamb et al. (1984) reinvestigated the effect of anti -antigen 
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antibodies on presentation using human TH cell clones recog- 
nizing a 24 amino acid synthetic peptide (termed p20) derived 
from the influenza haemagglutinin -1 molecule. In this highly 
refined system, it was found that antibodies raised against 
p20 could inhibit the proliferative response of the T cell 
clones. Inhibition was possible either by treating antigen -pulsed 
macrophages with antibody prior to using them to stimulate the 
cloned T cells or by coculturing p20 antigen and antibody to 
p20 with cloned T cells and macrophages. Berkower et al. 
(1983) using a similar experimental system found that the 
response of T cell clones to sperm whale myoglobin_ was 
inhibited by monoclonal antibody directed against the epitope 
recognised by the T cell clone. 
The reason why these studies succeeded in demonstrating 
inhibition of T cell responses by antibody against native 
antigen while so many previous attempts had failed is unknown, 
although the answer probably lies in the use of cloned T cells, 
small well- defined antigens and high titre monoclonal antibodies 
known to react with an antigenic determinant identical or very 
near that recognized by the T cells. Whatever the case may 
be, it would nevertheless seem that in addition to Ia, T cells 
also recognize antigenic determinants on the surface of a 
presenting cell. What then is the nature of the association 
between Ia and antigen? 
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Several studies have suggested that a direct physical 
association between antigen and Ia molecules is required for 
antigen presentation. Rock and Benacerraf (1983a,b) found 
that the presentation of the antigenic copolymer L- glutamic 
acid -L- alanine -L- tyrosine (GAT) could be competitively in- 
hibited by the structurally related copolyer L- glutamic acid - 
L- tyrosine (GT). This affect was strongly influenced by the 
MHC allele of the presenting cell. Thus presentation of GAT 
by a cell expressing I -Ad was effectively blocked by GT while 
presentation by a cell expressing I -Ab was not. The con- 
clusion drawn from these studies was that antigen physically 
associates with Ia determinants on the surface of a present- 
ing cell. The GAT association site on I -Ad cells may be 
blocked by GT while the similar site on I -Ab can not. 
Recently, further studies were undertaken in order to 
more directly test this model of antigen presentation (Rock 
and Benacerraf, 1984). It was argued that the ability of 
GT to inhibit presentation of GAT by I -Ad cells but not by 
I -Ab cells suggests that the GAT association site on these 
two cells may differ and as a result it should be possible 
to generate alloreactive H -2b clones which recognize the 
pututive GT /GAT interaction site on I -Ad. T cell hybridomas 
were derived from B10 (H -2b) T cells stimulated, in a primary 
mixed lymphocyte culture (MLC) with BALB /c (H -2d) stimulators 
and screened for IL -2 production in response to BALB /c cells. 
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Alloreactive T cell hybrids were identified, which as expected, 
demonstrated a clonal specificity for I -Ad or I -Ed. The 
response of these hybrids to I -Ad- bearing stimulator cells 
was tested in the presence or absence of antigen. It was 
predicted that if antigen associated with Ia, the response 
of the T cell hybrids would be inhibited either as a result 
of determinant blocking or some other focal change in Ia 
structure (e.g. conformational change). This was indeed 
the result which was obtained. A small percentage of the 
alloreactive T cell clones were inhibited in a dose dependent 
fashion if the stimulator cells were pulsed with GAT. More- 
over, there was a close correlation between the selective 
loss of allostimulatory activity and the ability of these 
cells to present GAT. Similar results were obtained using 
GT which specifically competes with GAT for presentation in 
association with I -Ad. 
The most likely interpretation of these findings is 
that macrophages present a complex of antigenic determinants 
and Ia to T cells for the generation of an effective immune 
response. Several other observations substantiate this 
general conclusion. For example, Erb and Feldmann (1975b) 
have described a factor containing both Ia and antigen that 
was released from antigen -pulsed macrophages and was able to tri- 
gger antigen- specific T cells. More recently, Puri and Lonai 
(1980) implicated a similar factor in the activation of TH cells. 
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3.3 Regulation of macrophage la expression 
Since T cells recognize antigen only in conjunction with 
Ia it follows that the regulation of Ia expression on the 
antigen presenting cell may well be a critical step in the 
control of immune responsiveness. Indeed, Beller (1984) 
demonstrated a stoichiometric relationship between macrophage 
Ia expression and accessory cell activity. A similar corre- 
lation was found using splenic accessory cells with genetically 
determined quantitative differences in Ia expression (Matis 
et al., 1982). 
The percentage of macrophages expressing Ia determinants 
varies from tissue to tissue, although in the absence of 
external stimuli, the figure for a given tissue is remarkably 
constant, (reviewed by Unanue, 1981). The regulatory mech- 
anisms that determine this basal level of macrophage Ia express- 
ion are not clear. Signals from mature T cells or microbial 
stimulation are probably not involved, since the same percent- 
age of Ia positive cells are found in the tissues of athymic 
(Lu et al., 1981) and pathogen free mice (Unanue et al., 1984). 
However, it is evident that Ia is associated mainly with young 
recently emigrated macrophages and unlike the expression of 
MHC class I molecules, the expression of Ia is a transient 
event (Beller and Unanue, 1981). Studies on Ia expression 
by peritoneal macrophages revealed a progressive loss with 
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time in culture so that by 72 hours most of the cells no longer 
expressed Ia (Beller and Unanue, 1980). Such a decrease could 
not be accounted for by selective loss of macrophages from the 
culture dish. Similarly, in vivo whole body X- irradiation 
resulted in a rapid decrease in the percentage of peritoneal 
macrophages which expressed Ia (Beller and Unanue, 1981). 
The kinetics of this loss was very similar to that found in 
culture and could not be attributed to the selective disappear- 
ance of a subset of macrophages from the peritoneal cavity. 
Presumably, irradiation prevents the generation of macrophage 
precursors in the bone marrow and as macrophages in the tissue 
gradually loose Ia expression the number of Ia positive cells 
is no longer maintained by an influx of young cells. 
Macrophage. Ia expression is also under both positive and 
negative regulatory control. For instance the phagocytosis 
of latex beads, killed Listeria monocytogenes organisms, opson- 
ized erythrocytes or soluble antigen- antibody complexes caused 
Ia- positive macrophages to synthesize new Ia determinants and pre- 
vented the subsequent loss of the antigen during culture 
(Beller and Unanue, 1980). Interestingly, only cells which 
were already Ia- positive could be stimulated to synthesize Ia 
by particle uptake. If macrophages expressing Ia were elimin- 
ated with antibody and complement the remaining Ia- negative 
cells did not synthesize Ia even after particle phagocytosis. 
In contrast, immature Ia- negative macrophages could be induced 
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to express la by exposure to lymphokines in vitro (Steeg 
et al., 1980; Steinman et al., 1980; Beller and Ho, 1982) 
or in vivo (Scher et al., 1980, 1982). The production by 
T cells of lymphokines that induce macrophage Ia expression 
takes place after activation by antigen- bearing Ia- positive macro- 
phages (Scher et al., 1980) and is a clear example of the funct- 
ional interdependence of two populations of cells. There 
is convincing evidence that 0 -interferon has Ia- inducing 
activity (Steeg et al.,1982; King and Jones, 1983; Beller, 
1984) but whether this is the only lymphokine with this 
activity remains to be determined. 
Macrophage Ia expression can also be actively down 
regulated by a number of inhibitory factors including prosta- 
glandins (Snyder et al., 1982) and a( -fetoprotein (Lu et al., 
1984). Thus the expression of la by macrophages in normal 
tissues may be controlled by local inhibitory factors. It 
is interesting to note that i.p. injection of indomethacin 
produced a considerable increase in the percentage of Ia- 
positive peritoneal macrophages (Snyder et al., 1982) suggest- 
ing the involvement of prostaglandin.s in the control of la 
expression by these cells in vivo. 
3.4 Differentiation and clonal expansion of TH cells 
The interaction of TH cells with antigen presented in 
conjunction with Ia determinants represents the initiating event 
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in T cell activation. However, the subsequent development 
of functional activity requires the involvement of various 
lymphostimulatory factors, produced by appropriately stimulated 
macrophages and lymphocytes, which induce clonal expansion and 
differentiation of the responding cells (reviewed by Howie and 
McBride, 1982a). 
The best studied macrophage- derived lymphostimulatory 
factor is interleukin 1 (IL -1) (reviewed by Oppenheim and 
Gery, 1982). Resting macrophages secrete only small and 
variable amounts of IL -1 but this basal level of secretion 
may be rapidly increased following interaction with a wide 
variety of different stimuli (Calderon et al., 1975; Unanue 
al., 1976). A particularly relevant stimulus is provided 
by immune T cells upon interaction with macrophage -bound antigen. 
The secretion of IL -1 required not only the presence of Ia- 
bearing macrophages but also that the macrophages and T cells 
share the same I -A region (Farr et al., 1977, 1979; Ziegler 
and Unanue, 1980). These results suggest that the presentation 
of antigen to T cells generates a signal which stimulates 
macrophages to secrete IL -1. Interestingly however, addition 
of lymphokine- containing medium to macrophages resulted in 
relatively weak stimulation of IL -1 secretion (Farr et al., 
1979). Thus if the signal which induces macrophage IL -1 
secretion is a T cell- derived factor it must be rather unstable 
compared with other lymphokines or perhaps cell -cell contact 
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is required. 
IL -1 is likely to play a central role in maintaining the 
proliferative response of TH cells to antigen. It should be 
noted however, that lymphocyte clonal expansion and differ- 
entiation are the end result of a complex network of inter- 
actions involving various populations of cells and the soluble 
mediators they produce. For example, one important effect 
of IL -1 is to induce Lyt 1+2-3- T cells to produce another 
major mediator known as interleukin 2 (IL -2) (reviewed by 
Howie and McBride, 1982a). IL -2 for its part causes continued 
proliferation of antigen- or mitogen- activated T cells 
(reviewed by Fathman et al., 1981). Responding T cells appear 
only to gain receptors for IL -1 and IL -2 following activation 
by antigen presented in conjunction with self Ia determinants 
(Smith and Ruscetti, 1981), once again emphasizing the central 
involvement of antigen presenting cells in initiating and 
maintaining T cell clonal expansion and differentiation. 
Although IL -1 has been most studied in the context of 
its lymphostimulatory activity, it is evident that a similar, 
if not identical, factor may be involved in the stimulation 
of connective tissue cell proliferation (reviewed by Whicher 
and Chambers, 1984) induction of fever (Dinarello et al., 1974, 
1982), stimulation of proteinase and prostaglandin production 
by connective tissue cells (Dayer et al., 1981), stimulation 
of the production of acute phase proteins (Wannenmacher et al., 
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1975), bone resorption in vitro (Gowen et al., 1983), B cell 
activation (Wood and Gaul, 1974) and the induction of neutro- 
philia (Merriman et al., 1977). Several of these functions 
may be important in the development and maintainance of 
chronic inflammatory lesions (reviewed by Whicher and Chambers, 
1984). In this connection it is interesting to note that 
both putative antigen presenting cells and T cells with the 
helper phenotype have been identified within various chronic 
inflammatory lesions (reviewed by Poulter, 1983) suggesting 
a role for these cells in the pathogenesis of such disease 
states. 
3.5 Role of accessory cells in the generation of 
anti -tumour immune responses 
Considering the vast amount of data that has been 
collected on accessory cell function it is perhaps rather 
surprising that so few of these studies examined the role of 
accessory cells in the generation of anti - tumour immune 
responses. Many factors contribute to the lack of progress 
in this area, not least of all the considerable difficulties 
associated with detecting specific immune responses to weak 
cellular antigens whose physiochemical nature is largely 
unknown and which may be unique to individual tumours. More- 
over, there is a lack of simple, reproducible in vitro assay 
systems that are amenable to the manipulations necessary to 
enable to various cellular interactions involved in the 
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generation of anti -tumour immunity to be adequately studied. 
However, the few reports that are available do suggest a role 
for accessory cells in the immune response to tumour antigens. 
In vivo, administration of microlitre quantities of 
anti -I -A antisera has been found to produce a marked enhance- 
ment of tumour growth in tumour -immune mice rechallenged with 
viable tumour cells (Perry et al., 1978). Studies in the 
ABA hapten system suggest that the primary effect of anti - 
I-A in vivo, may be at the level of the antigen presenting 
cell (Perry et al., 1980; Lowy et al., 1984). On the basis 
of this data, it seems likely that antigen presentation by 
I- A- positive accessory cells plays an important role in the 
development of anti -tumour responses in vivo. Supporting 
evidence comes from the finding that spleen cells removed 
from anti -I -A treated tumour -bearing mice contain a popul- 
ation of Ts cells which can suppress the anti -tumour immune 
response upon adoptive transfer (Perry et al., 1978). It 
is evident in other systems that the depletion of I- A- positive 
accessory cells can lead to the generation of antigen -specific 
Ts cells (Lowy et al., 1983, 1984). 
Several early studies noted that populations of lymphoid 
cells cultured in vitro with allogeneic or xenogeneic fibro- 
blasts (Ginsberg, 1970), allogeneic lymphocytes (Hayry and 
Defendi, 1970) or allogeneic or syngeneic tumour cells 
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(Ilfeld et al., 1973; Sharma and Terasaki, 1974; Small and 
Trainin, 1975) underwent a blastogenic response and acquired 
specific cytotoxic activity which could be readily demon- 
strated in vitro using the appropriate target cell. The 
cellular interactions involved in this response were not 
generally studied although Lonai and Feldmann(1971) did 
demonstrate that macrophages were required for the in vitro 
generation of cytotoxic lymphocytes against xenogeneic fibro- 
blasts. 
A role for macrophages in the in vitro generation of 
cytotoxic lymphocytes against syngeneic tumour cells was 
suggested by the studies of Treves et al. (1976). They 
observed that thioglycollate- elicited peritoneal macrophages 
pulsed with a cell -free preparation of syngeneic tumour could 
sensitize syngeneic spleen cells against the tumour. The 
effector cells were non -adherent to nylon wool, prevented 
tumour cell targets synthesizing DNA in vitro and inhibited 
tumour growth in vivo, most likely reflecting the presence of 
cytotoxic T cells. This cytotoxic response was generated by 
antigen -pulsed syngeneic macrophages but not allogeneic macro- 
phages, fibroblasts or the antigen preparation by itself. 
The most likely interpretation of these studies is that 
macrophages can present tumour antigen for the primary gener- 
ation of cytotoxic T cells. 
A large number of studies have confirmed the requirement 
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for accessory cells in the generation of cytotoxic T cells 
not only against tumours but also against virally infected 
cells and modified autologous cells (Wagner et al., 1972; 
Koren and Hodes, 1977; Woodward and Daynes, 1979; Woodward 
et al., 1979; Friedman et al., 1979; Taniyama and Holden, 
1979; Yamashita and Hamaoka, 1979; Pettinelli et al., 1980). 
However, the exact role of macrophages in this response, 
whether presenting antigen or merely supplying stimulatory 
factors, is by no means clear. Some reports demonstrated 
that the generation of primary cytotoxic T cells to tumour 
cells or allogeneic cells required the presence of Ia- positive 
macrophages although it did not seem to matter whether these 
were syngeneic or allogeneic to the responding lymphocytes 
(Yamashita and Hamaoka, 1979; Pettinelli et al., 1980). 
Similarly, although the in vitro generation of cytotoxic 
activity by T cells obtained from the lymph nodes draining 
a tumour mass required the presence of Ia- positive accessory 
cells the response did not need the addition of tumour antigen 
(Woodward and Daynes, 1979; Woodward et al., 1979). However, 
there has been at least one report which demonstrates an 
absolute requirement for syngeneic macrophages in the gener- 
ation of cytotoxic T cells to syngeneic tumours (Taniyama 
and Holden, 1979). Together these results emphasize that 
the part played by macrophages and other accessory cells in 
this complex response is still far from clear. 
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3.6 Macrophage suppressor cell activity 
Macrophages, particularly at high cell number, can exert 
potent inhibitory effects on various immune functions, including 
lymphocyte proliferation, the generation of cytotoxic T- lympho- 
cytes, antibody responses, lymphokine production and NK cell 
activity (reviewed by Varesio, 1983). Both unstimulated 
macrophages (Fernbach et al., 1976; Baird and Kaplan, 1977a,b; 
Varesio et al., 1979a; Forni et al., 1979) and cells activated 
in vivo (Kirchner et al., 1975a; Kirchner, 1978; Yung 
and Cudkowicz, 1978; Farr et al., 1979; Mehra et al., 1979; 
Riglar and Cheers, 1980) or in vitro (Taramelli and Varesio, 
1981) may possess this function and it has been suggested that 
this phenomenon represents a physiological mechanism that 
contributes to the homeostatic control of the immune system 
(Varesio et al., 1979b; Varesio and Holden, 19802; Herberman 
et al., 1980). 
Of particular interest are studies demonstrating the 
presence of suppressor macrophages in various tissues of 
tumour -bearing animals. Adler et al. (1971) observed a 
decrease in the induced proliferative response of spleen cells 
from mice bearing primary methylcholanthrene -induced tumours. 
Following tumour excision, the proliferative capability returned 
to normal levels. Gillette and Boone (1973, 1975) reported 
a similar decrease in the mitogenic response to PHA in mice 
bearing a variety of histologically distinct tumours. This 
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phenomenon was investigated further by Kirchner et al. (1974a,b) 
using spontaneously regressing Moloney murine sarcoma virus 
(MSV)- induced tumours. They found that the proliferative 
response to both ConA and PHA was normal during the early 
stages of tumour development, was maximally depressed at 
peak tumour size and rapidly returned to normal levels after 
tumour regression (Kirchner et al., 1974b; Weiland and 
Mussgay, 1977). Passage of hyporesponsive spleen cells over 
a rayon wool column or depletion of phagocytic cells by 
carbonyl iron treatment, completely restored responsiveness 
to PHA (Kirchner et al., 1974a,b, 1975a,b,). These results 
suggest that adherent and phagocytic spleen cells were 
responsible for the observed suppression and demonstrated that 
lymphocytes able to respond to the mitogens were present in 
the spleens of tumour -bearing animals. Additional evidence 
for the existence of suppressor cells was obtained in studies 
which showed that addition of spleen cells from tumour -bearing 
animals reduced the mitogen induced proliferative response of 
normal spleen cells. This inhibitory activity could be 
abrogated by removal of adherent, phagocytic and carrageenan- 
sensitive cells, but was unaffected by treatment with anti - 
Thyl or anti -Ig and complement and was not sensitive to X- 
irradiation, suggesting the involvement of a macrophage -like 
cell (Kirchner et al., 1974a, 1975a). 
Suppressor macrophages have also been identified in the 
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spleens of mice bearing methylcholanthrene- induced tumours 
(Pope et al., 1976; Whitney et al., 1978) and spontaneous 
tumours (Whitney et al., 1978; Forni et al., 1979; Varesio 
et al., 1979a). 
Much evidence in recent years has indicated that supp- 
ressor macrophages are also generated during human malignant 
disease. Peripheral blood leukocytes (PBL) from cancer patients 
frequently exhibit a decreased antigen- or mitogen- induced 
proliferative response (reviewed by Varesio, 1983). The 
study of Blomgren et al. (1976) was one of the first to 
suggest a role for suppressor macrophages in this phenomenon. 
They found that a considerable proportion of patients with 
cancer of the breast had a decreased lymphoproliferative 
response to PPD. However, following macrophage depletion 
the response generated returned to near normal levels. 
Berlinger et al. (1976) demonstrated that passage of 
PBL over a Sephadex G10- column, a process known to deplete 
macrophages restored the depressed proliferative response of 
these cells in mixed lymphocyte cultures (Berlinger et al., 
1976). Similar results were obtained by Berlinger and Good 
(1980) in a study of colon cancer patients. 
Zembala et al. (1977) found that PBL from 15 out of 27 
patients with advanced carcinomas of the lung or gastrointestinal 
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tract exhibited hyporesponsiveness to Con A or PHA. Adherent 
cells from such patients were usually able to exert suppressive 
activity on normal spleen cells, indicating the involvement of 
suppressor macrophages. However, in a few patients, T cells 
but not macrophages were shown to be responsible for the 
suppression. Similar results were obtained by Jerrells et 
al. (1978). Among 38 lung cancer patients, 15 had demon- 
strable suppressor cells. In experiments to characterize the 
nature of the suppressor cells, 5 out of 8 lung cancer patients 
were found to have adherent suppressor cells and the rest had 
nonadherent suppressor cells. 
The effectiveness of suppressor macrophages in vivo 
remains the subject of considerable debate (reviewed by 
Varesio, 1983). Anaclerio et al. (1978) showed that spleen 
cells from mice bearing Lewis lung carcinoma had a depressed 
proliferative response to PHA and LPS and that this finding 
was attributable to the presence of suppressor macrophages. 
When spleen cells from tumour -bearing animals were mixed with 
normal spleen cells and injected into the footpad of allo- 
geneic mice, a depression of the resultant graft- versus -host 
reaction was observed, suggesting that the suppressor macro- 
phages were also functional in vivo. Moreoever, depletion of 
phagocytic cells by carbonyl iron treatment abrogated the 
depression of the in vivo response. In contrast, Forni et al. 
(1982) found that mice bearing a transplanted spontaneous 
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adenocarcinoma rejected allogeneic mastocytoma cells as well 
as normal mice. The rejection of the allograft in both 
normal and tumour -bearing animals was T cell dependent. 
However, this T cell function was clearly unaffected despite 
the presence of suppressor macrophages in the tumour -bearer 
which were capable of inhibiting in vitro lymphoproliferative 
responses and lymphokine production (Forni et al., 1979; 
Varesio et al., 1979a). 
Although this very limited data does not rule out an 
important role for suppressor macrophages in vivo, it seems 
unlikely that they induce a generalized anergy and their effects 
are probably much more restricted. It is possible that such 
cells exert their suppressive activity only when they are in 
close contact with responding lymphocytes. This situation 
is of course selected for in vitro studies. However, supp- 
ressor macrophages are not evenly distributed throughout tumour - 
bearing animals, e.g. they may be present in the spleen but 
absent from the lymph nodes (Gillette and Boone, 1975; Oehler 
et al., 1978) and it is therefore possible that only a limited 
number of lymphocytes will come into contact with suppressor 
macrophages in vivo. 
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4.0 ROLE OF MACROPHAGES IN THE EFFERENT ARM OF THE IMMUNE 
RESPONSE 
4.1 Macrophage activation 
Normal macrophages can phagocytose and kill pyogenic 
bacteria such as Staphyloccus aureus and Escherichia coli 
(van Zwet et al., 1975). There are however a number of 
diverse microbial pathogens that can survive inside normal 
macrophages and eventually kill them through unrestricted 
intracellular multiplication. Such organisms include the 
bacteria Brucella, Listeria, Mycobacteria and Salmonella 
(Mackaness, 1962, 1964, 1970), and the protozoa Leishmania 
(Farah et al., 1975; Behin et al., 1975), Toxoplasma 
(Remington et al., 1972) and Trypanosoma (Nogueira et al., 
1977). Recently it was shown that the causative organism 
of Legionnaires disease, Legionella pneumophila could also 
survive and multiply inside normal macrophages (Nathan et al., 
1980). Animals can however acquire impressive levels of 
immunity to infection with these intracellular parasites 
(Cohn, 1978). Such immunity was found not to be passively 
transferable by serum (Miki and Mackaness, 1964), but was 
related to the development of an enhanced microbicidal 
activity by the host macrophages (Mackaness, 1962, 1964). 
The term "activated macrophage" was introduced by Mackaness 
(1962) for the purpose of describing the intrinsic adaptive 
changes that enable macrophages to express enhanced anti- 
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microbial resistance. However, it is now evident that 
activated macrophages obtained from animals with acquired 
immunity to infection with intracellular parasites not only 
show enhanced antimicrobial activity against the infecting 
organism but are also able to non- specifically kill anti - 
genically unrelated organisms (Mackaness, 1970), virally 
infected cells (Rodda and White, 1976) and transformed cells 
(Alexander and Evans, 1971). 
Inflammatory stimuli induce dramatic changes in the 
morphological, biochemical and functional characteristics 
of macrophage populations. The response generated depends 
upon the nature of the inflammatory stimulus used. Some 
workers refer to these macrophages as "activated" (Cohn, 1978; 
Karnovsky and Lazdins, 1978), while others restrict the use 
of this term to describe cells with a proven ability to kill 
facultative intracellular parasites or cause extracellular 
lysis of tumour cells, preferring to use the terms "primed ", 
"stimulated" or "angry" to refer to other states of altered 
activity (reviewed by Ogmundsdottir and Weir, 1980). 
It is clear that within a population of macrophages 
elicited by inflammatory stimuli, not all macrophages are 
activated in the strict sense of having acquired the ability 
to kill intracellular parasites or tumour cells (Hibbs, 1974a; 
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Hibbs et al., 1977). Furthermore, different subpopulations 
may be described as "activated" depending upon which function 
is measured and how it is measured. For example, populations 
of cells with the ability to kill tumour targets can be 
physically separated from cells with enhanced bactericidal 
activity (Wing et al., 1977). 
It is likely that there is more than one pathway which 
leads to macrophage "activation ". Some agents e.g. lipopoly- 
saccharide (LPS), pyran copolymer, poly I:C and certain lympho- 
kines can "activate" populations of resident peritoneal cells 
in vitro to a state where they can kill tumour cell targets 
(Weinberg et al., 1978; Ogmundsdottir and Weir, 1980; Sone 
and Fidler, 1980; Taramelli and Varesio, 1981). These agents 
can act directly on macrophages and the process does not have 
to involve other cell types or their products. Macrophage 
"activation" in vivo may be more complex. Inflammatory 
stimuli induce an influx of poorly differentiated cells from 
the blood such that recently arrived cells quickly make up 
the majority of cells in a tissue site (Bursuker et al., 1982). 
In addition, the activating signals may be distinct from the 
eliciting agent and produced as the result of its interaction 
with host -elements, particularly lymphocytes and the comple- 
ment system (reviewed by Ogmundsdottir and Weir, 1980). 
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Observations in several experimental systems suggest that 
activation of macrophages in vivo to a level where they can 
non -specifically kill tumour targets may occur via a sequential 
series of reactions (Hibbs et al., 1977; Russell et al., 
1977; Ruco and Meltzer, 1978; Meltzer, 1981). Each stage 
of the activation process requires the similtaneous presence 
of appropriate activation signals and responsive macrophages. 
It is likely that lymphokines play a central role in 
the activation process (reviewed by David et al., 1983). 
Both sensitized lymphocytes (Koster and McGregor, 1970) and 
Ia- positive macrophages (reviewed by Poulter, 1983) have 
been identified within inflammatory sites. At least in 
vitro, the secretion of several T cell -derived mediators 
including macrophage inhibitory factor (MIF) (Ben -Sasson 
et al., 1974; Wahl et al., 1975; Ohishi and Onoue, 1975; 
Landolfo et al., 1977), macrophage chemotactic factor (MCF) 
(Wahl et al., 1975) and macrophage activating factor (MAF) 
(Farr et al., 1979) has been shown to require antigen present- 
ation by histocompatible Ia- positive accessory cells. Once 
secreted however, the various lymphocyte mediators act on 
all macrophages irrespective of their strain of origin or 
Ia content (Fidler, 1975; Riisgaard et al., 1978; Farr 
et al., 1979). Presumably within inflammatory sites Ia- 
positive macrophages can present antigen to immunocompetent 
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lymphocytes and thereby induce lymphokine secretion. These 
various lymphokines may then lead to local macrophage accum- 
ulation and activation. 
The macrophages which accumulate at inflammatory sites 
have been shown to be 10 -20 times more responsive to lympho- 
kine- mediated activation than resident macrophages (Ruco and 
Meltzer, 1978). This increased responsiveness is not dir- 
ectly related to the poorly differentiated phenotype of inflam- 
matory macrophages. For example, although peritoneal cells 
collected 6 hours after injection of irritant were highly 
responsive to lymphokine activation in vitro, peripheral 
blood monocytes from the same animals did not develop cyto- 
lytic activity even when exposed to very high concentrations 
of lymphokines for extended periods of time (Meltzer et al., 
1982). Moreover, macrophages derived from bone marrow 
precursors in vitro were refractory to lymphokine activation 
(Falk et al., 1981). These studies were interpreted as 
demonstrating that the lymphokine reponsiveness of monocytes 
arriving at an inflammatory site is enhanced by exposure to 
local stimuli (Meltzer et al., 1982). 
Peritoneal exudate macrophages elicited by inflammatory 
stimuli rapidly develop strong cytolytic activity when ex- 
posed to high concentrations of lymphokines in vitro (Ruco 
and Meltzer, 1977; Meltzer et al., 1980.) However, the 
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level of cytolytic activity generated decreased as the lympho- 
kine was diluted. However if macrophages which had been 
exposed to low concentrations of lymphokines for 4 -5 hours 
were then treated with nanogram quantities of LPS or high 
concentrations of lymphokines for 1 hour, strong cytolytic 
activity was generated (Ruco and Meltzer, 1978; Meltzer 
et al., 1980; Meltzer, 1981). The synergistic interaction 
between lymphokines and.LPS was critically dependent upon 
treatment sequence. Cells treated similtaneously with 
lymphokine and LPS were strongly cytolytic; macrophages 
treated first with lymphokines for 5 hours and then with LPS 
for 1 hour were also cytolytic. In contrast cells treated 
with LPS for 1 hour and then exposed to lymphokines for 5 
hours showed little or no cytolytic activity. However, 
the treatment with LPS did not preclude further responses 
to lymphokines since macrophages that were treated with 
LPS for 1 hour, lymphokines for 4 hours and again with LPS 
for 1 hour were cytolytic (Ruco and Meltzer, 1978; Meltzer 
et al., 1980; Meltzer, 1981). 
On the basis of these results, the processes leading 
to the generation of cytolytically activated macrophages 
can be divided into three distinct phases. The first involves 
recruitment of immature macrophages to sites of inflammation 
and their conversion to lymphokine responsive cells by ill- 
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defined local factors. In the second phase these cells enter 
a "primed" non -cytolytic state in response to certain lympho- 
kines. The third phase involves triggering of lymphokine- 
primed cells by other diverse signals to develop functional 
cytolytic activity. 
Several different lymphokines may be involved in macro- 
phage activation forming a network of interrelated signals 
(Gemsa et al., 1983) some of which may actually cause differ- 
entiation rather than activation (Onozaki et al., 1983). The 
precise functional capabilities of activated macrophages may 
depend on the nature of the lymphokines to which they were 
exposed (Gemsa et al., 1983). A better understanding of the 
effect of lymphokines on macrophages is sure to come from 
studies of well- defined factors derived from mitogen- or 
antigen- stimulated continuous T cell clones (Gemsa et al., 
1983). 
The simultaneous requirement for effective activation 
signals and competent macrophages at each stage in the activ- 
ation process forms the basis of the control mechanism regulat- 
ingmacrophage effector function. Both the responsiveness of 
macrophages to activation signals and the final cytolytic 
state are short -lived functions which are rapidly lost with 
time and cannot subsequently be regained (Ruco and Meltzer, 
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1977; Meltzer et al., 1980; Meltzer et al., 1982; Meltzer, 
1981). Thus activated macrophages will only persist if 
activation stimuli and responsive macrophages are constantly 
replaced. 
4.2 Macrophage cytotoxic activity 
Macrophages'may exhibit a spectrum of cytotoxic reactions 
against tumour cells in vitro ranging from transient inhibition 
of cell growth to irreversible lysis (Meltzer et al., 1975; 
Keller, 1976; Kaplan et al., 1977). The final outcome of 
the interaction between macrophages and tumour cells in vitro 
presumably depends on the state of activation of the macrophage 
population, the sensitivity of the tumour targets and the 
conditions employed in the assay system. It is clear that 
within a population of activated macrophages not all cells 
are able to lyse tumour targets (Hibbs, 1974a; Hibbs et al., 
1977). Moreover, the expression of cytotoxic activity is 
not a property of cells sharing particular physical, morphol- 
ogical or biochemical characteristics but varies with the 
system under investigation. In some systems small cells 
appear to be particularly cytoxic (Ruco and Meltzer, 1978), while 
in others, large cells are more effective (Lee and Berry, 1977; 
Lee et al., 1981). 
The cytotoxic activity of activated macrophages is 
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immunologically non -specific and such cells efficiently 
kill a variety of syngeneic, allogeneic and xenogeneic neo- 
plastic targets while leaving non -neoplastic cells unharmed 
(reviewed by Fidler and Raz, 1981). The mechanism by which 
activated macrophages descriminate between neoplastic and 
non -neoplastic cells is not clear. Macrophage- mediated 
cytotoxicity, at least in vitro appears to occur independent- 
ly of tumour cell immunogenicity, drug sensitivity, invasive- 
ness and metastatic potential (Fidler and Raz, 1981; Fidler 
and Poste, 1982; Loveless and Heppner, 1983). For example, 
B16 melanoma variant cell lines of high or low metastatic 
potential which were either susceptible or resistant to 
syngeneic T cell -mediated lysis were all equally susceptible 
to lysis in vitro by lymphokine- activated macrophages (Fidler 
and Raz, 1981). Similarly cell lines derived from the 
UV -2237 fibrosarcoma which differed greatly in invasive and 
metastatic potential in vivo (Fidler and Cifone, 1979), as 
well as immunogenicity and susceptibility to NK cell- mediated 
lysis (Hanna and Fidler, 1980) were all killed by activated 
macrophages in vitro (Fidler and Poste, 1982). Attempts to 
isolate a tumour cell variant line resistant to macrophage 
cytolysis by repeated selection of the small percentage of 
B16 melanoma or UV -2237 fibrosarcoma target cells which 
survived exposure to activated macrophages in vitro proved 
unsuccessful (Fidler and Poste, 1982). Cell lines resistant 
52 
to cytolysis by T cells (B16) or NK cells (UV -2237) were 
readily obtained by selection with the appropriate effector 
cells. However, all these variants were still susceptible 
to macrophage- mediated cytolysis. These studies suggest 
that cytolytic macrophages recognize some tumour cell chara- 
cteristic which is intimately linked to the malignant pheno- 
type but distinct from that recognized by T cells or NK cells. 
Macrophage mediated cytolysis has generally been shown 
to be contact dependent, although phagocytosis does not seem 
to be involved (Evans and Alexander, 1976; Hibbs et al., 
1978). Macrophages activated in vivo by BCG infection or 
pyran copolymer (Marino and Adams, 1980a, 1980b; Marino 
et al., 1981) or in vitro by lymphokines (Piessens, 1978; 
Marino and Adams, 1980a)exhibited strong high -level selective 
binding to neoplastic target cells. In contrast, the binding 
between non- activated macrophages and neoplastic target cells 
or between activated macrophages and a variety of non -neoplastic 
target cells was weak, low -level and mostly non -specific (Piessens, 
1978; Marino and Adams, 1980a, 1980b; Marino et al., 1981). 
Examination of the interface between activated macrophages 
and attached targets by transmission electron microscopy 
revealed a zone of very close apposition between the two cells 
(Marino and Adams, 1980b; Adams et al., 1982). Indeed Hibbs 
(1974b)went as far as to suggest that activated macrophages 
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actually fuse with the target cells. 
Target cell binding although necessary, is not in 
itself sufficient for macrophage mediated cytotoxicity. 
Macrophages primed in vivo by BCG or in vitro by lympho- 
kines bound neoplastic target cells efficiently but did not 
lyse them until the macrophages were pulsed with traces of 
LPS (Adams and Marino, 1981; Adams et al., 1982). Similarly, 
activated macrophages cultured overnight lost the capacity to 
lyse tumour cells although they were still able to efficiently 
bind the target cells (Adams and Marino, 1981). 
Activated macrophages are very active secretory cells 
and synthesize and secret many substances that are not 
produced by resident macrophages or are synthesized without 
being secreted (reviewed by Davies and Bonney, 1979; Nathan 
et al., 1980). 
Several substances secreted by activated macrophages have 
been proposed as mediators of their cytotoxic activity. 
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(a) Lysosomal enzymes 
Activated macrophages secrete large amounts of lysosomal 
enzymes (reviewed by Davies and Allison, 1976). Hibbs (1974b) 
observed that lysosomal material was transferred from activated 
macrophages to attached tumour cell tárgets and proposed that 
secreted lysosomal enzymes were producing the resultant cytoly- 
tic effect, probably through their hydrolytic activity. 
However, the role of lysosomal enzymes in target cell killing 
has been questioned by the finding that the addition of even 
quite high concentrations of lysosomal enzymes to culture 
medium usually enhanced rather than inhibited tumour cell 
growth (Vischer et al., 1976). Clearly if lysosomal enzymes 
do mediate macrophage cytotoxic activity it must be by a 
mechanism other than a direct attack on the exterior surface 
of the target cell. 
(b) Oxygen metabolites 
Many stimuli induce activated macrophages to secrete 
reactive oxygen metabolites (Johnston et al., 1978). Several 
lines of evidence suggest that these products play an import- 
ant part in the killing of tumour cell targets. Firstly, 
target cells are susceptible to lysis by oxygen metabolites 
in the amounts released from activated macrophages in response 
to phorbol myristate acetate (PMA) (Nathan et al., 1979a). 
55 
Secondly, deprivation of either oxygen or glucose prevents 
PMA- induced oxygen metabolite release from activated macro- 
phages and greatly reduces target cell killing (Nathan et al., 
1979b; Nathan and Cohn, 1980). Finally, exogenous scavengers 
of oxygen metabolites such as catalase or thioglycollate broth, 
abolish PMA induced target cell killing by activated macrophages 
(Nathan et al., 1979b; Nathan and Cohn, 1980). 
(c) Neutral proteinases 
It is a frequent finding that culture supernatants con- 
ditioned by activated macrophages incubated alone or with 
tumour cells, were not cytotoxic to tumour targets in vitro 
(reviewed by Alexander, 1976; Evans and Alexander, 1976). 
Similarly if activated macrophages and target cells were 
separated by a porous filter, no cytotoxicity resulted if 
serum was present in the culture medium (Marino and Adams, 
1980b). In contrast, if the same experiment was performed 
in the absence of serum, significant cytotoxic activity was 
evident (Adams and Marino, 1981). These results strongly 
suggest that activated macrophages do secrete a soluble 
cytoxic product, but that this substance is effectively 
inhibited by serum components. 
Further studies using additional inhibitors (Adams, 1980; 
Adams et al., 1980; Johnson et al., 1981) and various 
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biochemical techniques (Adams et al.,1980) identified the 
cytotoxic principle present in culture supernants conditioned 
by activated macrophages as a neutral serine proteinase with 
a molecular weight of approximately 40,000 daltons. However, 
it should be noted that inhibitors of neutral proteinase 
activity may exert numerous effects including the suppression 
of reactive oxygen metabolite release by activated macrophages 
(Kitagawa et al., 1980).. 
(d) Complement component C3a 
Activated macrophages secrete neutral proteinases and 
complement component C3 (reviewed by Nathan et al., 1980). 
Neutral proteinases can cleave C3 to give C3a and Cab frag- 
ments. It has been suggested that C3a is cytotoxic for 
tumour target cells (Ferluga et al., 1976). However recent 
work by Goodman et al. (1980) has cast serious doubt on the 
cytotoxic capacity of C3a and clearly much more work needs 
to be carried out to clarify the importance of C3a in target 
cell killing. 
(e) Arginase 
Another recent suggestion is that arginase is responsible 
for the cytolytic capacity of activated macrophages (Currie, 
1978). Arginase was shown to be released by macrophages 
activated in vitro by zymosan or LPS but not by normal macro- 
57 
phages (Currie, 1978). It is presumed that arginase exerts 
its cytolytic effect by preventing the target cell obtaining 
sufficient arginine (Currie, 1978). 
(f) Thymidine 
Stadecker et al., (1977) suggested that the nucleoside 
thymidine is responsible for target cell killing. Thymidine 
is synthesized and secreted by activated macrophages 
(Stadecker et al., 1977) but few target cells are likely to 
be susceptible to lysis at the concentrations of thymidine 
attained. 
In summary, it appears that lysis of target cells by 
activated macrophages occurs in at least three stages. In 
the first stage, activated macrophages bind to target cells 
creating a zone contact between the two cells and triggering 
metabolic events within the macrophage. In the second stage 
macrophages secrete lytic effector substances into the zone of 
contact. It is likely that several such substances are 
involved and the relative importance of each may vary depending 
on the target cells or environmental conditions. The contact 
zone presumably acts to concentrate the lytic substances and 
protect them from inhibitors present in the extracellular 
compartment. Finally, the third stage involves target cell 
injury and eventual loss of viability. 
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4.3 Macrophage- induced stimulation of tumour cell proliferation 
It is apparent that under some conditions, immune 
reactions may stimulate cell proliferation rather than inhibit 
it (Prehn, 1976). Normal peritoneal macrophages have been 
shown to enhance the growth of lymphoid tumour cells which 
by themselves grew poorly in vitro (Namba and Hanaoka, 1972; 
Nathan and Terry, 1975; Hewlett et al., 1977). Similarly, 
Olivotto and Bomford (1974) reported that cultured mouse per- 
itoneal macrophages stimulated 3H- thymidine uptake by tumour 
cells. Moreover, enhancement of tumour cell proliferation 
is not limited only to resident macrophages. Krahenbuhl 
et al. (1976) showed that peritoneal macrophages from animals 
injected with Corynebacterium parvum or killed Toxoplasma 
gondii greatly enhanced 3H- thymidine uptake by L -929 cells 
at low effector to target cell ratios. Similar results were 
reported for proteose- peptone activated. macrophages (Keller, 
1973). 
The in vivo significance of the tumour growth promoting 
activity of macrophages remains to be elucidated. Hewlett 
et al. (1977) . suggested that macrophages enhance tumour cell 
proliferation in vitro simply by improving culture conditions. 
It is of course unlikely that an equivalent mechanism would 
be of importance in vivo. However, Prehn (1977) proposed that 
immunostimulationof tumour cell proliferation plays an 
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important part in the early stages of tumour development 
in vivo. In this connection it is interesting to note 
that in one study treatment of mice with the anti-macro- 
phage agent silica was reported to inhibit the growth of 
subcutaneously implanted Lewis lung carcinoma cells 
(Sadler et al., 1977). 
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5.0 TUMOUR -ASSOCIATED MACROPHAGES 
5.1 Accumulation of macrophages in tumours 
The accumulation of macrophages in tumours appears to 
be a well -regulated process. It is for instance generally 
accepted that although different tumours may contain differ- 
ent numbers of macrophages, once established, the macrophage 
content of a given tumour remains fairly constant during 
passage from one syngeneic host to another (Evans, 1972; 
Pross and Kerbel, 1976; McBride et al., 1982). Thus 
while primary chemically induced tumours may contain a 
high percentage of macrophages, this number often decreases 
sharply during early passage, eventually leveling off at a 
figure which may be maintained through many subsequent 
in vivo passages (Evans, 1972; Pross and Kerbel, 1976; 
McBride et al., 1982). In this connection, it is interest- 
ing to note that the immunogenicity of chemically induced 
tumours may also decrease during early passage (Prehn and 
Main, 1957; Globerson and Feldman, 1964; Menard et al., 
1973). The most likely explanation of these results is 
that repeated transplantation selects tumour cells particul- 
arly well adapted to growth under the set conditions that 
transplantation imposes and that such cells elicite, by 
some well regulated process, a characteristic host cell 
infiltrate (McBride et al., 1982). 
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The host cell origin of tumour- associated macrophages 
has been demonstrated in several studies. Tumour cell 
suspensions depleted of macrophages prior to inoculation 
into syngeneic hosts by treatment with anti -macrophage serum 
and complement (Evans, 1972) or by long term in vitro culture 
(Evans, 1972; Kerbel and Pross, 1976; Moore and Moore, 1977a) 
still developed a characteristic macrophage infiltrate, sugg- 
esting that tumour -associated macrophages were not derived 
from cells included in the tumour inoculum. Confirmation 
of the host origin of tumour -associated macrophages was 
obtained by growing parental strain tumours in F1 hybrid 
hosts (Kerbel et al., 1975; Kerbel, 1976; Kerbel and Pross, 
1976; Pross and Kerbel, 1976). For example, CBA (H -2k) 
methylcholanthrene -induced fibrosarcoma cells were injected 
into (C3H x DBA /2)F1 (H -2k x H -2d) recipients. Host cells 
infiltrating the tumour expressed H -2k and H -2d antigens 
since histocompatibility antigens are codominant, and were 
identified with anti -H -2d antisera. Tumour cells on the 
other hand expressed only H -2k antigens and did not react 
with anti -H -2d antisera (Kerbel and Press, 1976). 
The current dogma concerning the origin of macrophages 
in normal tissues or inflammatory sites suggests that these 
cells are derived mainly from blood monocytes, although in 
some circumstances, in situ macrophage proliferation may 
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also occur (section 2.2). The accumulation of macrophages 
within tumours presumably occurs by the same mechanism. 
Influx of monocytes into a tumour site undcubtably occurs 
(DeLusto and Haskill, 1978; Talmadge et al., 1981). However, 
identification of recently arrived monocytes in tumour cell 
suspensions by peroxidase staining, revealed very little 
staining that could net be accounted for by neutrophil 
contamination (Evans, 1982). This suggests a very rapid 
differentiation of tumour - infiltrating monocytes into macro- 
phages ( Karzer and Lala, 1977). The extent of in situ 
macrophage proliferation is much more uncertain. Following 
i.v. injection of 3H- thymidine, labelled macrophages were 
found in situ (Key and Haskill, 1981). In addition, in the 
presence of CSF, tumour - associated macrophages may form 
colonies in vitro (Stevens et al., 1978). However, prelim- 
inary data on labelling indices following i.v. injection of 
3H- thymidine were shown to be too low to account for the 
observed increase in macrophage number as the tumour grows 
(Evans, 1982). In addition, tumour cell suspensions pulsed 
with 3H- thymidine in vitro showed a similar low macrophage 
labelling index (Evans, 1982). In conclusion, it seems 
likely that most tumour associated macrophages are derived 
from an influx of blood monocytes into the tumour site 
although some in situ macrophage proliferation may also 
occur. The relative contribution of each of these mechanisms 
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presumably varies between different tumours. Some tumours 
have been shown to produce CSF (Milas et al., 1984) and 
with these, local macrophage proliferation may contribute 
significantly to the total macrophage content. 
Numerous authors have investigated the degree of macro- 
phage infiltration of tumours as a function of time after 
injection of tumour cells. It appears from these studies 
that the kinetics of macrophage infiltration may also vary 
from one tumour to another. In some, the percentage of 
macrophages peaked early in growth before declining to a 
level which was maintained throughout the remaining period 
of growth (Moore and Moore, 1977a; Evans and Eidlen, 1981). 
With other tumours, the same percentage of macrophages was 
found throughout the period of growth (Evans, 1972). In 
contrast, the macrophage content of several sarcomas and 
carcinomas has been shown to remain relatively constant 
until a critical tumour size is reached, after which time it 
decreased substantially, perhaps reflecting diminished 
infiltration of blood monocytes (Haskill et al., 1975a; 
Moore and Moore, 1977a; Normann and Cornelius, 1978; Evans 
and Eidlen, 1981). 
Several possible mechanisms may account for the accum- 
ulation of macrophages in tumours. 
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(a) Mediators of acute inflammation 
Evans (1972) reported no apparent correlation between 
the macrophage content of tumours and the degree of necrosis 
or neutrophil infiltration. In addition the anti- inflamm- 
atory drug indomethacin failed to affect the macrophage content 
of a variety of rat sarcomas and carcinomas (Moore and Moore, 
1977b). Similarly, the non -steroidal anti -inflammatory 
agent flurbiprofen which effectively inhibits prostaglandin 
synthesis did not alter either the migration of labelled 
monocytes into rat sarcomas or the number of macrophages 
found within these tumours (Eccles, 1982). Thus, on the 
basis of this evidence, it seems unlikely that macrophages 
are attracted to a tumour site by mediators of acute inflamm- 
ation. 
(b) Immune mechanisms 
It has been reported that the levels of macrophages 
associated with tumours appears to be related to the immuno- 
genicity of tumour cells, such that highly immunogenic tumours 
have a relatively high macrophage content, and weakly immuno- 
genic tumours a low content (Evans, 1972; Eccles and Alexander, 
1974; Moore and Moore, 1977a; Morantz et al., 1979). Such 
correlations were most clearly seen when tumours of similar 
aetiology,histclogy and host origin were compared (Eccles 
and Alexander, 1974). Of particular interest in this respect 
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are pairs of tumours where the macrophage content of an 
immunogenic line and its less immunogenic derivative were 
compared. For example, the macrophage content of the 
strongly immunogenic benzo(a)pyrene- induced sarcoma FS6 was 
around 44% while the weakly immunogenic mFS6 subline con- 
tained only 19% (Mantovani, 1978). Similar results were 
obtained using the L5718Y Eb and ESb lymphomas (Schirrmacher 
et al., 1979). 
The correlation between tumour immunogenicity and macro- 
phage content strongly suggests that macrophage accumulation 
is sustained by stimuli which are immunological in nature. 
This hypothesis is supported by studies which demonstrated 
a significant reduction in the macrophage content of various 
sarcomas and carcinomas grown in T lymphocyte depleted (Eccles 
and Alexander, 1974; Alexander et al., 1976; Parthenais and 
Haskill, 1979) or nude (Stutman, 1975; Eccles et al., 1979) 
animals. In addition, administration of Cyclosporin A, a 
potent immunosuppressive agent with selective inhibitory effects 
on T lymphocytes (White et al., 1979) decreased both the mig- 
ration of labelled monocytes into rat sarcomas and the number 
of macrophages found within these tumours (Eccles, 1982). 
However, the suggested involvement of specific anti -tumour 
immune responses in the accumulation of macrophages in tumours 
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is not supported by all studies. Evans and Lawler (1980) 
for instance, found no correlation between immunogenicity 
and macrophage content in an extensive study of 33 primary 
methylcholanthrene induced murine sarcomas. In addition, 
Szymaniec and James, (1976) found that the levels of tumour - 
associated macrophages in a mouse sarcoma were unaffected by 
transplantation into thymectomized animals. Similar findings 
have recently been reported for other methylcholanthrene - 
induced murine sarcomas transplanted into T- lymphocyte depleted 
(Evans and Lawler, 1980; Evans and Eidlen, 1981) or nude 
(Evans, 1982) mice. 
In view of the contradictory nature of some of these 
studies it is probably best to adopt a cautious approach. 
It appears that at least for some tumours, there is a good 
correlation between immunogenicity and macrophage content. 
However this is by nc means always the case, and for other 
tumours, different mechanisms may be more important. Many 
more studies must be performed before it can be ascertained 
whether the relationship between tumour immunogenicity and 
macrophage content applies to most, or to only a few tumours. 
(c) Tumour- derived chemetactic factors 
The accumulation of leukocytes at inflammatory foci is 
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part of the host defense response to many noxious agents. 
One of the mechanisms which leads to such localization is 
the elaboration of molecules chemotactic for leukocytes 
that diffuse out from the site of release. Leucocytes 
then migrate up the concentration gradient to form the 
inflammatory focus. Neutrophils, basophils, eosinophils 
and macrophages all respond to various chemotactic stimuli. 
Factors which preferentially attract a particular type of 
leukocyte have been described. Thus the nature of chemo- 
tactic factors may determine the cellular composition of 
inflammatory foci. 
There have been a few reports indicating that tumour 
cells may elaborate factors that are chemotactic for macro- 
phages. Meltzer et al. (1977) found that culture super- 
natants from 4 different murine methylcholanthrene -induced 
fibrosarcomas contained factors that were chemotactic for 
resident and BCG- activated peritoneal macrophages but not for 
peritoneal granulocytes. Activated peritoneal macrophages 
were more responsive to the tumour -derived chemotactic factors 
than were resident peritoneal macrophages. Minimal levels 
of chemotactic activity were found in supernatants from 
syngeneic mouse embryo fibroblast cultures. Similarly, 
in a recent extensive study Bottazzi et al. (1983) found 
chemotactic activity in the culture supernatants of most 
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murine and human sarcomas and carcinomas irrespective of 
their histology or origin (chemically induced or spontaneous). 
Leukaemias and lymphomas on the other hand were either in- 
active or elaborated a low chemotactic activity. The elab- 
oration of chemotactic factors by human tumour cells in 
vitro was confirmed by Peri et al. (1982) who demonstrated 
that culture supernatants from the human sarcoma cell line 
8387 and the human melafiomas 1080/2 and SKBR -3 were chemotactic 
for human monocytes whereas the K562, Raji and CEM lymphoma 
lines produced little chemotactic activity. 
The physiochemical nature of tumour derived chemotactic 
factors has been examined in at least two systems. Meltzer 
et al. (1977) found that the chemotactic activity present in 
the culture supernatant of a murine fibrosarcoma line eluted 
from Sephadex G100 in the 15,000 dalton molecular weight 
region. Similarly, preliminary characterization of the chemo- 
tactic factor elaborated by the human sarcoma line 8387 in 
vitro revealed that the activity was non -dialysible, heat - 
resistant, susceptible to proteolytic enzymes but unaffected 
by DNase or RNase and eluted from Sephadex G75 in the cyto- 
chrome C region, corresponding to a molecular weight of 
round 15,000 daltons (Bottazzi et al., 1983). Thus it 
seems that the chemotactic factors elaborated by murine and 
human tumour cells in vitro are fairly similar with respect 
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to molecular weight and may possibly be related. Indeed, 
chemotactic factors produced by murine cells were found to 
be active on human monocytes (Bottazzi et al., 1983). 
The elaboration of chemotactic factors by tumour cells 
has only been demonstrated in vitro. However, Bottazi et al. 
(1983) found a significant although far from absolute relation- 
ship between the macrophage content of 11 solid murine tumours 
and the ability of the tumour cells to produce chemotactic 
factors in vitro, suggesting that such a mechanism may also 
be important in vivo. Of course in vivo, the interaction 
of tumour cells with various host elements may result in 
the production of additional chemotactic factors. However, 
the macrophage content of primary and transplanted tumours 
was the same whether they were grown in normal cr C5 deficient 
mice, indicating that C5a- derived chemotactic factor was not 
involved (Evans, 1980). The possibility that soluble com- 
plexes of tumour antigen and antibody may attract macrophages 
to a tumour site has been proposed (Evans, 1977) but remains 
speculative. 
(d) Tumour -derived chemokinetic factors 
Several authors have described tumour cell- derived 
factors which can act up upon macrophages in vitro increasing 
their rate of random translational movement (chemckinesis). 
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ior example, Meltzer et al. (1975) using time lapse cinemicro- 
graphic analysis observed that the rate of translational 
movement of BCG- activated murine peritoneal macrophages 
cocultured with neoplastic cells was four times that ob- 
served if the macrophages were cocultured with non -neoplastic 
cells derived from the same cloned embryo cell line. The 
translational movement of resident peritoneal macrophages 
on the other hand was less than that of activated macrophages 
and was unaltered by the addition of neoplastic or non - 
neoplastic cells. Snodgrass et al. (1976, 1977) obtained 
similar results for resident and pyran copolymer activated 
murine peritoneal macrophages cocultured with Lewis lung 
carcinoma cells. In their studies, activated macrophages 
alone moved almost three times faster than resident macro- 
phages. The rate of translational movement of resident macro- 
phages was unaltered by coculture with neoplastic Lewis lung 
carcinoma cells or with non -neoplastic mouse embryo fibroblasts. 
Activated macrophages on the other hand moved three times 
faster when coincubated with, but not actually in contact 
with, carcinoma cells. However, when such a macrophage came 
into contact with a tumour cell, its rate of laceral movement 
slowed to one comparible with activated macrophages cultured 
alone. In contrast, activated macrophages cocultured with 
non -neoplastic mouse embryo fibroblasts showed no alteration 
in their rate of translational movement. 
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These results suggest that neoplastic cells elaborate 
chemokinetic factors which act to increase the rate of trans- 
lational movement of activated macrophages. Indeed, Snodgrass 
et al. (1976; 1978) and Schuller et al.(1978) have shown that 
addition of cell free culture supernatant from Lewis lung 
carcinoma cells greatly enhanced the translational movement 
of pyran copolymer- activated murine peritoneal macrophages 
while supernatant from primary mouse embryo fibroblast cultures 
had no effect. The rate of translational movement of resident 
peritoneal macrophages was either unaltered (Snodgrass et al., 
1976; 1978) or inhibited (Schuller et al., 1978) by addition 
of supernatant from Lewis lung carcinoma cell cultures. 
In a recent study, Lane et al. (1982) found that culture 
supernatants from six different syngeneic and allogeneic mouse 
tumour cell lines all increased the rate of translational move- 
ment of Corynebacterium parvum- activated murine peritoneal 
macrophages while supernatants from normal mouse embryo fibro- 
blast cultures had no effect. The chemokinetically active 
component of Lewis lung carcinoma conditioned medium was 
partially characterized and found to be a trypsin sensitive, 
heat stable, high molecular weight (300,000- 400,000 dalton) 
factor that exhibited no chemotactic activity. The factor 
increased the rate of translational movement of C.parvum -and 
pyran copolymer -actived macrophages but had no effect on oyster 
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glycogen -or thioglycollate- elicited macrophages. 
Reports on the molecular size of chemokinetic factors 
isolated from other tumours have been rather vague. Usually 
they were described as non -dialyzable indicating a molecular 
weight of greater than 12,000 daltons (Nelson and Nelson, 1978). 
Since all of the tumour -derived chemokinetic factors which 
have been described have a molecular weight above 12,000 daltons 
it is possible that all these molecules are related. 
Several factors with chemokinetic activity have been 
isolated from other sources. Aaskov and Anthony (1976) des- 
cribed a high molecular weight (> 150,000 daltons) factor in 
culture supernatants of BCG- stimulated human peripheral blood 
lymphocytes which enhanced the movement of normal mouse splenic 
macrophages in the MIF assay but had no chemotactic activity. 
A similar factor was found in supernatants of PPD stimulated 
lymphocytes (Weisbart et al., 1974). This factor was heat 
stable, had an electrophoretic mobility in the gamma -globulin 
region and increased the random movement of human buffy coat 
leukocytes from a well cut in agarose gel. Thus it appears 
that the physiochemical features of tumour -derived chemokinetic 
factors are not unusual when compared with factors from other 
sources. At present however, the precise nature of chemokinetic 
factors remains to be elucidated. In this connection, it is 
interesting to note that cell coat glycocalyx glycoproteins have 
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a molecular weight range of 200,000 to 500,000 daltons 
(Codington et al., 1972; Slayter and Codington, 1973) which 
is fairly similar to that suggested for chemokinetic factors. 
In summary, it appears that at least in vitro, neoplastic 
cells may elaborate factors which can enhance the random move- 
ment of activated macrophages while having little or no effect 
on non -activated macrophages. If these factors are produced 
in vivo and have similar effects on monocytes, then they could 
serve to specifically increase the rate of migration of activated 
cells out of the vascular system in response to an appropriate 
stimulus, while having little or no effect on non -activated cells. 
In this way these factors could influence not only the absolute 
number of macrophages in a tumour, but also their activity. 
(e) Depression of macrophage chemotactic and inflammatory 
responses by tumour- derived factors 
Patients with advanced malignant disease are often unable 
to express delayed type hypersensitivity (DTH) reactions to 
antigens with which they had previously been sensitized (Southam, 
1968) or produce normal cellular exudates in response to mild 
skin abrasions (Dizon and Southam, 1963) or inflammatory stimuli 
(Johnson et al., 1971). Equivalent results have been obtained 
in animal studies using both spontaneously arising (Normann 
et al., 1979a; Cianciolo et al., 1980) and transplanted 
(Bernstein et al., 1972; Normann and Sorkin, 1976; Snyderman 
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et al., 1976; Normann and Cornelius, 1978; Normann et al., 
1979b) tumours. 
In most instances the anergy associated with tumour 
burden appears to be the result ofa macrophage rather than a 
lymphocyte defect. Lymphocytes from tumour -bearing animals 
usually manifest normal in vitro responses to both antigens 
and mitogens (reviewed by Cianciolo and Snyderman, 1982). 
In contrast, several macrophage functions have been shown to 
be compromised in tumour -bearing animals or patients with 
advanced malignant disease (reviewed by Cianciolo and 
Snyderman, 1983). Of particular importance is the finding 
that macrophage chemotactic responsiveness in vitro is greatly 
reduced (Hausman et al., 1973, 1975; Boetcher and Leonard, 
1974; Pike and Snyderman, 1976; Rubin et al., 1976; Snyder - 
man et al., 1977; Snyderman et al., 1978). Such inhibition 
only becomes evident late in tumour progression and rapidly 
disappears if the tumour is excised (reviewed by Cianciolo and 
Snyderman, 1982). The most likely interpretation of these 
results is that tumours elaborate factors which inhibit macro- 
phage chemotactic responsiveness. 
Cell free homogenates of transplanted tumours (Pike and 
Snyderman, 1976; Snyderman and Pike, 1976; Cheung et al., 
1979), tumour ascitic fluid (Normann, 1978), plasma or urine 
from tumour -bearing animals (Snyderman and Cianciolo, 1979) and 
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tumour cell culture supernatants (Normann and Sorkin, 1977; 
Normann and Cornelius, 1982) have all been shown to inhibit 
macrophage chemotaxis in vitro and /or depress macrophage 
accumulation at inflammatory sites in vivo. Similarly, 
Cianciolo et al. (1981) found inhibitory activity in all of 
17 malignant effusions from patients with various types of 
neoplasms, whereas effusions from 17 patients with non -malignant 
diseases possessed no significant inhibitory activity. 
The physiochemical nature of tumour -derived anti -chemo- 
tactic anti -inflammatory factors has been investigated in 
several systems. Pike and Snyderman (1976) identified an 
anti -inflammatory factor with a molecular weight of between 
6,000- 10,000 daltons in sonicates of 4 histologically distinct 
tumours. Cianciolo et al. (1980) found a similar factor in 
spontaneously arising murine carcinomas. Nelson and Nelson 
(1978, 1980) reported that murine tumour cell culture super- 
natants contained both low (< 10,000 daltons) and high (> 10,000 
daltons) molecular weight factors which could inhibit the early 
phase of a prolonged DTH reaction in vivo and macrophage mig- 
ration and motility in vitro. Similarly, Norman and Cornelius 
(1982) found that the P815 mastocytoma and a murine methyl - 
cholanthrene- induced fibrosarcoma both produced at least two 
soluble anti -inflammatory factors that inhibited macrophage 
accumulation in vivo when injected into syngeneic recipients. 
One factor was a low molecular weight peptide (c 1,000 daltons) 
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while the other had a molecular weight of between 30,000- 
100,000 daltons. Cianciolo et al. (1981) found that the 
anti -chemotactic factor present in human malignant effusions 
was a polypeptide of molecular weight 15,000- 70,000 daltons. 
Interest' 1 ing y this factor also reacted with monoclonal anti- 
bodies against the P15 (E) structural protein of retroviruses. 
The mode of action of these tumour -derived anti -chemo- 
tactic anti -inflammatory factors has received little attention. 
Normann and Sorkin (1977) however found that culture super- 
natants from two rat tumour cell lines inhibited both macro- 
phage accumulation in vivo in response to i.p. injection of 
peptone and the chemotactic responsiveness of peptone elicited - 
peritoneal macrophages in vitro if mixed with the chemotactic 
agent or cells. If the responding macrophages were 
incubated with culture supernatnants for a short period 
of time and then washed their chemotactic responsiveness 
was also greatly reduced. The supernatants had no effect 
on macrophage viability and repetitive absorptions by 
macrophages, depleted culture supernatants of their capacity 
to inhibit the chemotactic responsiveness of fresh macrophages. 
Other groups obtained similar results using sonicated murine 
tumour cell dialysates (Cianciolo and Snyderman, 1982) and 
human malignant effusions (Cianciolo et al., 1981). These 
results suggest that tumour- derived anti -chemotactic factors 
act by binding to the macrophage cell surface. The events 
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which occur following this interaction remain to be elucidated. 
The part played by tumour -derived anti -chemotactic /anti- 
inflammatory factors in determining the macrophage content 
of tumours is difficult to evaluate. Although the effects 
of these inhibitors only become systemically evident late in 
tumour growth, it is possible that within the locality of the 
tumour mass functionally significant levels of inhibitors may 
be found at a much earlier stage. However no study to date 
has attempted to correlate the production of anti -inflammatory 
factors by tumour cells with the macrophage content of the 
tumour. Moreover, no one has yet examined the production of 
both chemotactic and anti -chemotactic factors within the same 
tumour system. If indeed certain tumours do produce both 
chemotactic and anti -chemotactic factors the two acting 
together could perhaps provide a rate limiting mechanism which 
determines the macrophage content of the tumour. 
5.2 Functional capabilities of tumour -associated macrophages 
As previously discussed in section 2, macrophages have 
been shown to exhibit considerable functional heterogeneity. 
Thus, in order to define the biological significance of tumour - 
associated macrophages, it is necessary to detail their functional 
capabilities. The standard approach used is to isolate macro- 
phages from enzymatically -disaggregated tumour cell suspensions 
usually by virbueof their ability to adhere tightly to glass 
or plastic surfaces, and then examine the functional capabilities 
of such cells in well -defined in vitro assay systems. Using 
this approach, tumour -associated macrophages have been shown 
to perform several functions which could have a bearing on 
tumour growth if they also occurred in situ. 
(a) Cytotoxic activity 
The frequent presence of macrophages in human and animal 
tumours, taken together with the observation that macrophages 
from other sites, activated in vivo or in vitro by a variety of 
agents, were able to kill phenotypically diverse tumour cells 
(see Section 4.2)prompted many groups to investigate the cyto- 
toxic activity of tumour -associated macrophages. It has 
since been demonstrated that macrophages isolated from a wide 
variety of human and animal tumours, differing greatly in their 
origin and histology, may exhibit a spectrum of cytotoxic reactions 
in vitro which may be specific or non -specific and range from 
transient, reversible growth inhibition to irreversible lysis 
(Evans, 1973; Evans, 1976; Holden et al., 1976; Russell and 
McIntosh, 1977; Korn et al., 1978; Mantovani, 1978; Loveless 
and Heppner, 1983). The mechanisms behind such cytotoxicity 
are unknown but are unlikely to differ from those proposed for 
other populations of tumouricidal macrophages (Section 4.2). 
In addition ILO direct cytotoxicity, tumour -associated 
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macrophages may also destroy tumour cell targets in vitro 
by ADCC (Haskill and Fett, 1976). In this connection it 
is interesting to note, that several studies have demon- 
strated the presence of immunoglobulins of various classes 
either bound to tumour cells (Witz, 1977; Koneval et al., 
1977; James et al., 1978, 1979) or tumour -associated macro- 
phages (Lewis et al., 1976; Wood et al., 1979) in situ. 
In addition, small numbers of plasma cells are found assoc- 
iated with many tumours (Ioachim et al., 1976; Schoorl et 
al., 1976; Howie et al., 1982). 
(b) Stimulation of tumour cell proliferation 
It is apparent, that under some conditions, immune 
reactions may stimulate cellular proliferation rather than 
inhibit it. (Section 4.3) A number of investigators have 
demonstrated that tumour -associated macrophages may stim- 
ulate neoplastic cell proliferation in vitro (Evans, 1977, 
1978; Mantovani, 1978; Salmon and Hamburger, 1978), or 
tumour growth in a Winn assay (Evans, 1978). Evans (1976) 
demonstrated that both neoplastic and non -neoplastic cells 
were stimulated to divide by culture medium conditioned by 
macrophages from solid murine tumours. Membrane filtration 
studies indicated that growth stimulation of SL -2 lymphoma 
cells by culture supernatant conditioned by macrophages 
isolated from the FS6 fribrosarcoma was mediated by a low 
molecular weight (< 10,000 daltons) factor (Evans, 1979). 
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Salmon and Hamburger (1978) reported that a similar growth 
promoting factor was produced by macrophages from human 
malignant effusions. In some circumstances, factors pro- 
duced by macrophages may replace substances such as 
2- mercaptoethanol(2ME), which are frequently added to 
culture media to support the growth and proliferation of 
lymphoid cells. For example, the L5178Y lymphoma failed 
to grow in culture unless the culture medium contained 2ME. 
However, if the cells were plated onto tumour macrophage 
monolayers, growth occurred in the absence of 2ME (Evans, 
1979) . 
The relationship between macrophage cytotoxic and growth 
promoting is difficult to reconcile. However it 
may be possible to explain these findings in terms of macro- 
phage heterogeneity. In this connection it is interesting 
to note that while macrophages from solid murine tumours were 
cytotoxic in vitro, culture supernatants from these same cells 
stimulated neoplastic cell proliferation (Evans, 1976). In 
addition, Mantovani (1978) reported that macrophages freshly 
isolated from the FS6 fibrosarcoma were cytotoxic in vitro. 
However, after 24 or 48 hours of culture these cells were 
found instead to stimulate 3H- thymidine uptake by the target 
cells. It is possible that distinct subpopulations of macro- 
phages exist within tumours each capable of performing diff- 
erent functions. Under conditions exployed in most in 
vitro 
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cytotoxicity assays, highly activated cytotoxic macrophages 
may prodominate over macrophages which promote tumour growth 
producing the net effect of cell killing. However, if the 
effects of cytotoxic macrophages are removed by culture in 
vitro or by looking at culture supernatants, then the growth 
promoting activity may be detected. 
(c) Suppressor cell activity 
For most immune reponses, regulatory mechanisms have 
been described that limit the generation, magnitude or length 
of the response. Various different classes of suppressor 
cell have been implicated, including macrophages (section 
3.6). There is some evidence that tumour -associated macro- 
phages may also possess immunosuppressive activity. 
Cells isolated from regressing MSV- induced tumours have been 
found to suppress lymphoproliferative responses to mitogens 
(Holden et al., 1976; Herberman et al., 1980). Similarly, 
macrophages obtained from human ascitic and solid ovarian 
tumours have been shown to suppress PHA- induced lymphocyte 
proliferation (Peri et al., 1982; Haskill et al., 1982). 
Functional lymphocyte responses may also be suppressed by 
tumour -associated macrophages. 
Gillespie and Russell (1980) studied the effect of 
tumour -associated macrophages on the in vitro development of 
cytolytic T lymphocyte activity. Noncytolytic cells obtained 
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from the lymph nodes draining MSV induced tumours underwent 
extensive blastogenesis and acquired high levels of antigen - 
specific cytolytic activity if cultured alone for 4 days 
(Gillespie and Russell, 1978). However, if macrophages 
isolated from syngeneic progressively growing SV40 -3T3 
neoplasms were added to the cultures, the development of 
cytolytic activity was effectively prevented (Gillespie and 
Russell, 1980). In contrast, although lymphokine activated 
peritoneal macrophages also suppressed the development of 
cytolytic activity at high cell number, at lower cell densities 
they produced a dramatic and consistent enhancement of the 
response. Whether the tumour -associated macrophages in- 
hibited the development of cytotoxic lymphocytes or affected 
the expression of cytotoxicity was not determined. 
Some proliferation independent immune responses can also 
be inhibited by tumour -associated macrophages. The production 
of MIF by lymphocytes has been shown to be independent of 
proliferation (Bloom et al., 1972) and mitomycin C treated 
cells were fully capable of effecting the response (Varesio 
et al., 1979b). Addition of adherent cells from regressing 
MSV- induced tumours to cultures of immune spleen cells and 
RBL -5 tumour cells resulted in abrogation of detectable MIF 
production ( Varesio et al., 1979b). In contrast, normal mouse 
peritoneal cells had no suppressive activity. Similarly, 
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macrophages from MSV- induced tumours have been shown to inhibit 
MIF production by alloimmune spleen cells in response to allo- 
geneic cells (Herberman et al., 1980). Extensive studies 
have shown that MIF is not absorbed to macrophages, inact- 
ivated by material produced by macrophages, nor do macrophages 
produce a material which counteracts the effects of MIF 
(Varesio and Holden, 1980a). Varesio and Holden (1980b) 
demonstrated that suppressor macrophages from regressing 
MSV- induced tumours inhibited protein synthesis by 
resting or Con A stimulated lymphocytes. Since protein 
synthesis is absolutely required for lymphocyte proliferation 
(Milner, 1978) and lymphokine production (Henney et al., 1974), 
it is possible that macrophage mediated inhibition of protein 
synthesis may cause suppression of the development of subse- 
quent immune responses. There are often large numbers of 
macrophages present within regressing MSV- induced tumours 
(Holden et al., 1976) and it is possible that the suppressor 
activity of these cells may account for the inability of 
lymphocytes from the tumour to be stimulated to produce MIF 
(Varesio et al., 1979b). 
5.3 In vivo significance of tumour -associated macrophages 
Considerable care must be taken in extending in vitro 
findings to the in vivo situation. Because a cell is able 
to perform a particular function in vitro does not necessarily 
indicate that it performs the same function in vivo. Isolation 
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of a specific cell type for study in vitro removes that cell 
from the positive or negative regulatory processes which may 
occur in vivo. Alternatively of course, the isolation pro- 
cedures used or the conditions employed in vitro may not be 
ideally suited to demonstrate certain cellular functions. 
Evans et al. (1978) demonstrated the difficulties 
encountered in relating_in vitro findings to the in vivo 
situation. They found that after excision of primary fibro- 
sarcomas, subsequent i.p. challenge with tumour cells pro- 
duced non -specific cytotoxic macrophages and specific cyto- 
toxic T lymphocytes. However, the non -specific killing 
of tumour cells by peritoneal macrophages in vitro did not 
reflect a similar occurrance in vivo. When immune animals 
were challenged with the immunizing tumour and with graded 
numbers of non -cross reacting tumour cells, growth of the 
non -related tumour occurred in all cases and only the specific 
tumour was rejected. Moreover, the non -specifically cyto- 
toxic peritoneal macrophages did not delay growth of unrelated 
tumour cells in a Winn assay. Thus no matter how effector 
cells react in vitro or even in the Winn assay, it is still 
necessary to show that they perform similar functions in vivo. 
What then is the evidence that tumour -associated macro- 
phages influence tumour development? Probably the best lines 
of evidence correlate the macrophage content of tumours either 
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with prognosis or their biological behaviour. 
(a) Correlation between mononuclear cell infiltration of 
human tumours and prognosis 
Initial reports demonstrating the presence of mononuclear 
cells within human tumour masses first appeared during the 
latter half of the 19th century (reviewed by Underwood, 1974). 
The gross similarity between the tumour -associated infiltrate 
and that present within sites of chronic inflammation gave 
rise to the quite logical theory that cancer originates at 
sites of previous chronic inflammation. Handley (1907) was 
the first to suggest a potentially beneficial role for mono- 
nuclear cell infiltration of tumours. He studied a single 
patient with disseminated melanoma and proposed that "the 
abundant round cell infiltration and the absence from 
this region of a network of small permeated lymphatics are 
clear indications that reparatory processes, inadequate for 
cure, are not wanting in melanotic sarcoma." 
Many authors have attempted to establish a correlation 
between mononuclear cell infiltration of tumours and their 
prognosis. MacCarty (1922) investigated the relationship 
between various histologically recognizable tumour features 
and postoperative survival in a group of 293 cases consisting 
of cancer of the stomach, breast and rectum. He reported a 
three fold increase in postoperative life provided that lympho- 
86 
cyte infiltration, tumour cell differentiation, fibrosis and 
hyalinization were all present within the primary tumour. 
Lymphocyte infiltration in the absence of the other features 
also improved survival prospects although the average length 
of post operative survival was greater if all the factors 
were present. 
In another retrospective study MacCarty and Mahle(1921) 
investigated the postoperative life span of 200 gastric cancer 
patients staged as to degree of spread. The results indicated 
that for the small number of patients with limited glandular 
involvement there was a marked survival advantage if tumour 
cell differentiation and mononuclear cell infiltration were 
present. 
The early studies of MacCarty (1922) and MacCarty and 
Mahle (1921) were the first to demonstrate an albeit rather 
weak association between mononuclear cell infiltration and 
improved prognosis and are particularly important for, unlike 
most of the more recent investigations, none of the patients 
received therapy other than surgery. Few recent studies 
comment on the possible effects of prior radiotherapy or 
chemotherapy on host cell content or survival. Recently, 
Underwood (1974) reviewed over 30 publications dealing with 
non -lymphoid tumours which have appeared since 1921. Most 
of these reported a positive association between lymphoreticular 
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infiltration and an improved prognosis, although there were 
several exceptions. 
One of the strongest arguments in favour of an important 
role of mononuclear cell infiltration in tumour growth comes 
from studies on medullary carcinoma of the breast. These 
tumours display highly "malignant" cytological features and 
in general would be expected to have poor long term survival 
rates. Moore and Foote (1949) in a study of 1,000 patients 
who had undergone radical mastectomy identified 52 cases of 
medullary carcinoma. In most instances such tumours were 
shown to contain dense lymphoid infiltration. These med- 
ullary carcinoma patients exhibited greatly enhanced survival 
as a group compared to other breast cancers. Only 6 (11.5 %) 
died within 5 years, a figure approximately five times better 
than was seen with other breast cancers. In addition, 
although 22 (42.3 %) had axillary metastasis at operation, 
11 (50 %) were well after 5 years compared with a 27% 5 year 
survival in other types of breast cancer with axillary involve- 
ment. Unfortunately, this study was retrospective and used 
historical controls for survival and some of the figures 
obtained are at odds with other more extensive studies 
(Morrison et al., 1973). 
Berg (1959) investigated the relationship between inflamm- 
ation and survival in patients with large anaplastic breast 
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tumours. He demonstrated that 73% of patients who survived 
more than 5 years after removal of the primary tumour had 
shown marked round cell (mainly plasma cell) infiltration at 
the junction of tumour and normal breast while only 30% of 
patients who survived less than three years had exhibited 
a similar infiltration. Berg concluded that the association 
between good prognosis and inflammation was probably the result 
of the lower metastatic potential of large anaplastic tumours 
associated with plasma cell infiltrate. 
A large number of studies have demonstrated a strong 
correlation between the content of host immune cells and 
prognosis in Hodgkin's lymphoma. For example, Keller et al. 
(1968) subgrouped 176 previously untreated cases of Stage I 
and II Hodgkin's disease as to whether they exhibited lympho- 
cyte predominance, nodular sclerosis, mixed cellularity or 
lymphocyte depletion. Lymphocyte predominance was observed 
in 5% of cases and such patients exhibited greatly improved 
prognosis as a group, with approximately 90% surviving longer 
than 5 years. In contrast, only 40% of patients with lympho- 
cyte depletion survived 5 years. Similar results have been 
obtained by many other groups (reviewed by Underwood, 1974). 
It appears that at least for certain human tumours there 
is a direct correlation between the degree of host cell infil- 
tration and an improved clinical prognosis. However, many 
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exceptions have been reported and some authors disappointed 
by inconsistant results have rejected the concept entirely 
(Champion et al., 1972; McGovern et al., 1973; Morrison 
et al., 1973). However, it would indeed be surprising if 
it were always possible to correlate a complex biological 
phenomemon such as survival with any single characteristic 
in all tumours. In addition, in many studies the nature 
of the infiltrate was not defined or loose generalized 
descriptions such as round cell or lymphoreticular were 
used. These descriptions do not take into account the 
functional heterogeneity that exists within populations of 
lymphocytes or macrophages nor do they consider the variable 
effects different tumours may have on immune cell function. 
Virtually all reports correlating survival with mono- 
nuclear cell infiltration have been concerned with the char- 
acteristics of a surgically removed primary tumour. However, 
it is metastatic disease which kills most patients (Clark, 
1979). This raises the question of how tumour -associated 
macrophages bring about improved prognosis. One possible 
explanation is that these cells benefit the host by prevent- 
ing or reducing metastasis. 
Lauder et al. (1977) suggested that the close assoc- 
iation of macrophages and tumour cells observed in primary 
breast carcinomas may have retarded tumour cell emigration 
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and contributed to the lack of metastasis in those patients 
with prominent host cell infiltrates. Similarly, Pelouze 
and Bonenfant (1979) showed that gastric carcinomas infil- 
trated by high numbers of host cells produced fewer nodal 
metastases and an increased duration of survival as compared 
to similar tumours infiltrated by low numbers of host cells 
(reviewed by Eccles, 1982). The possible relationship be- 
tween host cell content and metastasis has received consider- 
able attention in animal studies. 
(b) Correlation between macrophage infiltration of animal 
tumours and metastasis 
Evidence that mononuclear cell infiltration of tumours 
influences their capacity for spontaneous metastasis can be 
no more than circumstantial. It is however a frequent find- 
ing that tumours with the lowest incidences of spontaneous 
metastases tend to be immunogenic and contain the highest 
numbers of host cells, particularly macrophages. Such a 
correlation has been demonstrated for rat sarcomas (Eccles 
and Alexander, 1974), mouse sarcomas (Mantovani, 1978), 
mouse lymphomas (Davey et al., 1979) and rat gliomas and 
sarcomas (Morantz et al., 1979; Moore and Moore, 1977a). 
In studies where tumour immunogenicity but not host cell 
content was reported, various investigators have shown that 
highly immunogenic rat mammary carcinomas (Kim, 1970) and 
mouse colorectal carcinomas (Belnap et al., 1979) and sar- 
comas (Fidler et al., 1979) yielded fewer spontaneous 
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metastases than did similar poorly immunogenic tumours. 
There are of course many exceptions to this rule. For 
instance, Eccles (1982) found groups of Bittner factor pos- 
itive mouse mammary adenocarcinomas and chemically induced 
squamous cell carcinomas in which negligibly or weakly immuno- 
genic tumours containing low to moderate numbers of macro- 
phages failed to develop spontaneous metastases. It must 
be remembered however that metastasis is a complex biological 
phenomenon which depends on both the characteristics of the 
tumour cells and the host immune response. Presumably in 
some circumstances tumour characteristics alone may prevent 
or limit the possibility of spontaneous metastases develop- 
ing (Sugarbaker, 1979). Thus while low levels of infil- 
trating cells are not necessarily associated with tumours of 
high metastatic potential there are few examples in animal 
studies, of tumours containing a dense host cell infiltrate 
successfully producing high incidences of overt metastasis. 
Although these observations do not establish causality they 
are strongly suggestive of a role for tumour- associated host 
cells, particularly macrophages, in preventing metastasis. 
The major advantage of animal studies is the ability 
to manipulate various immunological parameters. Thus the 
importance of tumour-associated macrophages to the develop- 
ment of spontaneous metastases can be investigated by 
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increasing or decreasing the number of such cells. In some 
tumour systems T- lymphocyte depletion produces a considerable 
decrease in the number of tumour -associated macrophages and 
an associated increase in the incidence and /or distribution 
of metastases. This effect has been documented for rat 
sarcomas grown in animals T lymphocyte depleted by thymectomy 
plus whole body irradiation (Eccles and Alexander, 1974) or 
Cyclosporin A treatment.(Eccles et al., 1980) and in congen- 
ically athymic animals (Eccles, 1980; Eccles et al., 1979). 
Similar results were also obtained for mouse sarcomas or 
lymphomas grown in congenitally athymic animals (Eccles, 1982) 
or Cyclosporin A treated animals (Eccles et al., 1980) and 
mouse mammary adenocarcinomas grown in animals T- lymphocyte 
depleted by thymectomy and irradiation (Parthenais and Haskill, 
1979). Reconstitution of T- lymphocyte depleted animals with 
lymphoid cells usually restored metastasis to the levels found 
in control animals (Eccles, 1978; Pimm and Baldwin, 1978; 
Parthenais and Haskill, 1979). 
Thus it appears that manipulation of T cell responses 
reduces tumour -associated macrophage number and may affect 
metastasis, suggesting that these variables are somehow 
related. It should however be noted that the processes 
used to alter the macrophage content of a tumour frequently 
alter other factors that might influence metastasis, in part- 
icular lymphocyte- mediated responses. 
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Assuming for a moment that tumour -associated macrophages are 
important in controlling metastasis how might they produce 
this effect? Certainly, if it were possible to prevent 
malignant cells from leaving the primary tumour site, met- 
astasis would not occur. It is tempting to consider that 
high levels of tumour -associated macrophages, while failing 
to prevent local growth may still prevent or inhibit tumour 
cell emigration. If this mechanism does occur then one might 
expect macrophages from highly immunogenic, non -metastatic 
tumours to be more cytotoxic than those from weakly immuno- 
genic, metastatic tumours. Mantovani (1978) found that the 
highly immunogenic non -metastatic murine FS6 sarcoma contained 
more than twice the number of macrophages than its weakly 
immunogenic, subline mFS6. addition, 
while macrophages from the FS6 tumour inhibited the growth 
and DNA synthesis of tumour cells in vitro, macrophages obtained 
from the mFS6 tumour non -specifically enhanced the prolif- 
erative activity of tumour target cells. However, opposite 
results have been found in other tumour systems. For example, 
macrophages isolated from the highly immunogenic, non -metastatic 
rat HSBPA fibrosarcoma were poorly cytotoxic in vitro (Eccles 
and Alexander, 1974). In contrast macrophages from the 
poorly immunogenic, metastatic rat HSN and ASBP1 fibrosarcomas 
exhibited strong non -specific cytotoxic activity (Evans, 1975). 
Most recently, Loveless and Heppner (1983) compared the macro- 
phage content and function of a series of transplanted mouse 
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mammary tumours originally derived from a single spontaneously 
arising tumour. No correlation was found between macrophage 
content and metastatic capacity. Moreover, macrophages from 
every metastatic tumour used were found to be cytotoxic whereas 
only 6 out of 17 non -metastatic tumours contained cytotoxic 
macrophages. 
(c) Correlation between macrophage content of tumours 
and regression 
Spontaneous regression of established primary neoplasms 
in humans is a relatively rare event. There has however 
been infrequent observations of spontaneous regression of 
malignant melanoma in which partial or total disappearance 
of primary tumours has been clearly documented. Tumour 
regression was frequently accompanied by a dense host cell 
infiltrate (Burg and Braun -Falco, 1972; McGovern et al., 
1973) although several reports failed to find such an assoc- 
iation (Jones et al., 1968; Cochran, 1969). Tumour cell 
imprint preparations from a regressing melanotic lesion 
revealed numerous large macrophages in juxtaposition to 
melanoma cells (The et al., 1972). Epstein et al. (1973) 
reported a series of melanoma patients with skin metastases 
in whom removal of a primary melanoma was associated with the 
appearance of multiple prominent halo nevi. However, on this 
occasion lymphocytes and not macrophages were observed around 
typical degenerating melanoma cells. 
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In two well established murine tumour systems, the 
mammary adenocarcinoma T1699 (Haskill et al., 1975b) and 
the Moloney virus -induced sarcoma (Russell and Cochrane, 
1974; Holden et al., 1976), spontaneous regression was 
associated with the accumulation of lymphocytes, macrophages 
and granulocytes. Both tumour- associated lymphocytes and 
macrophages exhibited direct cytotoxic activity in vitro. 
Moreover, macrophages from regressing T1699 tumours were 
also capable of killing tumour targets by ADCC (Haskill and 
Fett, 1976). 
For some regressing tumours, histological studies show 
a close association between infiltrating macrophages and 
tumour cells. For example, in a regressing transplanted 
rat tumour, numerous macrophages were observed with long 
processes closely apposed to tumour cells, with all stages 
of phagocytosis of apparently intact tumour cells evident 
(Carr et al., 1974). Analogous appearances have been noted 
in regressing leukaemic intradermal tumours and hepatomas 
(Snodgrass and Hanna, 1973; Feldman et al., 1974). 
If tumour -associated macrophages do have the potential 
to destroy neoplastic cells, then it is logical to assume that 
experimental procedures which increase either their number, 
or functional activity will have an inhibitory effect on 
tumour growth. Indeed, treatment of tumour masses by intra- 
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lesional injection of BCG or C.parvum is based on the 
assumption that these procedures will increase both the 
number and activity of tumour -associated macrophages. 
Moreover, such treatments have on occasion been shown to 
produce dramatic regression of animal (Zbar et al., 1972; 
Likhite, 1974) and human (Morton et al., 1970, 1974; 
Holmes et al., 1976) tumours. In addition, several studies 
have demonstrated that bacterial adjuvants injected intra- 
tumourally or admixed with a tumour cell inoculum greatly 
increased the macrophage content of certain rat or mouse 
sarcomas and produced a decrease in the number or incidence 
of spontaneous metastases (reviewed by Eccles, 1982). 
Moore and McBride (1980) reported that regression of 
a murine methylcholanthrene- induced fibrosarcoma following 
a single intraveneous (i.v.) injection of C.parvum was 
accompanied by the appearance within the tumour of a pop- 
ulation of small highly activated macrophages. 
Liposomes constitute a convenient carrier to target 
biologically active materials to macrophages. Following i.v. 
administration, the vast majority (80 -90 %) of liposomes are 
taken up by macrophages (Poste et al.,1982). Moreover, 
liposome- encapsulated mediators of activation such as lympho- 
kines or the synthetic agent N- acetyl -L- alanyl -D- isoglut- 
amine (MDP) are able to induce cytolytic activity in macrophages 
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in vivo and in vitro (reviewed by Fidler and Poste, 1982). 
It has been reported that multiple i.v. injections of lipo- 
somes containing lymphokines (Fidler, 1980; Fidler et al., 
1980; Hart et al., 1981; Fidler et al., 1982; Poste et al., 
1982) or MDP (Fidler et al., 1980; Fidler, 1981; Fidler 
et al., 1981; Fidler et al., 1982) resulted in significant 
destruction of established murine melanoma lung metastases. 
It was assumed that the mechanism of this effect involves 
the localization of activated macrophages within the metastatic 
lesions (Fidler and Poste, 1982). 
In a recent study, Obrist and Sandberg (1983) reported 
that the number of macrophages infiltrating peritoneal hepa- 
tomas was significantly elevated by the i.p. injection of a 
covalent conjugate of the chemotactic peptide, formylmethio- 
nylleucyl- phenylalanine and a monoclonal antibody reactive 
with cell surface antigens on the hepatoma cells. This is 
a particularly important study as it provides a mechanism 
whereby macrophages can be specifically attracted to a tumour 
mass. The use of such chemotactic conjugates in conjunction 
with mediators of macrophage activation could perhaps constitute 
an effective method of immunotherapy. 
Whether accumulation of host cells within a tumour 
actually causes regression or is only circumstantial is often 
not clear. Treatment of sarcoma bearing mice with daily 
azathioprine injections resulted in an increase in the pro- 
portion of tumour -associated T lymphocytes and macrophages. 
However, individually neither macrophages or lymphocytes were 
cytotoxic in vitro (Evans, 1976). Thus it remains question- 
able whether tumour regression was the result of cell- mediated 
cytotoxicity or of drug action alone. Similarly, it was 
recently reported that during cyclophosphamide -induced tumour 
regression, there was an accumulation and infiltration of 
macrophages throughout the tumour mass (Evans, 1980; Evans 
et al., 1980). However, it was apparent in these studies 
that although the tumour mass became smaller, there was an 
actual increase in the number of tumourogenic cells within 
the regressing mass and most tumours eventually showed 
renewed growth (Evans, 1982). 
In summary, it seems that although tumour regression 
is commonly accompanied by a dense host cell infiltrate part- 
icularly macrophages, there is insufficient evidence at 
present to suggest that such host cells always cause the 
regression. Indeed what little evidence there is available 
suggests instead that these cells are often involved in other 
reactions such as clearance of debris (Key, 1983). 
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CHAPTER II - AIMS 
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From a historical point of view, the development of 
techniques for the disaggregation of solid tumour tissue (Evans, 
1972) and the separation of highly enriched populations of tumour - 
associated macrophages (Evans, 1973), came at a time when interest 
was focussed on the ability of macrophages from other sources 
(mainly the peritoneal cavity) to destroy neoplastic cells 
in vitro (reviewed by Evans and Alexander, 1976). Consequently, 
most studies on the functional capabilities of tumour -associated 
macrophages have tended to look only at the cytotoxic activity 
of these cells (reviewed by Evans and Haskill, 1983). There 
is however increasing evidence that macrophages play a pivitol 
role in many diverse immunobiological reactions (reviewed by 
Dougherty and McBride, 1984) and their presence within the 
tumour mass suggests various ways in which they may interact 
with the neoplasm. 
In recent years a vast amount of data has been collected 
implicating the macrophage as an essential accessory cell in 
the induction, expression and regulation of humoral and cell - 
mediated immune responses (reviewed by Unanue, 1981; Unanue 
et al., 1984). However, at present, very little is known 
about the accessory cell activity of tumour -associated macro- 
phages. It was the aim of the present study to identify and 
characterize the macrophages infiltrating the highly immuno- 
genic methylcholanthrene- induced murine fibrosarcoma FSA -R and 
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investigate the accessory cell activity of these cells in well 
defined in vitro assay systems. 
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CHAPTER III - MATERIALS AND METHODS 
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1.0 BUFFERS, MEDIA AND STAINS 
Unless otherwise stated all chemicals used in preparation 
of buffers, media and stains were analytical grade obtained 
from BDH Chemicals Ltd., Poole, England. 
1.1 Cacodylate buffer, pH 6.9, 0.28M 
60g of sodium cacodylate (Fisons Scientific Apparatus, 
Loughborough, England) was dissolved in 950 ml distilled water 
and the pH adjusted to 6.9 with approximately 11 ml IN HCC. 
The final volume of the solution was made up to 1 litre with 
distilled water. 
1.2 Dulbecco's phosphate buffered saline (modified) (D.PBS) 
D.PBS was prepared by dissolving 8.Og NaCl, 0.2g KC1, 
1.08g Nat HPO4, 0.2g KH2PO4, 0.89g CaC12.2H20 and 0.203g 
Mg C12.6H20 up to 1 litre with distilled water. 
1.3 Hank's balanced salt solution (HBSS) 
HBSS was made up from a powdered concentrate purchased 
from Oxoid Ltd., Basingstoke, England. 
1.4 Tris buffered saline, pH 7.6 (TBS) 
A stock solution of TBS was prepared by dissolving 6.05g 
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of 2- amino -2- (hydroxymethyl) propane - 1,3 -diol (Tris buffer) 
(Filons Scientific Apparatus, Loughborough, England) and 8.5g 
of NaC1 in 950 ml distilled water and the pH adjusted to 7.6 
with approximately 40 ml of IN HC1. The final volume of the 
solution was made up to 1 litre with distilled water. The 
stock solution was stored for up to 1 month at 4 °C and diluted 
1 in 10 with normal saline as required. 
1.5 Tissue culture medium 
RPMI 1640 medium containing 2.Og /1 Na HCO3 (Flow Laboratories 
Ltd., Irvine, Scotland) was supplemented with 10% heat inactivated 
foetal calf serum (FCS) (Gibco Bio -Cult Ltd., Paisley, Scotland), 
2mM glutamine, 5 x 10 -5M 2- mercaptoethanol, 200 units /ml penicillin 
(Sigma Chemical Company Ltd., Poole, England) and 100µg /m1 
streptomycin (Sigma Chemical Company Ltd., Poole, England). 
1.6 Giemsa stain 
Giemsa stain was diluted 1 in 10 with D.PBS. Cells were 
stained for 2 minutes followed by 5 minutes destaining in D.PBS. 
1.7 Mayer's haematoxylin stain 
3.Og haematoxylin, 0.4g NaI03 and 100g All (SO4)2. 12H20 
were made up to 2 litres with distilled water. To this solution 
was added 100g CC13.CH(OH)2 and 2g of citric acid. Immediately 
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before use, the haematoxylin stain was "ripened" by boiling 
for 5 minutes. Cells were stained for 1 minute at room tem- 
perature. 
1.8 Trypan Blue 
A 0.05% (w /v) solution of trypan blue was prepared in 
saline. To perform a viable cell count 1 part cell suspension 
was added to 9 parts stain. 
1.9 White cell diluting fluid 
A stock solution was prepared by adding 0.1g gentian 
violet to 100 ml 1% acetic acid. To perform a total nucleated 
cell count, the stock solution was diluted 1 in 10 with 1% 





Hybridomas secreting the M1/70.15.11.5 rat monoclonal 
antibody reactive with the macrophage -granulocyte "specific" 
antigen Mac -1 (Springer et al., 1979) or the 10 -2.16 mouse 
monoclonal antibody reactive with I -Ak (0i et al., 1978) were 
obtained from the American Type Culture Collection, Rockville, 
Maryland, USA. Rat anti -mouse Thy -1.2 was a kind gift from 
Dr H.S.Micklem, Department of Zoology, University of Edinburgh. 
ATH anti -ATL, a broadly- reactive anti -Iak antiserum was pur- 
chased from Sera -Lab Ltd., Crawley Down, England. Hyper - 
immune rabbit anti -CRBC antiserum was a kind gift from 
Dr W. H.McBride, Department of Bacteriology, University of 
Edinburgh- 
2.2 Complement 
Pooled normal guinea pig serum served as a source of 
complement for use in haemolytic plaque assays and anti -Ia 
cytotoxicity. In order to remove any naturally occurring 
antibodies, the serum was absorbed for 1 hour at 4 °C with 
30-40% (v /v). packed erythrocytes (for plaque- forming cell 
assay) or an equivalent volume of packed enzymatically dis- 
aggregated FSA -R tumour cells (for anti -Ia cytotoxicity). 
The cells were then spun down, and the serum aliquoted and 
stored in liquid nitrogen. 
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2.3 Erythrocytes 
Calf red blood cells (CRBC) in Alsever's solution were 
purchased from Tissue Culture Services, Slough, England. 
Sheep red blood cells (SRBC) in Alsever's solution were a 




Male C3Hf /Bu Kam mice aged 8 -18 weeks were bred and 
maintained in the animal unit, Department of Bacteriology, 
University of Edinburgh. In some experiments syngeneic 
athymic nude (nu /nu) mice and their phenotypically normal 
heterozygous (nu / +) littermate controls were used. These 
mice were derived from breeding stock kindly provided by 




The FSA -R tumour used in the present study was a well 
characterized, highly immunogenic, methylcholanthrene -induced 
fibrosarcoma syngeneic for C3H f /Bu Kam mice (Suit and 
Kastelan, 1970; Milas et al., 1974; Peters et al., 1978; 
McBride et al., 1980; Moore and McBride, 1980; Howie and 
McBride, 1982b). It was maintained by serial passage in vivo 
and used at transplant generation 8 -18. Experimental tumours 
were induced by s.c. inoculation of 5 x 105 viable enzymatically 
disaggregated tumour cells into the right flank. 
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5.0 IDENTIFICATION, CHARACTERIZATION AND SEPARATION OF 
MACROPHAGES 
5.1 Preparation of antibody- coated erythrocytes 
One ml of 5% (v /v) washed CRBC in HBSS was mixed with 
an equal volume of hyperimmune rabbit anti -CRBC antiserum 
diluted to one -half maximum subagglutinating concentration 
in HBSS, and the mixture incubated at 37 °C for 30 minutes. 
The antibody- coated erythrocytes (EA) were washed three times 
and finally resuspended at 2% (v /v) in HBSS. 
5.2 Detection of Fc receptor -positive cells in sections 
of tumour tissue 
Frozen sections were cut from tumour tissue using a 
Teddington Type QR cryostat (Bright Instrument Company Ltd., 
Huntingdon, England). Tumours were excised and rapidly 
frozen in liquid nitrogen. A suitably sized block of tissue 
was cut from the frozen tumour, mounted on the cryostat specimen 
plate in Cryo -M -Bed embedding medium (Bright Instrument Company 
Ltd., Huntingdon, England) and rapidly cooled using Arctic 
spray (Warecare Ltd., Leic., England). The specimen plate 
was mounted in the cryostat and a large number of 6 pm thick 
serial sections cut. These cryostat sections were mounted 
on clean uncoated glass slides and rapidly dried at 37 °C for 
45 minutes. 
To detect Fc receptor -positive cells, tissue sections were 
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overlayed with 0.5% (v /v) EA in HBSS and incubated at room 
temperature for 45 minutes. After incubation, non -adherent 
cells were removed by immersion with gentle agitation in HBSS. 
The sections were then fixed in 2% glutaraldehyde (BDH Chemicals 
Ltd., Poole, England) in cacodylate buffer and the distribution 
and extent of EA absorption determined. 
5.3 Preparation of enzymatically disaggregated tumour 
cell suspensions 
Enzymatically disaggregated tumour cell suspensions were 
prepared as previously described by Moore and McBride (1980). 
Briefly, tumours were excised and any obviously necrotic areas 
removed. Non -necrotic tissue from three tumours was pooled 
and thoroughly minced using a No 11 scalpel blade (Swan Morton 
Ltd., Sheffield, England). The minced material was washed 
three times with HBSS to remove cell debris and erythrocytes. 
Approximately 1g of washed tumour tissue was added to 20 ml of 
0.05% Dispase (Boehringer, Mannheim, W. Germany) and 0.002% 
Deoxyribonuclease -1 E.C. 3.1.4.5 (DNase) (BDH Chemicals Ltd., 
Poole, England) in HBSS and stirred briskly for 45 minutes at 
room temperature. Any non -disaggregated material was allowed 
to settle for 3 -5 minutes. The released tumour cells present 
in the supernatant were drawn off by pipette, centrifuged at 
200g for 10 minutes and washed twice with HBSS. 
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5.4 Preparation of mechanically disaggregated tumour 
cell suspensions 
Approximately 1g of minced tumour tissue (prepared as in 
section 5.3) was added to 5g of 3mm diameter glass beads and 
20m1 HBSS. This mixture was shaken vigorously for 45 minutes 
at room temperature. The glass beads and remaining tumour 
tissue fragments were allowed to settle for 3 -5 minutes. 
Released tumour cells present in the supernatant were drawn 
off by pipette, centrifuged at 200g for 10 minutes and washed 
twice with HBSS. 
5.5 Collection of resident or C.parvum- elicited peritoneal 
cells 
Normal mice, or mice which had received an intraperitoneal 
injection of 0.25mg C.parvum (Lot 776/1, Wellcome Research 
Laboratories, Beckenham, England) in 0.25m1 saline 4 days 
previously, were killed by cervical dislocation and their 
peritoneal cavities vigorously lavaged with 10m1 HBSS. The 
cell suspensions obtained were centrifuged at 200g for 10 minutes. 
5.6 Separation of macrophages 
Macrophages were enriched from enzymatically disaggregated 
tumour cell suspensions or populations of resident or C.parvum- 
elicited peritoneal cells by virtue of their capacity to adhere 
tightly to solid substrates. 
Enzymatically disaggregated tumour cells were resuspended 
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in HBSS containing 0.1% Dispase and 20% FCS, a mixture which 
effectively prevents lymphocytes and neoplastic cells from 
adhering. One ml aliquots of the cell suspension were placed 
in the wells of a Nunc 24 well tissue culture plate (Gibco 
Bio -Cult Ltd., Paisley, Scotland) and the plate incubated at 
37 °C for 30 minutes. Following the incubation period non- 
adherent cells were removed by vigorously washing the cell 
monolayers three times with HBSS. 
Macrophages were enriched from populations of resident 
or C.parvum -elicited peritoneal cells by the same procedure 
except that these cells were resuspended in HBSS containing 
20% FCS but no Dispase. 
Macrophage monolayers for use in the immunoperoxidase assay 
were prepared using the same technique except that these cells 
were adhered to 13mm diameter glass coverslips placed in the 
bottom of tissue culture wells. 
Adherent cells were quantitated by inverted phase microscopy. 
The area of a field was determined for each microscope objective, 
using a calibrated graticule. The average number of cells present 
per field was then determined for 10 randomly selected, well 
dispersed fields. A suitable magnification was chosen such 
that each field contained 25 -75 cells. Since the area of each 
field was known, it was possible to calculate the number of cells 
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present in the culture simply by multiplying the average number 
of cells per field by the number of fields which make up the 
area of the culture vessel. 
5.7 Detection of Fc receptor -positive cells in cell suspensions 
Enzymatically disaggregated tumour cells and resident or 
C.parvum- elicited peritoneal cells were resuspended in HBSS at 
a concentration of 2 x 106 viable cells /ml. 0.5ml of each 
cell suspension was placed in a 3m1 plastic test tube, 0.5ml 
of EA suspension was added and the mixture centrifuged at 
100g for 5 minutes. Pelleted cells were incubated at room 
temperature for 30 minutes without disturbing. After the 
incubation period, the pellet was gently disrupted by shaking 
and the cells loaded into an Improved Neubauer Haemocytometer. 
A total of 200 cells was counted to determine the percentage 
of EA rosette -forming cells binding three or more erythrocytes. 
5.8 Detection of Fc receptor -positive cells in monolayers 
of adherent cells 
Monolayers of adherent cells were overlayed with 0.5ml 
HBSS and 0.25m1 EA suspension was added. Plates were centri- 
fuged at 100g for 5 minutes and incubated at room temperature 
for 30 minutes. Non -adherent EA were removed by washing mono - 
layers three times with HBSS and a total of 200 cells was counted 
to determine the percentage of EA rosette -forming cells binding 
three or more erythrocytes. 
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5.9 Identification of phagocytic cells by latex particle 
uptake 
Enzymatically disaggregated tumour cells and resident or 
C.parvum- elicited peritoneal cells were resuspended at 1 x 106 
viable cells /ml in tissue culture medium. Latex particles, 
0.81 pm in diameter (Difco Laboratories, Detroit, Michigan, 
USA) were washed three times in HBSS and resuspended at 5 x 
108 particles /ml in tissue culture medium. One ml aliquots 
of each cell suspension were placed in Nunc "minisorp" polyethylene 
tubes (Gibco Bio -Cult Ltd., Paisley, Scotland), 100u1 of the latex 
particle suspension was added and mixture incubated for 1 hour 
at 37 °C in an atmosphere containing 5% CO2. The cells were 
washed three times with HBSS, resuspended in 1 ml of fresh 
tissue culture medium and incubated at 37 °C for a further 30 
minutes to allow ingestion of attached particles. A total of 
200 cells was then counted under phase to determine the per- 
centage of cells which had taken up 5 or more latex particles. 
Phagocytic cells were also identified in monolayers of 
adherent cells using the same procedure as described above. 
5.10 Preparation of cytocentrifuged cell smears 
Cell smears were prepared using a Cytospin cytocentrifuge 
(Shandon Southern Instruments, Runcorn, England). Cells were 
resuspended in HBSS containing 10% FCS at 2 x 105 cells /ml. 
0.2ml aliquots of the cell suspension were added to the cyto- 
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centrifuge chambers and spun at 1500 rpm for 5 minutes. 
5.11 Immunoperoxidase technique 
An indirect immunoperoxidase technique was used to deter- 
mine antigen expression on cytocentrifuged cell smears or mono - 
layers of cells adherent to glass coverslips. All procedures 
were carried out at room temperature in a humidified atmosphere. 
Cells were fixed in 1% paraformaldehyde (Fisons Scientific 
Apparatus, Loughborough, England) in cacodylate buffer for 20 
minutes. The fixative was removed and the cells washed three 
times in TBS. Endogenous peroxidase activity was blocked by 
incubating the fixed cells in methanol containing 0.3% hydrogen 
peroxide (BDH Chemicals Ltd., Poole, England) for 15 minutes. 
The cells were then washed three times in TBS and any available 
Fc receptors blocked by incubating with TBS containing 20% 
normal rabbit serum (NRS) (Scottish Antibody Production Unit, 
Carluke, Scotland) for 15 minutes. After this incubation period, 
the fluid was gently drawn off and the cells incubated with the 
appropriate hybridoma culture supernatant for 30 minutes. The 
cells were then washed for three 5 minute periods to remove 
unbound antibody, and incubated for 10 minutes with the approp- 
riate peroxidase- conjugated rabbit second antibody (Dakopatts, 
Copenhagen, Denmark) diluted 1/80 in TBS containing 2% NRS. 
The cells were then washed for three 10 minute periods and 
cell -bound peroxidase- conjugated antibodies visualised using 
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the substrate 3, 4, 3', 4'- tetra -aminobiphenyl hydrochloride 
(DAB) (BDH Chemicals Ltd., Poole, England). The substrate 
was made up by dissolving 4mg DAB in 20 ml stock TBS contain- 
ing 10p1 30% (v /v) hydrogen peroxide. Cells were incubated 
with the substrate for 4 minutes, thoroughly washed with 
distilled water, counterstained with haematoxylin and mounted 
in D.P.X. 
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6.0 DETERMINATION OF MACROPHAGE ACCESSORY CELL ACTIVITY 
6.1 CRBC priming 
Animals were injected i.p. with 0.1m1 1% (v /v) CRBC in 
HBSS on two occasions 4 weeks apart. Spleens were used as 
a source of CRBC- specific TH cells 2 -4 weeks after the last 
injection. 
6.2 Separation of splenic T lymphocytes 
T lymphocytes were purified by passage of spleen cells 
over a nylon wool column as described by Julius et al. (1973). 
Briefly, 1g of scrubbed nylon fiber (Fenwal Laboratories, 
Deerfield, Illinois, USA) was packed into a plastic 5m1 dis- 
posable syringe.(Becton Dickinson and Co. Ltd., Ireland), giving 
a column approximately 3 cm high. Columns were rinsed with 
25ml tissue culture medium and incubated at 37 °C for 1 hour in 
a 5% CO2 atmostphere. After the incubation period the columns 
were allowed to run dry and 1 x 108 spleen cells in 1m1 of tissue 
culture medium were gently layered onto the top of the column 
and allowed to penetrate the nylon wool. The columns were then 
sealed using the syringe plunger and incubated at 37 °C for 1 hour 
in a 5% CO2 atmostphere. Non -adherent cells were eluted by 
washing columns with tissue culture medium pre- warmed to 37 °C. 
Only the first 15 ml eluted from the column were collected. 
Approximately 10 -15% of the cells initially applied were recovered 
following this procedure and 85 -95% of these were found to be 
Thy -1.2 positive by immunofluorescence (Howie and McBride, 1982b). 
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6.3 Depletion of accessory cells from spleen cell suspensions 
Spleen cells were depleted of accessory cells by passage 
through a column of Sephadex G -10. The method used was a 
slight modification of that described by Ly and Mishell (1974). 
250g of Sephadex G -10 (Pharmacia Fine Chemicals, Uppsala, 
Sweden) was added to 2 litres of saline and allowed to swell 
overnight at 4 °C. After this period, the saline was removed 
from the settled Sephadex by suction and the gel resuspended in 
a volume of fresh saline that was approximately four times the 
estimated bed volume. The Sephadex was allowed to settle for 
15 minutes and any unsettled fine particles were removed by 
suction. This process was repeated three or four times or 
until the majority of fine Sephadex particles had been removed. 
A volume of saline equal to 30 -50% of the estimated bed volume 
was added to the Sephadex. The slurry produced was aliquoted 
and autoclaved at 110 °C for 40 minutes with slow exhaust. The 
sterile Sephadex was stored at room temperature until required. 
Approximately 1g of glass wool (May and Baker Ltd., 
Dagenham, England) was tightly packed into the bottom of a 60m1 
disposable plastic syringe (Becton Dickinson and Co. Ltd., 
Ireland) and sufficient Sephadex G -10 added to give a packed 
column up to the 50m1 mark on the syringe. The column was 
washed with 100 -150m1 of HESS containing 5% FCS. After the 
last of the HESS plus 5% FCS had been added, the top of the 
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Sephadex was stirred with a pipette to give a level top to the 
column. When all the fluid had penetrated the column, 5 ml 
of spleen cell suspension containing 1 x 108 viable cells /ml 
was carefully added. Once the cells had penetrated the column, 
small amounts of HBSS plus 5% FCS were added until the cell 
band was midway down the column. At this point the syringe 
was filled to the top with HBSS plus 5% FCS. When the cell 
band reached the glass wool layer the next 15 ml of column 
effluent was collected. The cell suspension was allowed 
to stand for 2 -3 minutes to allow any contaminating Sephadex 
to settle before the cells were transferred to another container 
and centrifuged at 200g for 10 minutes. 
6.4 Depletion of Ia- positive cells from adherent cell 
monolayers 
Monolayers of adherent cells were overlayed with 0.5ml of 
ATH anti -ATL antiserum diluted 1/20 in HBSS and incubated for 
30 minutes on ice. The antiserum was drawn off, replaced by 
absorbed guinea pig serum diluted 1/20 in HESS and the plates 
incubated at 37oC for 1 hour. At the end of this time, mono- 
layers were washed three times with HBSS and the number of 
adherent cells remaining determined by inverted phase microscopy. 
6.5 Separation of enzymatically disaggregated tumour cells 
by centrifugal elutriation 
Enzymatically disaggregated tumour cells were separated 
into populations of differing modal diameter using the Beckman 
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JE -6 elutriator rotor fitted with a standard horizontal chamber 
and driven by a modified J2 -21 centrifuge. Fluid was pumped 
through the system using a Masterflex peristaltic pump with 
fine adjustable velocity control. Cells were elutriated in 
D.PBS at room temperature. The rotor was maintained at a 
constant speed of 2000 rpm and i x 108 viable cells were loaded 
into the chamber. The pump speed was then progressively 
increased and 5 150m1 fractions were collected at the flow rates 
indicated in the results section. The cells present in each 
fraction were spun down at 200g for 10 minutes, resuspended in 
10m1 tissue culture medium and their size distribution deter- 
mined using a Coulter Channelyser system (Coulter Electronics 
Ltd., Luton, England) which was previously calibrated using latex 
beads of known size. The cellular composition of each fraction 
was determined from Giemsa stained cytocentrifuge preparations. 
6.6 Preparation of macrophage conditioned medium 
Monolayers of tumour -derived adherent cells were prepared 
as described in Section 5.6. Monolayers were overlayed with 
1 ml of tissue culture medium and incubated at 37 °C for 24 or 
48 hours in a 5% CO2 atmostphere. Supernatants from at least 
6 replicate wells were pooled, centrifuged at 450g for 20 minutes 
to remove any cell debris and stored in liquid nitrogen until 
required. 
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6.7 Trinitrophenylation of tumour cells and erythrocytes 
Irradiated (5000 rads) enzymatically disaggregated FSA -R 
tumour cells at 106 cells /ml or washed CRBC or SRBC at 10% 
(v /v) were mixed with an equal volume of cacodylate buffer con- 
taining 2mg /ml 2,4,6 -trinitrobenzene sulfonic acid (TNBS) 
(Eastman Kodak Co., Rochester, NY, USA) and incubated for 10 -15 
minutes at room temperature. At the end of this time, the 
reaction was halted by the addition of 10mg /m1 glycylglycine 
(Sigma Chemical Company, Poole, England). The trinitrophenyl 
(TNP)- coupled cells were spun down and washed 3 times with 
HBSS. TNP- coupled tumour cells were resuspended in HBSS con- 
taining 10% dimethyl sulfoxide and 20% FCS, aliquoted and stored 
in liquid nitrogen. TNP- coupled erythrocytes were stored at 
4 °C in HBSS and used within 3 days. 
6.8 Determination of macrophage accessory cell activity 
Macrophage accessory cell activity was examined in the 
generation of PFC responses against CRBC or TNP, in the presence 
or absence of added TH cells. Triplicate 2m1 cultures in RPM' 
1640 tissue culture medium were set up as described in the 
results section incubated at 37 °C in a 5% CO2 atmosphere and the 
PFC responses generated were normally determined on day 4. 
6.9 Detection of haemolytic PFC 
The method used was essentially that previously described 
by Cunningham (Cunningham, 1965; Cunningham and Szenberg, 1968). 
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Indicator erythrocytes, lymphoid cells and complement were mixed 
together, placed in a microchamber and allowed to settle as a 
monolayer. Antibodies released by single lymphocytes bind to 
surrounding erythrocytes which are subsequently lysed as the 
result of complement activation thereby producing plaques. The 
method is relatively simple, economic and sensitive and permits 
the enumeration of antibody -producing cells even when they con- 
stitute a small minority of the total lymphocyte population. 
Microchambers were constructed from pre -cleaned glass 
microscope slides. Approximately 25 slides were aligned along 
the edge of a bench and strips of 5mm wide, double- sided, pressure 
sensitive Scotch tape were placed along the middle and both ends 
of the row of slides. Other pre -clean slides were placed directly 
on top of the taped slides thereby forming a microchamber between 
the two slides. Microchambers prepared in this fashion had a 
capacity of approximately 175p1. 
To determine the number of PFC generated in vitro, the cells 
present in each tissue culture well were gently resuspended and 
the cell suspensions transferred to small plastic centrifuge tubes. 
The cells were centrifuged at 25Og for 5 minutes and resuspended in 
1ml of HBSS containing 5% of FCS. 50- 15011 of the cell sus- 
pensions were added to 2Op1 20% (v /v) indicator erythrocytes and 
10F1 absorbed guinea pig serum and the mixture made up to a final 
volume of 2001 with HBSS plus 5% FCS. With an appropriate 
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pipette a measured volume of this mixture was loaded into a 
microchamber. The edges of the chamber were sealed with 
molten wax and the slides incubated at 37 °C for 1 hour. The 
haemolytic plaques produced were quite visible with the naked 
eye but for accuracy were counted using a low powered micro- 
scope with oblique illumination. CRBC indicator erythrocytes 
were used to determine anti -CRBC PFC responses while anti -TNP 
responses were determined by subtracting the number of back- 
ground PFC found using SRBC indicator cells from the number of 
PFC found using TNP -SRBC indicator cells. 
125 
7.0 STATISTICS 
The statistical significance of data was determined using 
Student's t -test. 
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CHAPTER IV - RESULTS 
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SECTION I - IDENTIFICATION, CHARACTERIZATION AND 
SEPARATION OF TUMOUR -ASSOCIATED 
MACROPHAGES 
1.0 TUMOUR CHARACTERIZATION 
The FSA -R tumour used in these studies is a highly 
immunogeneic methylcholanthrene- induced fibrosarcoma. It 
was maintained in syngeneic C3H f /Bu Kam mice by serial s.c. 
passage of 5x105 viable tumour cells. With this inoculum 
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100% of animals developed tumours. Palpable tumours first 
became evident around 7 days post inoculation and grew prog- 
ressively killing all animals by day 32 (Figure 1). Tumour 
masses were discrete and circumscribed with minimal invasion 
of surrounding tissues. There was no evidence of obvious 
metastatic disease, although tumour cells could occasionally 
be cultured from the spleen of tumour -bearing animals. Tumours 
less than 20 mm in diameter were usually firm with only a few 
small necrotic areas. After exceeding 20 mm in diameter, 
however, central portions of the tumour mass were frequently 
either cystic, necrotic or both. Consequently, unless 
otherwise stated, tumours of less than 20 mm in diameter, 
obtained 14 -21 days post inoculation (Figure 1) were used for 
all subsequent experiments. Haemorrhagic tumours or tumours 
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Figure 1 Growth rate of the FSA -R tumour. Animals received 
5x105 viable tumour cells s.c. on day 0. At 
intervals thereafter tumour growth was determined 
by taking the mean of opposing diameters. Each 
point represents the mean diameter - 1 SEM of at 
least 8 tumours. 
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2.0 IDENTIFICATION AND QUANTITATION OF TUMOUR -ASSOCIATED 
MACROPHAGES 
2.1 Identification and quantitation of macrophages in 
sections of tumour tissue 
In this and various other tumour systems, a good corre- 
lation has generally been found between the percentage of Fc 
receptor -positive cells and the percentage of tumour- assoc- 
iated macrophages as determined by other criteria (Kerbel and 
Pross, 1976; Wood and Morantz, 1979; Moore and McBride, 1980, 
1983). Consequently, absorption of EA to frozen sections of 
tumour tissue was used to determine the approximate percentage 
of macrophages and their distribution in the intact tumour. 
Roughly 25% of the surface area of tumour sections bound EA. 
The pattern of binding obtained could best be described as 
diffuse, suggesting that Fc receptor -positive cells, presumably 
macrophages, were distributed throughout the tumour mass. 
2.2 Identification and quantitation of macrophages 
in tumour cell suspensions 
In order to more accurately quantitate tumour -associated 
macrophages and isolate these cells for further study it was 
necessary to disaggregate the tumour tissue. Although it was 
considered desirable to avoid the use of enzymes, mechanical 
disruption always produced preparations of low yield and poor 
viability (< 40% excluded trypan blue). In contrast, Dispase/ 
DNase treatment resulted in almost complete disaggregation of 
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tumour tissue and gave single cell suspensions of relatively 
high viability (> 80% excluded trypan blue). 
The percentage of cells present in tumour cell suspensions 
which could be characterized as macrophages was determined by 
enumeration of both Fc receptor -positive and phagocytic cells. 
Fc receptor -positive cells were identified by rosette formation 
and phagocytic cells by uptake of latex particles. The 
results presented in Table I show that on average, 24.5% of 
the cells present in enzymatically disaggregated tumour cell 
suspensions expressed Fc receptors while only 20% phagocytosed 
latex particles. Equivalent results obtained for resident 
or C.parvum -elicited peritoneal cells are included for com- 
parison. in agreement with published accounts of 
the macrophage content of these populations (Daems, 1980), 
and serve as a control for the reagents and procedures used. 
On the basis of these results it would seem that approx- 
imately 20 -25% of enzymatically disaggregated tumour cells may 
be classified as macrophages. This figure is very similar to 
the percentage of macrophages identified in tumour tissue 
sections by EA absorption (see section 2.1) and suggests that 
the enzymatic disaggregation procedure does not preferentially 
enrich or deplete macrophages. 
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TABLE I Identification and characterization of FSA -R 
tumour -associated macrophages. 







I -Ak MAC -id 
Whole resident N.D. 
peritoneal cells 
Adherent resident 97.7 -1.4 
peritoneal cells 
Whole C.parvum- N.D. 
elicited peritoneal 
cells 
Adherent C.parvum- 98.7 ±0.3 
elicited peritoneal 
cells 
FSA -R tumour 24.5 -0.8 
cell suspension 
Adherent tumour- 96.4 ±1.1 
derived cells 
43.811.0e N.D. 46.0 ±4.5 
93.0 ±2.1 36.8 ±1.9 91.5 ±1.0 
45.2 -1.0 N.D. 41.5 ±1.3 
92.2 ±1.9 N.D. 88.7 -1.3 
20.0 -0.4 9.1 -0.7 0.3 ±0.2 
92.1 ±1.7 56.0 -1.1 4.2 -0.5 
a 
Fc receptor -positive cells were identified by EA rosette 
formation. 
b Phagocytic cells were identified by uptake of latex 
particles. 
c I- Ak- positive cells were identified by an indirect immuno- 
peroxidase assay using monoclonal antibody 10 -2.16. 
d 
Mac -l- positive cells were identified by an indirect immuno- 
peroxidase assay using the rat anti -mouse -macrophage 
monoclonal antibody M1/70. 
e Each result represents the mean of 3 experiments - 1 SEM. 
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3.0 SEPARATION OF MACROPHAGES BY ADHERENCE TO 
SOLID SUBSTRATES 
Macrophages were enriched from tumour cell suspensions 
and populations of resident or C.parvum -elicited peritoneal 
cells by virtue of their capacity to adhere tightly to glass 
or plastic surfaces. Graded numbers of cells were added to 
tissue culture wells and incubated at 37 °C for 30 minutes in 
the presence of 20% FCS (peritoneal cells) or 0.1% Dispase 
and 20% FCS (tumour cell suspensions). Non -adherent cells 
were removed by gentle washing and the number of adherent 
cells estimated by inverted phase microscopy. 
For each of these cell populations an excellent linear 
correlation (R 0.99) was found the number 
added to each tissue culture well and the number of cells 
which remained adherent (Figure 2). From the appropriate 
linear regression equations it can be calculated that at 
all cell concentrations which were examined, approximately 
17.6% of tumour cells, 17.5% of resident peritoneal cells and 
20.7% of C.parvum elicited peritoneal cells were adherent. 
As shown in Table I more than 90% of the adherent cells 
isolated from tumour cell suspensions and resident or C.parvum- 
elicited peritoneal cells could be characterized as macrophages 




HUMBER CELLS / CULTURE 
Quantitation of adherent macrophages by inverted phase 
microscopy. Various numbers of enzymatically dis- 
aggregated FSA -R tumour cells ( -), resident periton- 
eal cells (0 - - --0) or C.parvum- elicited peritoneal cello 
(A,--41L) were added to tissue culture wells and incub- 
ated at 37 °C for 30 mins in presence of 20% FCS 
(peritoneal cells) or 0.1% Dispase and 20% FCS (tumour 
cell suspension). Non- adherent cells were removed by 
gentle washing and the adherent cells quantitated by 
inverted phase microscopy. For each of these cell 
populations an excellent linear correlation (R> 0.99) 
was found between the number of cells added to each 
tissue culture well and the number of cells which 
remained adherent. 
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4.0 EFFECT OF SERIAL TRANSPLANTATION ON THE MACROPHAGE 
CONTENT OF THE FSA -R TUMOUR 
The effect of serial transplantation on the number of 
macrophages infiltrating FSA -R tumours was investigated. 
Tumours were harvested 15 -20 days after inoculation of 
5x105 viable tumour cells and the percentage of macrophages 
present in enzymatically disaggregated tumour cell suspensions 
and monolayers of tumour- derived adherent cells was determined 
by EA rosette formation. As can be seen in Table II, there 
was no significant change in the percentage of macrophages 
in either of these two populations during serial transplant- 
ation of the tumour (pass 8 -18). 
TABLE II Effect of serial transplantation on the macrophage 
content of the FSA -R tumour. 
Passage 
Number 
Fc receptor -positive cellsa 
Whole FSA -R Adherent RSA -R 
8 22.2 ± 1.4 b 92.2 ± 1.5 
10 23.2 t 1.2 92.8 ± 2.1 
12 22.5 ± 1.4 93.7 ± 2.3 
13 23.2 
± 
0.9 96.5 ± 1.6 
17 24.2 
± 
0.4 97.0 ± 1.3 
18 24.8 ± 0.6 93.7 ± 1.3 
a 
b 
Fc receptor -positive cells were identified by EA 
rosette formation. 
Each result represents the mean of 3 experiments 
± 1 SEM. 
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5.0 EFFECT OF TUMOUR GROWTH ON THE MACROPHAGE CONTENT 
OF THE FSA -R TUMOUR 
The percentage of macrophages infiltrating the FSA -R 
tumour was determined as a function time. Tumours were 
harvested at intervals after s.c. inoculation of 5x105 viable 
tumour cells, and the percentage of macrophages present in 
enzymatically disaggregated tumour cell suspensions and 
monolayers of tumour -derived adherent cells was determined 
by EA rosette formation. As indicated in Table III there 
was no significant change in the percentage of macrophages 
in either of these two populations during the observed period 
of tumour growth despite the finding that tumours, particularly 
late in growth, differed considerably with respect to size 
and degree of necrosis. 
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TABLE III Effect of tumour growth on the macrophage content 
of the FSA -R tumour. 
Number of days 
postinoculation 
Fc receptor -positive cells a 
Whole FSA -R Adherent FSA -R 
7 23.3 ± 1.0b 94.0 ± 2.8 
14 23.0 ± 1.3 93.8 ± 1.4 
21 24.7 ± 1.0 94.2 ± 0.2 
28 24.2 ± 1.5 95.5 ± 2.1 
a 
Fc receptor -positive cells were identified by EA rosette 
formation. 
b Each result represents the mean of 3 experiments ± 1 SEM. 
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6.0 EXPRESSION OF MAC -1 BY TUMOUR -ASSOCIATED MACROPHAGES 
Ho and Springer (1982) have proposed that the Mac -1 
antigen defined by the rat anti- mouse -macrophage monoclonal 
antibody M1/70 (Springer et al., 1979) constitutes a universal 
macrophage marker. Consequently an attempt was made to use 
this marker to identify macrophages in tumour cell suspensions 
and monolayers of tumour -derived adherent cells. 
As indicated in Table I an excellent correlation was 
found between the percentage of macrophages present in the 
whole or adherent populations of resident and C.parvum -elicited 
peritoneal cells as defined by Fc receptor expression and /or 
latex phagocytosis, and the percentage of Mac -1 positive cells 
identified using an indirect immunoperoxidase assay. In 
contrast, although 20 -25% of enzymatically disaggregated tumour 
cells could be classified as macrophages on the basis of Fc 
receptor expression and latex phagocytosis, less than 1% of 
these cells expressed Mac -1. Similarly, although more than 
90% of tumour -derived adherent cells were identified as macro- 
phages on the basis of Fc receptor expression and latex phago- 
cytosis, only around 4% of these cells expressed Mac -1. 
6.1 Effect of enzyme treatment on Mac -1 expression 
The possibility that the enzymatic disaggregation pro- 
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cedure used may have adversely affected the expression of 
Mac -1 by tumour -associated macrophages was investigated. It 
can be seen in Table IV that the enzyme treatment used to 
disaggregate tumour tissue and separate out macrophages from 
tumour cell suspensions did not significantly alter the per- 
centage of whole or adherent resident peritoneal cells which 
expressed Mac -1. Thus it is not possible to attribute the 
very low level of Mac -1 expression on tumour -associated macro- 
phages to the effect of the enzymatic disaggregation 
procedure. 
6.2 Effect of in vitro culture on Mac -1 expression by 
tumour -associated macrophages 
Tumour -derived adherent cells were cultured for various 
times up to 18 hours to investigate whether these cells would 
re- express Mac -1. The results presented in Table V show 
clearly that no significant change occurred in the percentage 
of such cells which expressed Mac -1 during 18 hours of culture. 
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TABLE IV Effect of enzyme treatment on Mac -1 expression 
by resident peritoneal cells. 
Enzyme treatment 
% Mac -1- positive cells a 
Whole peritoneal Adherent peritoneal 
Nil 41.7 ± 0.9 b 94.0 ± 1.0 
0.05% Dispase/0.002% DNase 41.2 ± 1.6 94.3 - 0.5 
45 mins at roam temp. 
0.05% Dispase /0.002% DNase 40.9 ± 1.3 93.7 ± 0.8 
45 mins at room temp. plus 




Mac -l- positive cells were identified by an indirect 
immunoperoxidase assay using the rat anti- mouse- 
macrophage monoclonal antibody M1/70. 
Each result represents the mean of 3 experiments ± 1 SEM. 
TABLE V Effect of in vitro culture on Mac -1 expression by 
tumour -associated macrophages. 
Number of hours 
in culture % Mac -l- positive cells a 
0 4.2 ± 0.5 
1 3.6 ± 0.8 
4 3.6 ± 0.6 
5 3.4 ± 0.5 
18 3.7 t 1.2 
a 
b 
Mac -1- positive cells were identified by an indirect 
immunoperoxidase assay using the rat anti- mouse- 
macrophage monoclonal antibody M1/70. 
Each result represents the mean of 3 experiments ± 1 SEM. 
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7.0 EXPRESSION OF I -Ak BY TUMOUR -ASSOCIATED MACROPHAGES 
In most experimental systems the generation of an 
effective immune response requires cooperation between immuno- 
competent lymphocytes and non -lymphoid accessory cells 
(reviewed by Unanue, 1981). One essential accessory cell 
function is to take up and process antigenic material and 
present the appropriate epitopes to T cells in association 
with Ia molecules (reviewed by Unanue et al., 1984). As a 
first step towards understanding the accessory cell activity 
of tumour -associated macrophages, the expression of Ia- deter- 
minants on these cells was investigated. 
It can be seen in Table I that around 9.1% of enzymat- 
ically disaggregated tumour cells and around 56% of tumour - 
derived adherent cells expressed I -Ak. Although fairly 
heterogeneous, most of these cells appeared by morphological 
criteria to be "typical" macrophages (Plate 1). It is 
interesting to note that the I -Ak- positive cells varied 
considerably with respect to staining density, presumably 
reflecting differing levels of I -Ak expression. 
7.1 Effect of enzyme treatment on I -Ak expression 
The possibility that the enzymatic disaggregation pro- 
cedure used may have altered the expression of I -Ak by tumour- 
PLATE I I -Ak expression by enzymatically disaggregated tumour 
cells. Cytocentrifuge preparations of enzymatically 
disaggregated tumour cells were made and I -A -positive 
cells identified by an indirect immunoperoxidase assay 
using monoclonal antibody 10.2 -16. (Haematoxylin 
counterstain, x 2000 magnification). 
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associated macrophages was investigated. However, it can 
be seen from Table VI that the enzyme treatment used to dis- 
aggregate the tumour tissue and separate macrophages out 
from tumour cell suspensions did not significantly alter 
the percentage of adherent resident peritoneal cells which 
expressed either I -Ak or Fc receptors. 
7.2 Effect of serial transplantation of the FSA -R tumour 
on I -AK expression by tumour -associated macrophages 
Tumours were harvested 15 -20 days after inoculation of 
5x105 viable tumour cells and the percentage of I -Ak- positive 
cells present in enzymatically disaggregated tumour cell 
suspensions and monolayers of tumour -derived adherent cells 
was determined. The results presented in Table VII show that 
there was no significant change in the percentage of I -Ak- 
positive cells in either of these two populations during 
serial transplantation of the tumour (pass 8 -18). 
7.3 Effect of tumour growth on I -Ak expression by 
tumour -associated macrophages 
Tumours were harvested at intervals after s.c. inocul- 
ation of 5x105 viable tumour cells, and the percentage of 
I -Ak- positive cells present in enzymatically disaggregated 
tumour cell suspensions and monolayers of tumour -derived 
adherent cells was determined. As indicated in Table VIII 
there was no significant change in the percentage of I -Ak 
TABLE VI Effect of enzyme treatment on I -Ak and Fc receptor 
expression by adherent resident peritoneal cells. 
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Enzyme treatment % I -Ak- positive a % Fc receptor -positive b 
Nil 35.5 ± 2.6 c 95.8 ± 1.5 
0.05% Dispase /0.002% 34.2 
± 
1.4 95.5 ± 1.5 
DNase 45 mins at room 
temp. 
0.05% Dispase /0.002% 36.7 
± 
1.7 94.3 ± 1.3 
DNase 45 mins at room 
temp plus 0.1% Dispase 
30 mins at 37 °C. 
a 
I -Ak- positive cells were identified by an indirect 
immunoperoxidase assay using monoclonal antibody 
10 -2.16. 
b 
Fc receptor -positive cells were identified by EA rosette 
formation. 
c Each result represents the mean of 3 experiments - 1 SEM. 
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TABLE VII Effect of serial transplantation on I -Ak 
expression by tumour -associated macrophages. 
Passage % I -Ak- positive cells a 
number Whole FSA -R Adherent FSA -R 
8 10.2 ± 0.4 b 48.2 ± 0.7 
10 10.8 - 0.2 50.3 ± 0.6 
12 9.5 ± 0.3 49.2 - 1.3 
13 9.8 ± 0.2 50.2 ± 0.6 
17 10.8 ± 0.8 50.2 ± 0.9 
18 11.5 ± 0.3 51.7 ± 1.3 
I -Ak- positive cells were identified by an indirect 
immunoperoxidase assay using monoclonal antibody 10 -2.16. 
b 
Each result represents the mean of 3 experiments ± 1 SEM. 
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TABLE VIII Effect of tumour growth on I -Ak expression by 
tumour -associated macrophages. 
Number of days 
postinoculation 
I -Ak- positive cells 
a 
Whole FSA -R Adherent FSA -R 
7 10.3 ± 0.7 b 51.7 ± 1.7 
14 10.0 ± 0.9 52.2 ± 1.4 
21 10.3 ± 1.0 54.7 ± 0.7 
28 9.8 1 0.4 51.2 ± 0.6 
a 
I -Ak- positive cells were identified by an indirect 
immunoperoxidase assay using monoclonal antibody 10 -2.16. 
b Each result represents the mean of 3 experiments - 1 SEM. 
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positive cells present in either of these two populations 
during the observed period of tumour growth. 
7.4 Regulation of I -Ak expression by tumour -associated 
macrophages 
The effect of in vitro culture on I -Ak expression.by 
tumour -associated macrophages was investigated. The results 
presented in Figure 3 show that I -Ak expression progressively 
decreased with time in culture such that after three days, the 
percentage of I -Ak- positive cells had fallen from approximately 
50% to less than 6 %. No further reduction in I -Ak expression 
was found if the cells were cultured for 4 days. The cells 
which continued to express I -Ak after 4 days in culture 
appeared by morphological criteria to be "typical" macrophages. 
Since I -Ak expression by tumour -associated macrophages 
seems to be a transient event, the question arises as to 
what mechanisms operate in situ to induce and maintain I -Ak 
expression on such a large percentage of these cells. The 
involvement of T cells or their products was investigated by 
comparing the expression of I -Ak by macrophages obtained from 
tumours grown in nu /+ or nu /nu mice. The nu /nu animals lack 
a functional T cell system and did not reject allogeneic or 
xenogeneic tissue grafts. The nu /+ animals are phenotypically 
normal and rapidly rejected allogeneic or xenogeneic tissue 
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4 
Effect of time in culture on I -Ak expression by 
tumour -associated macrophages. Adherent cells 
derived from 1x106 viable enzymatically disaggre- 
gated tumour cells were cultured for various 
periods of time, fixed and the percentage of I -Ak- 
positive cells determined by an indirect immuno- 
peroxidase assay using monoclonal antibody 
10 -2.16. Each point represents the mean of 3 
experiments ± 1 SEM. 
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TABLE IX I -Ak expression by macrophages obtained tumours 
grown in nu /+ or nu /nu mice. 
% Fc receptor -positivea % I -Ak- positive b 
Tumour -bearing Whole Adherent Whole Adherent 
mice FSA -R FSA -R FSA -R FSA -R 
nu/+ 24.0 -0.8c 94.0 -0.8 11.1 -0.6 50.2 -0.9 
nu/nu 24.2 -0.6, 93.7 -0.6 1.1 -0.2 0.8 -0.2 
a 
Fc receptor -positive cells were identified by EA rosette 
formation. 
b 
I -Ak- positive cells were identified by an indirect immuno- 
peroxidase assay using monoclonal antibody 10 -2.16. 
c Each result represents the mean of 3 experiments ±1 SEM. 
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enzymatically disaggregated tumour cell suspensions prepared 
from FSA -R tumours grown in nu /+ or nu /nu mice did not differ 
significantly in their content of Fc receptor -positive cells. 
However, while around 11.1% of enzymatically disaggregated 
tumour cells derived from tumours grown in nu /+ animals 
expressed I -Ak only 1.1% of cells derived from tumours,grown 
in nu /nu animals expressed the antigen. Similarly, 50.2% 
of adherent cells derived from tumours grown in nu /+ animals 
were I -Ak positive, but only 0.8% of adherent cells from 
tumours grown in nu /nu animals were positive. 
These results suggest that T cells or their products 
constitute a major regulatory mechanism which determines 
I -Ak expression by tumour -associated macrophages. 
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SECTION II - ACCESSORY CELL ACTIVITY OF TUMOUR- ASSOCIATED 
MACROPHAGES. I. GENERATION OF A PRIMARY 
PFC RESPONSE IN VITRO. 
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1.0 DETERMINATION OF OPTIMAL CULTURE TIME AND DOSE OF 
ANTIGEN FOR THE GENERATION OF A PRIMARY ANTI -CRBC 
PFC RESPONSE IN VITRO 
PFC responses were generated in Nunc 24 well tissue culture 
plates (Gibco Bio -Cult Ltd., Paisley, Scotland.). 5X 106 
whole normal spleen cells were cultured with various numbers 
of CRBC in 2 ml of RPMI + 10% FCS. The magnitude of the anti - 
CRBC PFC response generated depended on both the time in 
culture and the dose of antigen used (Table X). Maximal 
responses were consistantly obtained in cultures harvested 
on day 4 which received 107 CRBC. Consequently, these same 
culture conditions and the optimal culture time and antigen 
dose were used for all subsequent experiments. 
TABLE X Determination of optimal culture time and dose of 
antigen for the generation of a primary anti - 
CRBC PFC response in vitro.a 
Number CRBC Number anti -CRBC PFC /culture 
culture Day 2 Day 3 Day 4 Day 5 
Nil 33 ± 7b 33 ± 9 23 ± 9 20 ± 6 
105 47 ± 12 50 ± 11 123 ± 15 47 ± 9 
106 33 ± 9 117 ± 32 270 ± 17 150 ± 25 
107 60 ± 12 287 ± 29 613 ± 14 403 ± 12 
108 53 - 12 310 - 51 500 L 15 420 - 17 
a 
b 
5 x 106 whole normal spleen cells were incubated with 
various numbers of CRBC and the magnitude of the anti - 
CRBC PFC response generated was determined on day 2 to 
day 5 of culture. 




2.0 ROLE OF ACCESSORY CELLS IN THE GENERATION OF A 
PRIMARY ANTI -CRBC PFC RESPONSE IN VITRO 
Normal spleen cells were depleted of accessory cells 
by passage through a Sephadex G -10 column (Ly and Mishell, 
1974). Approximately 35 -40% of those cells initially applied 
to the column were recovered following this procedure.. 
Analysis of cell surface markers by indirect immunoperoxidase 
(Table XI) revealed that passage through Sephadex G -10 reduced 
the percentage macrophages (Mac -1- positive cells) present in 
the cell suspension from 10% to less than 0.5 %. In contrast, 
the ratio of T lymphocytes (Thy -l- positive cells) to B 
lymphocytes (Ig- positive cells) in the effluent population 
was approximately the same as found in normal spleen cell 
suspensions. 
Passage of normal spleen cells through Sephadex G -10 
also greatly reduced the ability of these cells to generate 
a primary anti -CRBC PFC response in vitro (Figure 4). In 
order to ensure that such depletion was the result of the 
removal of accessory cells and not some other cell type, it 
was necessary to show that the depleted response could be 
reconstituted by the addition of accessory cells. The results 
presented in Figure 4 show that the primary anti -CRBC PFC 
response of Sephadex G -10 passed spleen cells could be recon- 
stituted in a dose -dependent fashion by the addition of adherent 
resident peritoneal cells. Maximum reconstitution was 
TABLE XI Characterization of whole and Sephadex G -10 
passed spleen cell suspensions 
Mac -1 
Positive Cells a 
Thy -1.2 Ig 
Whole 10.1 -3.6 22.3 -2.6 58.3 -4.2 
Sephadex 0.4 -0.1 28.8 ±3.5 69.6 -5.1 
G -10 passed 




NIL 3125x104 6.25x104 125x105 25x105 5 0x105 10x106 
NUMBER RESIDENT PERITONEAL CELLS/ CULTURE 
Reconstitution of the primary anti -CRBC response 
of Sephadex 0 -10- passed spleen cells by adherent 
resident peritoneal cells. x 106 whole normal 
spleen cells () or 5 x 10 Sephadex -G10 passed 
spleen cells and varying numbers of resident 
peritoneal cells (O ) were incubated with 107 
CRBC and the primary anti -CRBC PFC response gener- 
ated was determined on day 4. Each point represents 
the mean - 1 SEM of triplicate cultures. Equivalent 
cultures which did not receive CRBC generated less 
than 70 anti -CRBC PFC /culture. 
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obtained with adherent cells from 5x105 resident peritoneal 
cells. This cell number gives monolayers containing approx- 
imately 8.75x104 adherent cells (Figure 2) more than 90% 
of which may be classified as macrophages on the basis of 
Fc receptor expression, latex phagocytosis and Mac -1 expression 
(Table 1). Thus optimal responses were obtained in cultures 
containing 1 -2% macrophages. Exceeding this number resulted 
in a reduction in the magnitude of the response generated. 
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3.0 ACCESSORY CELL ACTIVITY OF TUMOUR -ASSOCIATED MACROPHAGES 
The ability of adherent cells isolated from the FSA -R 
tumour to reconstitute the primary anti -CRBC PFC response of 
Sephadex G -10 passed spleen cells was investigated. The 
results presented in Figure 5 demonstrate that the tumour - 
derived adherent cells were fully capable of reconstituting 
the depleted response. The degreeof reconstitution obtained 
depended on the number of adherent cells added. Maximum 
reconstruction was obtained in cultures which received adher- 
ent cells from 5x105 enzymatically disaggregated tumour cells. 
This cell number gives monolayers containing approximately 
8.8x104 adherent cells (Figure 2), 90% of which may be class- 
ified as macrophages more than on the basis of Fc receptor 
expression and latex phagocytosis (Table I). Thus as with 
resident peritoneal cells, optimal responses were obtained 
in cultures which contained 1 - 2% tumour -associated macro- 
phages. Exceeding this number resulted in a considerable 







NIL 3.125x104 6.25x101. 125x105 25x105 50x105 10x106 
NUMBER FSA -R CELLS /CULTURE 
Reconstitution of the primary anti -CRBC PFC response 
of Sephadex G -10 passed çpleen cells by tumour -derived 
adherent cells. 5 x 10 whole normal spleen cells 
(0) or 5 x 106 Sephadex G -10 passed spleen cells and 
various numbers of tumour -derived adherent cells (O ) 
were incubated with 107 CRBC and the primary anti - 
CRBC PFC response generated was determined on day 4. 
Each point represents the mean 1 SEM of triplicate 
cultures. Equivalent cultures which did not receive 
CRBC generated less than 70 anti -CRBC PFC /culture. 
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4.0 CHARACTERIZATION OF THE ACCESSORY CELLS PRESENT IN THE 
TUMOUR -ASSOCIATED MACROPHAGE POPULATION 
4.1 Effect of anti -Ia serum and complement treatment 
on the accessory cell activity of tumour -associated 
macrophages 
Monolayers of adherent tumour -associated macrophages were 
depleted of cells expressing Ia antigens by treatment with 
anti -Ia serum plus complement. This procedure resulted in 
the loss of approximately 40% of the macrophages from the 
monolayers and less than 5% of the remaining cells were found 
to express I -Ak determinants using an indirect immunoperoxi- 
dase assay (Table XII). The ability of untreated and anti- 
Ia serum plus complement treated tumour -associated macrophages 
to reconstitute the primary anti -CRBC PFC response of Sephadex 
G -10 passed spleen cells was investigated. The results 
presented in Figure 6 show clearly that treatment of tumour - 
associated macrophages with anti -Ia serum and complement 
effectively abolished the ability of these cells to recon- 
stitute the depleted response. The use of various macrophage 
doses rules out the possibility that this finding was the 
result of an inappropriate number of macrophages remaining in 
the tissue culture well after anti -Ia serum plus complement 
treatment. Instead, it appears that Ia- positive cells are 
required for the expression of accessory cell activity by 
tumour -associated macrophages. 
TABLE XII Effect of anti -Ia serum plus complement 
treatment on I -Ak expression by tumour - 
derived adherent cells 





Guinea pig serum (1/20) 
45 mins at 37 °C. 
ATH anti -ATL serum (1/20) 
30 mins at 0oC plus 
Guinea pig serum (1/20) 
45 mins at 37 °C 
52.0 -1.7 100 
51.0 -2.5 92 
4.0 -0.6 59 
a 
b 
I -Ak- positive cells were identified by an indirect 
immunoperoxidase assay using monoclonal antibody 
10 -2.16. 
The percentage of cells remaining adherent after 













NIL 3125x104 125x105 50x105 
NUMBER FSA-R CELLS /CULTURE 
Effect of anti -Ia serum plus complement treatment 
on the ability of tumour -derived adherent cells to 
reconstitute the primary anti -CRBC PFC response of 
Sephadex G -10 passed spleen cells. 5 x 106 whole 
normal spleen cells () or 5 x 106 Sephadex G -10 
passed spleen cells (0) were incubated with 107 CRBC 
and the primary anti -CRBC PFC response generated was 
assayed on day 4. The effect of the addition of 
various numbers of untreated (AL) or anti -Ia serum 
plus complement treated (A) tumour -derived adherent 
cells on the response of Sephadex G -10 passed spleen 
cells +was determined. Each point represents the 
mean - 1 SEM of triplicate cultures. Equivalent 
cultures which did not receive CRBC generated less 
than 30 anti -CRBC PFC /culture. 
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4.2 Comparison of the accessory cell activity of 
macrophages obtained from tumours grown 
in nu /+ or nu /nu mice 
Macrophages obtained from tumours grown in nu /+ animals 
were approximately 50% I -Ak positive (Table IX) and were able 
to reconstitute the primary anti -CRBC PFC response of 
Sephadex G -10 passed spleen cells (Figure 7). In contrast, 
macrophages obtained from tumours grown in nu /nu animals 
did not express detectable I -Ak (Table IX) and were unable 
to reconstitute the Sephadex G -10 depleted response (Figure 7). 
These results support the view that Ia- positive cells are 
required for the expression of accessory cell activity by 







NIL 3.125x101. 625x101. 125x105 25x105 50x105 10x106 
NUMBER FSA -R CELLS /CULTURE 
Reconstitution of the primary anti -CRBC PFC response 
of Sephadex G -10 passed spleen cells by adherent cells 
derived from tumours grown in nu /+ or nu /nu mice.6 
5 x 106 whole normal spleen cells ( ) or 5 x 10 
Sephadex G -10 passed spleen cells (0) were incubated 
with 107 CRBC and the primary anti -CRBC PFC response 
generated was determined on day 4. The effect of the 
addition of various numbers of adherent cells derived 
from tumours grown in nu /+ ( ) or nu /nu (D) mice on 
the response of Sephadex G -10 passed spleen cells was 
determined. Each point represents the mean - 1 SEM 
of triplicate cultures. Equivalent cultures which 




SECTION III ACCESSORY CELL ACTIVITY OF TUMOUR -ASSOCIATED 
MACROPHAGES. II. COOPERATION BETWEEN TH 
CELLS AND B CELLS IN THE GENERATION OF A PFC 
RESPONSE IN VITRO 
167 
1.0 EFFECT OF NYLON WOOL- PASSED CRBC- PRIMED SPLEEN CELLS ON 
THE ANTI -CRBC PFC RESPONSE OF WHOLE NORMAL SPLEEN CELLS 
One of the most important factors limiting the number of 
PFC generated in cultures of whole normal spleen cells and 
antigen is the number of TH cells that can recognise and respond 
to the antigen (Gisler et al., 1981). Previous studies have 
shown that nylon wool -passed spleen cells from animals primed 
against CRBC constitute.an excellent source of CRBC- specific 
TH cells (Howie and McBride, 1982b). As indicated in Figure 8 
the addition of these cells to cultures of whole normal spleen 
cells and CRBC increased considerably the magnitude of the 
anti -CRBC PFC response generated. Initially, this increase 
depended on the number of nylon wool -passed spleen cells added. 
However no further increase was observed if more than 5 x 105 
cells were added. Presumably at this point TH is now in 
excess and it is the number of responding B lymphocytes or 
accessory cells that limit the magnitude of the response gener- 
ated. If nylon wool -passed spleen cells from normal unprimed 
mice were added to cultures of whole normal spleen and CRBC, 
there was no significant increase in the anti -CRBC PFC response 
generated. Presumably this population does not contain suff- 







NIL 125x105 5.0x105 20x106 
NYLON WOOL PASSED SPLEEN CELLS / CULTURE 
Effect of nylon wool -passed CRBC -primed spleen cells 
on the anti -CRBC PFC response of whole normal spleen 
cells. 5 x 105 whole normal spleen cells were in- 
cubated with 107 CRBC and the primary anti -CRBC PFC 
response generated was assayed on day 4 (ID). The 
effect of the addition of various numbers of nylon 
wool -passed CRBC -primed (0) or unprimed (A) spleen 
cells on response generated was determined. Each 




2.0 ACCESSORY CELL ACTIVITY OF TUMOUR -ASSOCIATED MACROPHAGES 
IN THE GENERATION OF AN ANTI -CRBC PFC RESPONSE IN THE 
PRESENCE OF EXCESS TH CELLS 
Cultures containing 5 x 106 whole normal spleen cells, 
1 x 106 nylon wool -passed CRBC -primed spleen cells and 107 CRBC, 
generated a large anti -CRBC PFC response (Figure 9). If the 
responding normal spleen cells were passed through a Sephadex 
G -10 column then the response generated was greatly reduced 
(Figure 9). However the Sephadex G -10 depleted response could 
be reconstituted in a dose -dependent fashion by the addition of 
tumour -derived adherent cells (Figure 9). These results suggest 
that cooperation between antigen -primed TH cells and normal 
B cells in the generation of an antibody response in vitro 
requires the presence of accessory cells and that tumour - 
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NIL 3125x104 1.25x105 50x105 
NUMBER FSA -R CELLS /CULTURE 
Accessory cell activity of tumour -associated macro- 
phages in cooperation between CRBC -primed T cells and 
normal B cells in the generation of an anti -CRBC PFC 
response. 5 x 106 whole normal spleen cells () or 
5 x 10 Sephadex G -10 passed spleen cells and various 
numbers of tumour- derved adherent cells ( O) were 
incubated with 1 x ,y0 nylon wool -passed CRBC -primed 
spleen cells and 10 CRBC. The anti -CRBC PFC response 
generated was assayed on day 4. Each point represents 
the mean - 1 SEM of triplicate cultures. Equivalent 
cultures which did not receive CRBC generated less than 
150 anti -CRBC PFC /culture. 
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3.0 EFFECT OF NYLON WOOL- PASSED CARRIER -PRIMED SPLEEN CELLS 
ON THE ANTI -HAPTEN PFC RESPONSE OF WHOLE NORMAL SPLEEN CELLS 
Cultures containing 5 x 106 whole normal spleen cells and 
107 TNP -CRBC generated a small anti -TNP PFC response (< 400 
PFC /culture) (Figure 10). However this response was enhanced 
in a dose -dependent fashion by the addition of nylon wool -passed 
spleen cells from animals primed against the CRBC carrier 
(Figure 10). Maximum enhancement was obtained in cultures 
which received 5 x 105 or more such cells. Addition of nylon 
wool -passed spleen cells from unprimed animals produced no 
increase in the anti -TNP PFC response generated. These results 
indicate that carrier- primed T cells can cooperate with normal 
B cells to generate an anti -hapten PFC response in the presence 











NIL 125x105 50x105 2.0x106 
NYLON WOOL PASSED SPLEEN CELLS/ CULTURE 
Effect of nylon wool -passed carrier -primed spleen cells 
on the anti- hapten PFC response of whole normal spleen 
cells. 5 x 10 whole normal spleen cells and various 
numbers of nylon wool -passed CRBC -primed spleen cells 
were incubated with 107 TNP -CRBC and the anti -TNP PFC 
response generated was assayed on day 4. Each point 
represents the mean - 1 SEM of triplicate cultures. 
Equivalent cultures which did not receive TNP -CRBC 
always generated less than 250 anti -TNP PFC /culture. 
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4.0 MACROPHAGE ACCESSORY CELL ACTIVITY IN THE GENERATION OF 
AN ANTI- HAPTEN PFC RESPONSE IN THE PRESENCE OF EXCESS 
CARRIER -SPECIFIC TH CELLS 
Cultures containing 5 x 106 whole normal spleen cells, 
1 x 106 nylon wool -passed CRBC -primed spleen cells and 107 
TNP -CRBC generated a large anti -TNP PFC response (Figures 11 and 
12). Passage of the responding normal spleen cells through 
Sephadex G -10 greatly reduced the magnitude of the response 
generated (Figures 11 and 12). However, this depleted response 
could be reconstituted in a dose dependent fashion by the addition 
of adherent resident peritoneal cells (Figure 11) or adherent 
tumour -derived cells (Figure 12). These results suggest that 
cooperation between carrier -primed TH cells and B cells in the 
generation of an anti- hapten PFC response in vitro requires the 
presence of accessory cells, and that both resident peritoneal 
macrophages and tumour -associated macrophages can provide this 
accessory cell function. 
Howie and McBride (1982b)have demonstrated the presence of 
significant numbers of tumour -specific TH cells in the spleens of 
animals bearing FSA -R tumours. Experiments were performed to 
evaluate the accessory cell activity of tumour -associated macro- 
phages in cooperation between tumour -specific TH cells and normal 
B cells. 5 x 106 whole normal spleen cells incubated with 
1 x 106 nylon wool -passed spleen cells from a day 14 tumour 
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NIL 2 5x104 10x105 40x105 
NUMBER PERITONEAL CELLS/ CULTURE 
Accessory cell activity of resident peritoneal macro- 
phages in cooperation between CRBC -primed T cells 
and normal B cells in the generation of an anti -TNP 
PFC response in the presence of TNP -CRBC6 5 x 106 
whole normal spleen cells () or 5 x 10 Sephadex 
G -10 passed normal spleen cells and various numbers 
of adherent resident $ eritoneal cells (0) were 
incubated with 1 x 30 nylon wool -passed CRBC -primed 
spleen cells and 10 TNP -CRBC and the anti -TNP PFC 
response generated was assayed on day 4. Each point 
represents the mean 1 SEM of triplicate cultures. 
Equivalent cultures which did not receive TNP -CRBC 
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Accessory cell activity of tumour -associated macro- 
phages in cooperation between CRBC -primed T cells 
and normal B cells in the generation of an anti -TNE 
PFC response in the presence of TNP -CRBC 5 x 10 
whole normal spleen cells () or 5 x 10 Sephadex 
G -10 passed spleen cells and various numbers of tumour 
derived adherent cells (0) were incubated with 17 x 10C 
nylon wool -passed CRBC -primed spleen cells and 10 
TNP -CRBC, and the anti - T N P PFC response generated was 
assayed on day 4. Each point represents the mean - 1 
SEM of triplicate cultures. Equivalent cultures 
which did not receive TNP -CRBC generated less than 
100 anti -TNP PFC /culture. 
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(Figure 13). This response was dependent upon the presence of 
accessory cells and was greatly reduced if the responding normal 
spleen cells were passed through Sephadex G -10 (Figure 13). The 
Sephadex G -10 depleted response could however be reconstituted 
in a dose -dependent fashion by the addition of tumour -derived 
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NIL 6.25x104 25x105 1.0x10° 
NUMBER FSA -R /CULTURE 
Figure 13. Accessory cell activity of tumour -associated macrophages 
in cooperation between tumour -specific T cells and 
normal B cells in the generation of an anti -TNE PFC 
response in the presence of TNP- FSA6 -R. 5 x 10 whole 
normal spleen cells () or 5 x 10 Sephadex G -10 
passed spleen cells and various numbers of tumour - 
derived adherent cells (0) were incubated with 1 x 106 
nylon wool- passed spleen cels from an animal bearing 
a day 14 FSA -R tumour and 10 TNP- FSA -R. The anti - 
TNP PFC response generated was assayed on day 4. 
Each point represents the mean - i SEM of triplicate 
cultures. Cultures which did not receive TNP -FSA -R 
generated less than 100 anti -TNP PFC /culture. 
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SECTION IV ACCESSORY CELL ACTIVITY OF TUMOUR -ASSOCIATED 
MACROPHAGES. III. ENHANCEMENT OF THE 
PRIMARY PFC RESPONSE OF WHOLE NORMAL SPLEEN 
CELLS 
179 
1.0 EFFECT OF RESIDENT PERITONEAL MACROPHAGES ON THE PRIMARY 
ANTI -CRBC PFC RESPONSE OF WHOLE NORMAL SPLEEN CELLS 
In order to evaluate macrophage suppressor cell activity, 
graded numbers of adherent resident peritoneal cells were added 
to cultures containing 5 x 106 whole normal spleen cells and 
107 CRBC, and their effect on the anti -CRBC PFC response gener- 
ated was determined. It was found that even at the highest 
concentrations examined, adherent resident peritoneal cells did 
not significantly alter the anti -CRBC PFC response, (Figure 14). 
Furthermore, treatment of adherent resident peritoneal cells 
with the enzyme procedure used to disaggregate tumour tissue 
and separate out tumour -associated macrophages did not alter 
their activity in this assay system (Figure 14). 
Figure 14 
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NIL 3125x101` 625x101. 125x105 25x105 50x105 10x106 
NUMBER OF PERITONEAL CELLS PER CULTURE 
Effect of untreated and enzyme treated resident peri- 
toneal macrophages on the primary anti -CRBC PFC6 
response of whole normal spleen cells. 57x 10 whole 
normal spleen cells were incubated with 10 CRBC and 
the primary anti -CRBC PFC response generated was 
assayed on day 4 (411). The effect of addition of 
various numbers of untreated adherent resident peri- 
toneal cells (A) or adherent resident peritoneal cells 
which had been treated with 0.05% Dispase/0.002% DNase 
for 45 minutes at room temperature plus 0.1% Dispase 
for 30 minutes at 37 °C (Ai, was determined. Each 
point represents the mean - 1 SEM of triplicate cultures 
Equivalent cultures which did not receive CRBC generated 
less than 50 anti -CRBC PFC /culture. 
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2.0 EFFECT OF TUMOUR -ASSOCIATED MACROPHAGES ON THE PRIMARY ANTI - 
CRBC PFC RESPONSE OF WHOLE NORMAL SPLEEN CELLS 
Graded numbers of tumour -derived adherent cells were added 
to cultures containing 5 x 106 whole normal spleen cells and 
107 CRBC and their effect on the primary anti -CRBC PFC response 
generated was determined. It is evident from the results 
presented in Figure 15, that instead of suppressing the anti - 
CRBC PFC response as expected, tumour -associated macrophages 
actually caused a dose -dependent increase in the magnitude of 



















NIL 3125x104 625x104 125x105 25x105 50x105 10x106 
NUMBER FSA -R CELLS /CULTURE 
Effect of tumour -associated macrophages on the primary 
anti -CgBC PFC response of whole normal spleen cells. 
5 x 10 whole normal spleen cells were incubated with 
va'ious numbers of tumour- derived adherent cells and 
10 CRBC, and the anti -CRBC PFC response generated 
was assayed on day 4. Each point represents the mean 
- 1 SEM of triplicate cultures. Equivalent cultures 
which did not receive CRBC generated less than 30 
anti -CRBC PFC /culture. 
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3.0 CHARACTERIZATION OF THE TUMOUR -ASSOCIATED MACROPHAGE 
POPULATION RESPONSIBLE FOR ENHANCEMENT 
3.1 Effect of anti -Ia serum plus complement treatment on the 
enhancing activity of tumour -associated macrophages 
Monolayers of adherent tumour -associated macrophages were 
depleted of cells expressing Ia antigens by treatment with 
anti -Ia serum plus complement (Table XII). The results pre- 
sented in Figure 16, show clearly that this treatment did not 
significantly alter the capacity of tumour -associated macro- 
phages to enhance the primary anti -CRBC PFC response of whole 
normal spleen cells. Since anti -Ia serum plus complement 
treatment resulted in approximately 40% of cells being lost from 
the monolayers (Table XII), it is clear that if both Ia- negative 
and Ia- positive cells had possessed enhancing activity then 
such treatment would have shifted the dose response curve to 
the right. Since no such change was found it can be concluded 
that only Ia- negative cells are involved in enhancement. 
3.2 Comparison of the enhancing activity of macrophages 
obtained from tumours grown in nu /+ or nu /nu mice 
FSA -R tumours grown in either nu /+ or nu /nu animals both 
contained approximately 24% macrophages (Table IX). However, 
while macrophages obtained from tumours grown in nu /+ animals 
were approximately 50% I -Ak- positive, those obtained from tumours 








A, I 1 , I 
NIL 3.125x104 125x105 50x105 
NUMBER FSA -R CELLS/ CULTURE 
Effect of anti -Ia serum plus complement treatment on 
the engancing activity of tumour -associated macrophages 
5 10 whole normal spleen cells were incubated with 
10 CRBC and the anti -CRBC PFC response generated was 
assayed on day 4 (). The effect of addition of 
various numbers of untreated (111), complement treated ( ) or anti -Ia serum plus complement treated (IV 
tumour -derived adherent cells on the magnitude of the 
response generated was determined. Each point repre- 
sents the mean ± 1 SEM of triplicate cultures. 
Equivalent cultures which did not receive CRBC gener- 
ated less than 70 anti -CRBC PFC /culture. 
11 
Nevertheless, macrophages obtained from tumours grown in nu /nu 
animals were as efficient as those obtained from tumours grown 
in nu /+ animals at enhancing the primary anti -CRBC PFC response 
of whole normal spleen cells (Figure 17). These results support 
the view that Ia- positive cells are not required for enhancement 
by tumour- associated macrophages. 
3.3 Comparison of the enhancing activity of populations of 
tumour -associated cells separated by centrifugal 
elutriation 
The cells present within enzymatically disaggregated tumour 
cell suspensions were found to be very heterogeneous with respect 
to cell size (Figure 18). Centrifugal elutriation was used to 
separate tumour cell suspensions into 5 fractions of differing 
modal diameter (Figure 19; Table XIII).More than 96% of the 
cells initially loaded were recovered following this procedure. 
The cells present in Fractions II -V were examined for their 
ability to enhance the anti -CRBC PFC response of whole normal 
spleen cells. The results presented in Figure 20 show that 
significant enhancing activity was found only in fractions II 
and III, the fractions which contained the majority of tumour - 
associated macrophages (Table XIII).Fractions IV and V which 
were composed mainly of tumour cells had no enhancing activity 
(Figure 20). It is interesting to note that although Fractions 
III contained only 13.4% Fc receptor -positive cells, it produced 
a similar degree of enhancement as Fraction II which contained 






NIL 3125x104 625x104 125x105 25x105 50x105 10x106 
NUMBER FSA -R CELLS /CULTURE 
Comparison of the enhancing activity of macrophages 
obtaingd from tumours grown in nu /+ or nu /nu mice. 
5 10 whole normal spleen cells were incubated with 
10 CRBC and the anti -CRBC PFC response generated 
was assayed on day 4 ( ) The effect of addition of 
various numbers of adherent cells derived from tumours 
grown nu /+ ( ) or nu /nu ( A ) mice on the magnitude 
of the response generated was determined. Each point 
represents the mean ± 1 SEM of triplicate cultures. 
Equivalent cultures which did not receive CRBC gener- 
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Figure 18 Coulter Channelyzer size distribution graph of 
enzymatically disaggregated FSA -R. Each X -axis 
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CELL VOLUME 
Figure 19 Coulter Channelyser size distribution graph of 
populations of tumour -associated cells separated by 
centrifugal elutriation. Fraction I - flow rate = 
10.02 ml /min ( ), Fraction II - flow rate = 15.12 
ml /min (- x -i -), Fraction III - flow rate = 22.97 ml /min 
( - -), Fraction IV - flow rate = 28.46 ml /min ( ), 
Fraction V - flow rate = 54.98 ml /min ( -- -). 3Each 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































NIL 625x101' 125x105 25x105 50x105 10x106 20x106 
NUMBER OF CELLS /CULTURE 
Figure 20 Enhancement of' the primary anti -CRBC PFC response of 
whole normal spleen cells by populations of tumour - 
associated cells separated by centrifugal elutriation. 
5. 10 whole normal spleen cells were incubated with 
10 CRBC and the anti -CRBC PFC response generated was 
assayed on day 4 (). The effect of the addition of 
various numbers of tumour -associated cells separated 
by centrifugal elutriation was determined. Whole 
unfractionated ( ), adherent unfractionated (O ) , 
Fraction II (Ls) , Fraction III (A ) , Fraction IV ( ) , 
Fraction V (a). Each point represents the mean 
- 1 SEM of triplicate cultures. Equivalent cultures 
which did not receive CRBC always generated less than 
40 anti -CRBC PFC /culture. 
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most likely interpretation of this finding is that enhancing 
activity is associated mainly with large macrophages which 
presumably predominate in fraction III but are fewer in fraction 
II. The finding that tumour -derived adherent cells were as 
efficient as the whole tumour cell suspension at enhancing the 
PFC response (Figure 20) argues against the possibility that 
the small tumour cells present in fractions II and III were 
responsible for enhancement. 
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4.0 ROLE OF SOLUBLE FACTORS IN MACROPHAGE- MEDIATED ENHANCEMENT 
Macrophages are known to secrete a number of soluble factors 
(monokines) which may exert diverse effects on the immune response 
(reviewed by Unanue, 1981). The possibility that enhancement of 
the primary anti -CRBC PFC response of whole normal spleen by 
tumour -associated macrophages was mediated by soluble factors 
was investigated. Culture supernatants conditioned by tumour - 
derived adherent cells were found to be highly efficient at 
enhancing the PFC response (Figure 21). The magnitude of the 
enhancement obtained depended on the number of adherent cells used 
to condition the medium and whether supernatants were harvested 
after 24 or 48 hours. Culture medium conditioned for 48 hours 
was less efficient at enhancing the response than medium conditioned 
for 24 hours. 
These results suggest that enhancement of the primary anti -CRBC 
PFC response of whole normal spleen cells by tumour -associated 















NIL 3125x104 625x104 125x105 25x105 5.0x105 1.0x106 
NUMBER FSA -R CELLS OR CONDITIONED SUPERNATANT EDUIVALENT /CULTURE 
Figure 21 Enhancement of the primary anti -CRBC PFC response 
of whole normal BSpleen cells by macrophage -conditioned 
medium. 5 x 10 whole normal spleen cells were 
7 
incubated with 10 CRBC and the anti -CRBC PFC response 
generated was assayed on day 4 (0). The effect of 
the addition of various numbers of tumour-derived 
adherent cells (0) or 50% (v /v) of medium conditioned 
by an equivalent number of tumour -derived adherent 
cells for 24 hours (A) or 48 hours () was deter- 
mined. Each point represents the mean - i SEM of 
triplicate cultures. Equivalent cultures which did 
not receive CRBC generated less than 80 anti -CRBC 
PFC /culture. 
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5.0 MACROPHAGE- MEDIATED ENHANCEMENT OF THE ANTI -CRBC PFC 
RESPONSE OF WHOLE NORMAL SPLEEN CELLS IN THE PRESENCE 
OF EXCESS TH CELLS 
5 x 106 whole normal spleen cells and 107 CRBC were 
cultured with or without 1 x 106 nylon -wool passed CRBC -primed 
spleen cells and the effect of the addition of tumour -derived 
adherent cells on the anti -CRBC PFC response generated was 
determined. The results presented in Figure 22 show clearly 
that while tumour -derived adherent cells enhanced the PFC 
response of cultures which did not receive added TH cells, they 
had no significant effect on the response of those cultures 


















NIL 3.125x10 1.25x105 5.0x10 5 
NUMBER FSA -R CELLS / CULTURE 
Macrophage- mediated enhancement of the anti -CRBC PFC 
response of whole normal spleen cells in the presence 
of excss T cells. 5 x 10 whole normal spleen cells 
and 106 CRBC' were incubated with (O ) or without AD) 
1 x 10 nylon wool -passed CRBC -primed spleen cells and 
the anti -CRBC PFC response generated was assayed on 
day 4. The effect of the addition of various numbers 
of tumour -derived adherent cells to these cultures was 
determined. Each result represents the mean - 1 SEM 
of triplicate cultures. Equivalent cultures which did 
not receive CRBC generated less than 50 anti -CRBC 
PFC /culture. 
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CHAPTER V - DISCUSSION 
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The preparation from solid tumour tissue of suspensions of 
viable single cells with minimum contamination by erythrocytes, 
aggregates, cell debris and other unwanted material is necessary 
in order that tumour -associated host cells can be accurately 
quantitated and their functional characteristics examined. There 
is however no universal method which is suitable for the dis- 
aggregation of all tumours and the advantages and disadvantages 
of any given method need to be carefully assessed in each experi- 
mental system. Ideally, the disaggregation procedure used should 
not enrich or deplete particular cell types, nor should it ad- 
versely affect the expression of markers used for the differential 
characterization of the diverse cellular components which make 
up the tumour. In addition, studies concerned with the function- 
al characteristics of tumour -associated host cells must take 
into account the effect of tumour disaggregation and cell separ- 
ation procedures on the parameter under investigation. 
In the present study, an enzymatic disaggregation procedure 
employing a combination of Dispase and DNase was used to prepare 
single cell suspensions from tumour tissue. This procedure 
proved highly effective and resulted in almost complete disaggre- 
gation of tumour material. There is however no satisfactory 
method available for estimating the yield of cells recovered 
after such treatment and the composition of the tumour is repre- 
sented only by those cells that survive the disaggregation pro- 
cedure. It is quite possible that some cells may be preferen- 
tially lost, while others may not be easily released from stromal 
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constituents. However, cell suspensions may be considered 
representative if individual cellular components are present in 
the same proportions as in the intact tumour (Moore and Moore, 
1977a). An excellent correlation was found between the percentage 
of Fc receptor -positive cells present in tumour sections as 
determined by EA absorption (Section I, 2.1) and the percentage 
of Fc receptor -positive cells identified in enzymatically dis- 
aggregated tumour cell suspensions by EA rosetting (Table I). 
It is therefore assumed that the ratio of the various cell types 
present in enzymatically disaggregated tumour cell suspensions 
was representative of that found within the intact tumour. 
Proteolytic enzymes have been shown to alter both the ex- 
pression of cell surface structures and dependent functional 
characteristics (Askenase and Hayden, 1974; Unkeless, 1977; 
Stahl et al., 1980). There was however no evidence that the 
enzymatic disaggregation procedure used in the present study had 
any deleterious effect on the properties of host cells necessary 
for their identification or characterization. Unfortunately 
it was not possible to compare the characteristics of enzymat- 
ically disaggregated tumour cells with equivalent cells obtained 
by some other procedure. Mechanical disruption of tumour tissue 
always gave preparations of low yield and poor viability. Pop- 
ulations of cells obtained under these conditions are likely to 
represent only those cells which were easily released from the 
tumour matrix and which were most resistant to the harsh dis- 
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aggregation procedure. However, the enzyme treatment used to 
disaggregate tumour tissue and separate out tumour -associated 
macrophages did not significantly alter the percentage of whole 
resident peritoneal cells which expressed Mac -1 (Table IV), or 
the percentage of adherent resident peritoneal cells which 
expressed Fc receptors (Table VI), Mac -1 (Table IV)or I -Ak 
(Table VI). It is assumed therefore that the enzymatic dis- 
aggregation procedure did not alter the expression of these 
same characteristics on tumour -associated host cells. 
The percentage of macrophages present in tumour cell sus- 
pensions has been estimated by morphology (Talmadge et al., 
1981), histochemical staining (Svennevig and Saar, 1979), Fc 
and C3 receptor expression (Evans, 1972; Kerbel et al., 1975; 
Moore and Moore, 1977a; Wood and Morantz, 1979; Moore and 
McBride, 1980) and various functional criteria including 
adherence (Evans, 1972; Mantovani, 1981) phagocytosis (Evans, 
1972; Moore and Moore, 1977a; McBride et al., 1982) and 
colony formation in vitro (Nash et al., 1981). It is unlikely 
however that any one method will identify all macrophages in a 
mixed population of cells while excluding from the determination 
all non -macrophage cell types. The macrophage phenotype is 
very heterogeneous and likely to depend on differentiation stage 
and previous exposure to modulating signals (Dougherty and 
McBride, 1984). Moreoever, many of the markers used to identify 
macrophages are by no means unique to this cell type. For 
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example, one of the more notable features of Fc receptors is 
their ubiquity. In addition to macrophages, they have also 
been detected on B lymphocytes, NK cells, K cells,eosinophils, 
neutrophils, basophils and some T lymphocytes (Kerbel and Davies, 
1974; Basten et al., 1975). Several non -immune cell types 
may also express Fc receptors including liver parenchymal cells 
(Hopf et al., 1976), certain gut epithelial cells (Guyer et al., 
1976) and some malignant cells (Noltenius, 1981; Svennevig and 
Andersson,1982). There is also the possibility that "released" 
Fc receptors may be passively absorbed by Fc receptor- negative 
cells. Such an occurrence has apparently been demonstrated for 
thymocytes (Rubin and Hertel -Wulff, 1975). Similarly, although 
macrophages are particularly efficient at phagocytosis many 
other diverse cell types may express this function. For example, 
latex particles are rapidly taken up by neutrophils and have been 
used extensively to study endocytosis by L -cells (Rabinovitch, 1969). 
However, with cell suspensions derived from the FSA -R tumour it 
is likely that the vast majority of cells expressing Fc receptors 
or phagocytosing latex particles are indeed macrophages. Lympho- 
cyte infiltration of the tumour was found to be very modest, with 
average values only around 5% (Moore and McBride, 1983). Simil- 
arly, neutrophils were only rarely observed in cell suspensions 
prepared from non -nec rotic tumour tissue (Moore and McBride, 
1983). In addition, neoplastic cells isolated by centrifugal 
elutriation did not express Fc receptors (Table XIII). 
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On the basis of Fc receptor expression and latex phago- 
cytosis 20 -25% of enzymatically disaggregated tumour cells may 
be classified as macrophages (Table I). The percentage of 
phagocytic cells was, on average, 4.5% less than the percentage 
of Fc receptor -positive (Table I) although almost all cells 
identified by either of these markers had typical macrophage 
morphology. The reason for the difference in the percentage 
of macrophages identified by these two different techniques is 
not clear. However, phagocytic cells were observed to differ 
greatly in the number of latex particles they ingested and it 
is possible that the conditions employed in the latex phago- 
cytosis assay did not allow for the detection of the more poorly 
phagocytic cells. 
Macrophages were enriched from tumour cell suspensions by 
virtue of their capacity to adhere tightly to glass or plastic 
surfaces in the presence of 0.1% Dispase and 20% FCS (Moore and 
McBride, 1980). The presence of proteolytic enzymes enhances 
macrophage spreading and effectively prevents tumour cells from 
adhering (Evans, 1973). Dispase is particularly useful in this 
respect since its activity is not abolished by serum proteins 
(Moore and McBride, 1980). The presence of serum proteins such 
as fibronectin promotes macrophage adherence while inhibiting 
the adherence of lymphocytes and other cells (Rabinovitch and 
DeStefano, 1973; Mosier, 1981). Under these conditions approx- 
imately 17.6% of cells present in the tumour cell suspension 
were adherent (Figure 2). More than 90% of these could be 
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classified as macrophages on the basis of Fc receptor expression 
and latex phagocytosis (Table I). The small percentage of non - 
macrophage cells present among the adherent population appeared 
by morphological criteria to be lymphocytes or tumour cells which 
were usually bound tightly to adherent macrophages. 
The accumulation of macrophages within the FSA -R tumour 
appears to be a well regulated process. The percentage of 
tumour -associated cells which expressed Fc receptors remained 
constant throughout the observed period of tumour growth (Table 
III), and during serial passage from one syngeneic host to 
another (Table II). The mechanisms responsible for determining 
and maintaining the characteristic macrophage content of the 
tumour are unknown. However, it seems unlikely that mediators 
of acute inflammation derived from necrotic tissue are involved 
since large necrotic tumours contained the same percentage of 
Fc receptor -positive cells as smaller non -necrotic tumours 
(Table III). In addition, the finding that tumours grown in 
nu /nu mice contained the same percentage of macrophages as tumours 
grown in nu /+ littermate controls (Table IX) suggests that T cells 
or their products are also not involved in macrophage accumul- 
ation. 
Monoclonal antibodies constitute a powerful tool for the 
analysis of cell surface antigen expression and have proven 
extremely useful in the identification and separation of various 
2 03 
functionally distinct lymphocyte subsets (Ledbetter and Herzenberg, 
1979). A similar application of hybridoma technology to macro- 
phages could provide a means to identify and separate these cells 
from complex cell mixtures. In recent years a substantial 
number of anti -macrophage monoclonals have been developed and 
these are already proving invaluable reagents for the study of 
macrophage cell surface antigen structure, differentiation and 
function (reviewed by Dougherty and McBride, 1984). 
The rat antibody M1/70 was the first monoclonal to identify 
an antigen expressed by myeloid cells but not lymphocytes 
(Springer et al., 1979). The antigen defined by M1/70 has been 
designated Mac -1 (Springer et al., 1979) and more recently, 
several other monoclonal antibodies to it have been obtained 
(Mellman et al., 1980; Springer et al., 1982; Sanchez -Madrid 
et al., 1983). Although raised against murine macrophages, 
M1/70 crossreacts with human Mac -1, an antigen which shows an 
identical distribution to murine Mac -1 (Ault and Springer, 1981), 
and which is apparently equivalent to the OKMÌ and Mol antigens 
(Beller et al., 1982). 
The Mac -1 antigen is composed of two subunits, an OK 
subunit with a molecular weight of 170,000 daltons and a ß 
subunit of 95,000 daltons. The De-and subunits are tightly, 
but non -covalently, linked in an o<1, r lcomplex (Kurzinger 
and Springer, 1982; Kurzinger et al., 1982). Monoclonal 
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antibodies against the Mac -1 antigen bind to the oC subunit 
(Sanchez- Madrid et al., 1983). The LFA -1 antigen on lympho- 
cytes has a different OCsubunit associated with the same 
subunit (Kurzinger et al., 1982; Sanchez -Madrid et al., 1983) 
and thus antibodies to the 
/- 
subunit have a broader pattern of 
cellular reactivity (Sanchez- Madrid et al., 1983). Both the 
o4 and 
/- 
subunits are glycosylated and have surface exposure 
( Kurzinger and Springer, 1982). 
It has been proposed that Mac -1 constitutes a universal 
macrophage marker (Ho and Springer, 1982). The antigen is 
expressed on more than 95% of resident or elicited peritoneal 
macrophages (Ho and Springer, 1982). It is also present on 
splenic macrophages in both the red pulp and marginal zones 
(Ho and Springer, 1982), and on lymph node and medullary cord 
macrophages (Flotte et al., 1983). Histocytes in the lamina 
propria of the intestine and alveolar macrophages are positive, 
but Kupffer cells are negative (Flotte et al., 1983). Eight 
independent macrophage cell lines ranging in phenotype from 
mature (J774 and P388D1) to relatively immature (WEHI -3) all 
expressed Mac -1 (Ralph et al., 1983). 
Mac -1 appears to be acquired by macrophages at an early 
stage in their differentiation from immature precursor cells. 
Studies in humans have shown that GM -CFC are Mac-1-negative 
or express only low amounts of Mac -1 (Griffin et al., 1982). 
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Similarly, the immature myelomonocytic leukemia cell line M1 
is Mac -l- negative (Ralph,et al.,1983). However treatment of 
M1 with phorbol ester or lymphokines caused these cells to 
differentiate and acquire macrophage characteristics including 
the Mac -1 antigen (Ralph et al., 1983). 
Mac -1 expression is however not entirely unique to macro- 
phages and the antigen is also found in appreciable amounts on 
exudate granulocytes and committed granulocyte precursors in the 
bone marrow (Springer et al., 1979), and on cells with natural 
killer activity obtained from the nylon wool non -adherent fraction 
of peritoneal exudates (Holmberg et al., 1981) or isolated directly 
from human peripheral blood (Ortaldo et al., 1981; Zarling et 
al., 1981; Ault and Springer, 1981). Alloactivated or cloned 
NK cells may be either Mac- 1/0KM1 positive (Krensky et al., 1982; 
or negative (Brooks et al., 1982; Hercend et al., 1983; Sheehy 
et al., 1983). 
Blocking studies suggest a close association or identity 
between Mac -1 and the type 3 complement receptor (CR3) specific 
for C3bi. For example, the M1/70 anti -Mac -1 monoclonal antibody 
was found to strongly inhibit rosette formation between macrophages 
and complement coated erythrocytes (Beller et al., 1982). Lack 
of inhibition by a panel of eight other antibodies demonstrated 
the specificity of blockade. Macrophages bear receptors for both 
Cab (CR1) and C3bi (CR3) (Ross, 1980). However, when erythrocytes 
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bearing only C3b or C3bi were prepared with homogeneous comple- 
ment components, it was found that M1 /70 inhibited CR3 but not 
CR1 mediated binding (Beller et al., 1982). Similar results 
were obtained with human granulocytes (Beller et al., 1982). 
The most likely interpretation of these findings is that Mac -1 
is the CR3. In this connection it is interesting to note that 
Mac -1 and the CR3 appear to have an identical cellular and 
tissue distribution (Ross, 1980; Fearon and Wong, 1983). 
In the present study, an attempt was made to use Mac -1 
expression as a marker to identify and quantitate tumour- assoc- 
iated macrophages. In control experiments, an excellent corre- 
lation was found between the percentage of whole or adherent 
resident peritoneal cells which expressed Fc receptors and /or 
phagocytosed latex particles, and the percentage of Mac -l- positive 
cells identified using an indirect immunoperoxidase assay (Table 
I). Similar results were obtained for whole or adherent C.parvum 
-elicited peritoneal cells (Table I). This was as expected 
since all of these techniques should identify mainly macrophages. 
In contrast, although approximately 24.5% of enzymatically dis- 
aggregated tumour cells expressed Fc receptors and around 20% 
phagocytosed latex particles, less than 1% of these cells ex- 
pressed Mac -1 (Table I). Similarly, more than 90% of tumour - 
derived adherent cells expressed Fc receptors or phagocytosed 
latex, but only around 4% expressed Mac -1 (Table I). 
The possibility was considered that the enzyme treatment 
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used to disaggregate tumour tissue may have had a deleterious 
effect on Mac -1 expression by tumour -associated macrophages. 
However, tumour -derived adherent cells cultured for up to 18 
hours did not re- express Mac -1 (Table V). In addition, Mac -1 
expression by whole or adherent resident peritoneal cells was 
unaltered by enzyme treatment (Table IV). This finding is in 
agreement with recent studies by Unkeless and Springer (1984) 
which demonstrated that._ treatment of macrophages with trypsin or 
pap did not alter Mac -1 expression. Taken together these 
results suggest that it is not possible to attribute the very 
low level of Mac -1 expression on tumour -associated macrophages 
to the effect of the enzymatic disaggregation procedure. 
The lack of Mac -1 expression by tumour -associated macrophages 
suggests that these cells do not express CR3. In this connection 
it is interesting that neither B lymphocytes or macrophages har- 
vested from acutely rejecting cardiac allografts in rats formed 
a significant number of rosettes with complement coated erythro- 
cytes (Tilney et al., 1975). In addition, Moore and Moore, 
(1977a)in a study of the nature of the host -derived cells present 
in five different transplanted rat tumours, found that very few 
cells formed rosetts with complement- coated erythrocytes despite 
the presence of significant numbers of macrophages. Finally, 
Sher et al. (1980) found that relatively few of the Ia- positive 
macrophages present in peritoneal exudates induced by either live 
Listeria monocytogenes or a lymphokine elaborated by immune T cells 
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expressed complement receptors. 
On the basis of the available data any explanation for 
the apparent absence of Mac -1 on FSA -R tumour -associated macro- 
phages can be no more than speculation. It is however interest- 
ing to note that the CR3 receptor has been implicated in the 
phagocytosis of immune complexes (Ross, 1980). It is quite 
likely that immune complexes could occur within highly immuno- 
genic tumours such as FSA -R. These immune complexes could 
perhaps bind to and block the CR3. Alternatively, although 
very little information is available on the synthesis and turn- 
over of complement receptors (Fearon, 1984), it is possible that 
interaction of CR3 with immune complexes could lead to internal- 
ization of the receptor reducing its surface expression to below 
detectable levels. In this connection, it would be most 
interesting to compare Mac -1 expression on macrophages obtained 
from tumours of differing immunogenicities. An alternative 
explanation for the absence of Mac -1 on tumour -associated 
macrophages could be that these cells represent a distinct 
subpopulation of macrophages which do not express CR3. The 
finding that Kupffer cells do not express Mac -1 (Flotte et al., 
1983) lends some support to this possibility. 
When the function of surface markers is known, their presence 
or absence on a particular cell type takes on a greater signi- 
ficance. CR3 (Mac -1) enables macrophages to bind cells or 
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particles opsonized with complement component C3bi (Fearon, 
1984). Moreover, on activated macrophages, the CR3 mediates 
phagocytosis (Michl et al., 1979) and on resident macrophages, 
the CR3 is synergistic with the Fc receptor for phagocytosis 
(Bianco and Nussenzweig, 1977). Similarly, when target cells 
are coated with C3bi in addition to IgG lysis by ADCC effectors 
is greatly enhanced (Perlmann et al., 1981). From these results it 
is clear that the absence of CR3 from the surface of tumour - 
associated macrophages may have important implications with 
respect to the anti -tumour activity of these cells in situ. 
Macrophages can be grouped as to whether they express or 
do not express detectable la antigens (reviewed by Unanue, 1981). 
The expression of I -Ak by tumour -associated macrophages was 
examined using an indirect immunoperoxidase technique. Approx- 
imately 10% of enzymatically disaggregated tumour cells and 
around 50% of tumour -derived adherent cells were found to express 
the I -Ak antigen (Table I). By morphological criteria most of 
these I -Ak positive cells appeared to be typical macrophages, 
although such cells did show considerable heterogeneity both 
with respect to their expression of various morphological char- 
acteristics (size, nuclear shape, cytoplasmic structures etc) 
and the density of immunoperoxidase staining, presumably reflecting 
differences in the amount of I -Ak expressed per cell (Plate I). 
Assuming that approximately 20% of enzymatically disaggregated 
tumour cells are macrophages (see above) and that all I -Ak- 
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positive cells present in the tumour cell suspension are also 
macrophages, then one would expect approximately 50% of tumour - 
associated macrophages to express I -Ak. Since the tumour- 
associated macrophages enriched from tumour cell suspensions by 
adherence were indeed approximately 50% I -Ak- positive (Table I), 
it would seem that the separation procedure used to isolate 
these cells does not specifically enrich or deplete I -Ak- positive 
cells. It is likely therefore that the population of adherent 
macrophages is representative of those found within the enzym- 
atically disaggregated tumour cell suspension. 
The percentage of macrophages which express Ia determinants 
varies from tissue to tissue, although in the absence of external 
stimuli, the ratio for a given tissue is remarkably constant 
(reviewed by Unanue, 1981). In order to maintain this basal 
level of Ia expression there is a need for a continuous influx 
of young macrophages into the tissue (Scher et al., 1982). It 
seems that Ia expression develops mainly in young macrophages 
and unlike the expression of class I molecules, it is a transient 
event which is rapidly lost with time (Beller and Unanue, 1981 ; 
Scher et al., 1982). 
The percentage of tumour -associated macrophages which 
expressed I -Ak remained constant during both the observed period 
of tumour growth (Table VIII) and serial passage from one syn- 
geneic host to another (Table VII). As with other macrophages, 
the expression of I -Ak by the tumour -associated population appears 
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to be a transient event. The percentage of such cells express- 
ing I -Ak decreased rapidly with time in culture and after 3 days 
only around 6% of the macrophages continued to express the 
antigen (Figure 3). No further reduction in I -Ak expression 
was found if the cells were cultured for 4 days. Those cells 
which continued to express I -Ak after 4 days in culture appeared 
by morphological criteria to be typical macrophages. Whether 
they constitutively express I -Ak or represent a subpopulation 
which loses I -Ak more slowly is unknown. 
Since I -Ak expression by tumour -associated macrophages 
appears to be a transient event, the question arises as to what 
mechanisms operate in situ to induce and maintain the antigen 
on such a large percentage of these cells. At least three 
distinct mechanisms have been implicated in the regulation of 
macrophage Ia expression: 
1) some agents that trigger phagocytosis can slow down 
or prevent the loss of Ia (Beller and Unanue, 1981); 
2) T cell- derived lymphokines can induce Ia- negative macrophages 
to express la (Scher et al., 1980, 1982); 
3) macrophage Ia expression can be actively down regulated 
by various inhibitory molecules including prostaglandins 
(Snyder et al., 1982). 
The possible involvement of T cells in the regulation of 
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I -Ak expression by tumour -associated macrophages was investigated 
by comparing the expression of I -Ak by macrophages obtained from 
tumours grown in nu /+ or nu /nu mice. It was found that although 
tumours grown in nu /+ or nu /nu animals both contained the same 
percentage of macrophages (Table IX), very few of the macrophages 
present in tumours grown in nu /nu animals expressed 'detectable 
I -Ak (Table IX). These findings suggest that although T cells 
or their products are probably not involved in determining the 
macrophage content of the tumour, they do nevertheless play an 
important role in regulating I -Ak expression by these cells. 
In most experimental systems, the generation of an effective 
immune response has been shown to require cooperation between 
immunocompetent lymphocytes and non -lymphoid accessory cells 
(reviewed by Unanue, 1972, 1981). Although our understanding 
of this interaction is far from complete, it seems that TH cells 
are not activated as the result of a simple encounter with native 
antigen (Ishizaka and Adachi, 1976; Pierres and Germain, 1978). 
Instead, accessory cells are required to take up and "process" 
antigenic material and "present" the appropriate epitopes to 
T cells in association with Ia determinants (reviewed by Unanue 
et al., 1984). A large number of studies have demonstrated 
that Ia- positive macrophages, normally obtained from the spleen 
or peritoneal cavity, can perform this accessory cell function 
(reviewed by Unanue, 1981). 
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Ia- positive putative accessory cells have been identified 
within the inflammatory lesions associated with a number of path- 
ological conditions including inflammatory bowel disease (Selby 
et al., 1981, 1983); infectious diseases such as schistomiasis 
(Stadecker et al., 1982); and several diseases of unknown 
aetiology including rheumatoid arthritis (Klareskog .et al., 
1981; Winchester and Burmester, 1981; Poulter et al., 1982) 
and sarcoidosis (Mishra et al., 1983). Of these various con- 
ditions, the synovial inflammation associated with rheumatoid 
arthritis has probably received most attention. Large numbers 
of HLA- DR- positive macrophages have been identified within the 
hyperplastic synovial lining (Poulter et al., 1982; Burmester 
et al., 1983) and interdigitating cells appear to accumulate 
in the deeper stroma (Poulter et al., 1982). Combination 
immunohistochemical analysis of the synovial lining has revealed 
a close association between these HLA -DR- positive cells and 
infiltrating T cells expressing the helper phenotype (Duke 
et al., 1982). Moreover, functional studies have shown that 
HLA -DR- positive non -T cells from the rheumatoid synovium can 
stimulate autologous mixed lymphocyte reactions (Forre et al., 
1982). Such findings have lead to the suggestion that the 
pathogenesis of rheumatoid arthritis may in part be due to the 
generation of local immune responses (Janossy et al., 1981). 
Although the presentation of antigen in association with 
la determinants on the surface of an accessory cell is essential 
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for the initiation of T cell responses, it is important to 
realise that the generation of an effective immune response 
requires the involvement of other diverse signals which promote 
T cell clonal expansion and differentiation (reviewed by Howie 
and McBride, 1982a). Thus in order to define a role for I -Ak- 
positive tumour -associated macrophages in the generation of anti - 
tumour immune responses, it is necessary to show that these 
cells possess functional accessory cell activity. 
Many different experimental approaches have been exploited 
to examine macrophage accessory cell function (reviewed by 
Unanue, 1981). In vitro systems have proven particularly useful 
in this respect since the effect of the removal or manipulation 
of macrophages on the generation of an immune response can be 
studied using uniform well defined cell populations and standard- 
ized conditions. The antibody response to heterologous erythro- 
cytes has been most frequently used probably because of its ease 
of production (Mishell and Dutton, 1966, 1967; Marbrook, 1967) 
and analysis (Jerne and Nordin, 1963; Cunningham, 1965; 
Cunningham and Szenberg, 1968; Jerne et al., 1974). 
The requirement for an adherent accessory cell population 
as well as T cells and B cells for the generation of an efficient 
in vitro antibody response to erythrocyte antigens was first 
described by Mosier (1967) and has subsequently been confirmed by 
a large number of different groups (e.g. Pierce, 1969; 
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Roseman, 1969; Shortman et al., 1970; Feldmann and Palmer, 
1971; Sjoberg et al., 1972; Niederhuber, 1978; Niederhuber 
and Allen, 1980; Wong and Hercowitz, 1979). More recently, 
a similar requirement for adherent accessory cells was demon- 
strated for in vitro antibody reponses to soluble protein antigens 
(Pierce et al., 1974), or TNP conjugated to synthetic peptides 
or proteins such as haemocyanin (Hodes and Singer, 1977; Hodes 
et al., 1978; Singer et al., 1978). Only very occasional 
studies have found no requirement for accessory cells in the 
generation of an in vitro antibody response (Pierce, 1969; 
Bluestein and Pierce, 1973a,ó; Katz and Unanue, 1973) and 
in most instances such findings can be readily ascribed to 
insufficient depletion of accessory cells from the responding 
lymphoid population (Unanue, 1981). 
In the present study, whole normal spleen cells were found 
to generate a primary anti -CRBC PFC response in vitro, the 
magnitude of which depended on both the antigen dose used and 
the period of time in culture (Table X). Maximum responses 
were consistently obtained when 5 x 106 whole normal spleen 
cells were cultured for 4 days with 107 CRBC. 
If the responding spleen cells were depleted of accessory 
cells by passage through a Sephadex G -10 column (Ly and Mishell, 
1974) (Table XI) prior to culture, then the magnitude of the 
anti -CRBC PFC response generated was considerably reduced 
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(Figure 4). However, merely reducing responsiveness by a 
depletion procedure known to remove accessory cells cannot be 
taken as definitive proof that these cells are required for 
the response. Clearly, Sephadex G -10 does not deplete only 
accessory cells. Indeed, only 35 -40% of the cells initially 
applied to the column were recovered following this. procedure. 
Although the recovered cell population had the same T cell to 
B cell ratio as the original spleen cell suspension (Table XI), 
it is possible that the separation procedure may have selectively 
depleted certain populations of T cells and B cells. In addition 
to macrophages, the passage of murine spleen cell suspensions 
through Sephadex G -10 has been reported to deplete antibody - 
forming cells (Ly and Mishell, 1974), some of the cells which 
mediate ADCC (Pollack et al., 1976) and activated TS cell blasts 
(Pickel and Hoffman, 1977). Thus in order to establish a 
requirement for accessory cells in the generation of a primary 
anti -CRBC PFC response it was necessary to show that the Sephadex 
G -10 depleted response could be reconstituted by the addition 
of a source of accessory cells. 
Adherent resident peritoneal cells have been shown in many 
studies to constitute a readily obtainable source of accessory 
cells (reviewed by Unanue, 1981). As indicated in Figure 4, 
the primary anti -CRBC PFC response of Sephadex G -10 passed normal 
spleen cells could be reconstituted in a dose -dependent fashion 
by the addition of adherent resident peritoneal cells. Maximum 
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reconstitution was obtained in cultures which contained approx- 
imately 2% adherent resident peritoneal cells. Cultures which 
received more than this number of cells generated somewhat 
lower responses. 
From these studies it can be concluded that the generation 
of an anti -CRBC PFC response in vitro is absolutely dependent 
upon the presence of accessory cells. Consequently, the 
capacity of a population of cells to reconstitute the primary 
anti -CRBC PFC response of Sephadex G -10 passed spleen cells can 
be taken as a measure of accessory cell activity. 
Adherent macrophages derived from the FSA -R tumour con- 
stituted an excellent source of accessory cells and were able 
to fully reconstitute the primary anti -CRBC PFC response of 
Sephadex G -10 passed normal spleen cells (Figure 5). Maximum 
reconstitution was once again obtained in cultures which received 
approximately 2% macrophages. However, it is clear that tumour - 
associated macrophages produced significant reconstitution over 
a narrower range of cell concentrations than resident peritoneal 
macrophages. The reasons for such differences are unclear but 
presumably relate to differences in the number of various distinct 
macrophage subsets within the two populations. 
The accessory cells present within the tumour -associated 
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macrophage population were further characterized. It was found 
that treatment of tumour -associated macrophages with anti -Ia 
serum plus complement effectively depleted those cells bearing 
Ia determinants (Table XII) and the remaining mainly Ia- negative 
macrophages were unable to reconstitute the primary anti -CRBC 
PFC response of Sephadex G -10 passed spleen cells (Figure 6). 
The use of various macrophage doses rules out the possibility 
that this finding was the result of an inappropriate number of 
accessory cells remaining in the tissue culture wells after 
anti -Ia serum plus complement treatment. Instead, it appears 
that Ia- positive cells are required for the expression of 
accessory cell activity by tumour -associated macrophages. This 
conclusion is strongly supported by the finding that macrophages 
obtained from FSA -R tumours grown in nu /nu animals not only 
lacked detectable I -Ak antigen (Table IX) but were also unable 
to reconstitute the primary anti -CRBC PFC response of Sephadex 
G -10 passed spleen cells (Figure 7). 
Although quite likely, it is not possible from these 
results to state definitively that the accessory cell function 
of FSA -R tumour -associated macrophages in the reconstitution 
of the primary anti -CRBC PFC response of Sephadex G -10 passed 
spleen cells involves presentation of antigen in association 
with Ia determinants. It is possible that Ia- positive macro- 
phages perform some other function unrelated to antigen pre- 
sentation. For example, several reports have demonstrated that 
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although the generation of a primary Tc cell response against 
tumour cells or allogeneic cells required the presence of Ia- 
positive macrophages, it did not seem to matter whether these 
were syngeneic or allogeneic to the responding lymphocytes 
(Yamashita and Hamaoka, 1979; Pettinelli et al., 1980). In 
order to formally demonstrate that tumour -associated macrophages 
present antigen it would be necessary to investigate the require- 
ment for I- region identity between the accessory cell population 
and the responding lymphocytes using various congen is mouse 
strains. 
One of the most important factors limiting the number of 
PFC generated in cultures of whole normal spleen cells and 
antigen is the number of TH cells which can recognise and 
respond to the antigen (Gisler et al., 1981). As indicated in 
Figure 8, the addition of nylon -wool passed CRBC -primed spleen 
cells to cultures of whole normal spleen and CRBC caused a 
dose -dependent increase in the number of anti -CRBC PFC gener- 
ated. Maximum enhancement was found in cultures which received 
5 x 105 nylon wool -passed CRBC -primed spleen cells, and no 
further increase in the response generated was found if more 
than 5 x 105 cells were added. Presumably at this point TH 
cells are in excess and it is number of responding B lympho- 
cytes or accessory cells which limit the magnitude of the 
response generated. 
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The question of how the "help" signal is delivered to 
the appropriate B cell is still the subject of some consider- 
able debate. It is likely that more than one pathway exists 
and the particular pathway activated will probably depend on 
such factors as the dose and form of antigen, the degree of 
involvement of non -antigen specific lymphostimulatory mediators 
and the extent of priming (Howie and McBride, 1982a). 
There is some evidence that interaction between TH cells 
and B cells is a localized phenomenon involving direct cell 
contact (Phillips and Waldmann,1977). This was shown using 
a limiting dilution system in which very low numbers of Keyhole 
Limpet Haemocyanin (KLH)- specific TH cells were added to cultures 
containing excess TNP- primed B cells. Some wells contained 
no TH and failed to produce antibody to TNP when challenged 
with TNP -KLH. In those wells which did contain TH the number 
of B cell clones generating antibody against TNP was determined 
on the basis of the isoelectric focusing pattern of the anti -TNP 
antibody produced. It was found that the observed distribution 
of anti -TNP B cell clones compared well with estimated numbers 
of TH cells added per well implying that a single TH cell can 
help only one B cell. 
Antigen- specific T cell- derived soluble helper factors 
have been described in a limited number of systems. For instance, 
Feldmann and Basten (1972) demonstrated that the IgM response of 
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DNP- primed B cells to DNP -KLH was the same irrespective of 
whether KLH -specific TH cells were mixed together with the 
B cells or if the two populations were separated by a cell 
impermeable membrane. The most likely interpretation of this 
finding is that T cells released a soluble helper factor which 
diffused into the B cell compartment. A similar T,cell- 
derived factor with activity in vivo has also been described 
(Taussig, 1974). In this study, SRBC primed T cell which were 
challenged in vitro with antigen, produced a soluble mediator 
which could substitute for T cells in the response of unprimed 
B cells to SRBC in irradiated recipients. 
Although they are antigen- specific, T cell -derived helper 
factors do not possess immunoglobulin constant region epitopes. 
They have however been described as having idiotypic determinants 
that are common to antibodies (Mozes and Haimovich, 1979) and 
do have Ia determinants which could be responsible for the 
MHC- restricted activity found with some of these factors 
(Shiozawa et al., 1977). 
In contrast to the vast amount of data which has been 
collected on the role of macrophages in the induction of TH 
cells (reviewed by Unanue, 1972, 1981), very little is known 
about the role of accessory cells in cooperation between TH 
cells and B cells for the generation of an antibody response. 
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Where it has been studied accessory cells appear to be at 
least desirable if not obligatory for effective cooperation 
(Feldmann and Basten, 1972; Howie and Feldmann, 1978; 
Feldmann et al., 1978). In the present study, cooperation 
between CRBC -primed T cells and normal B cells in the generation 
of an anti -CRBC PFC response in vitro was found to be absol- 
utely dependent upon the presence of accessory cells (Figure 9). 
If these cells were removed by passage through a Sephadex G -10 
column the response was considerably diminished. However, 
this depleted response could be reconstituted by the addition 
of accessory cells, and tumour -associated macrophages could 
provide this accessory cell function (Figure 9). As with 
anti -CRBC PFC responses generated in the absence of added TH 
(Figure 5), maximum reconstitution was obtained in cultures 
which contained approximately 2% macrophages. 
Cooperation between carrier -primed TH cells and normal 
hapten- specific B cells in the generation of an anti -hapten 
antibody response in vitro also required the presence of 
accessory cells. Whole normal spleen cells cultured with 
TNP -CRBC generated a rather small anti -TNP PFC response (Figure 
10). However, this response was enhanced in a dose -dependent 
fashion by the addition of nylon wool -passed CRBC -primed spleen 
cells (Figure 10). These results indicate that carrier -primed 
TH cells can cooperate with normal B cells to generate an anti - 
hapten antibody response in the presence of hapten- carrier 
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conjugates. If accessory cells were removed by passage of 
the responding spleen cells through a Sephadex G -10 column 
then the anti -TNP response generated was greatly decreased 
(Figures 11 and 12). However this depleted response could 
be reconstituted by the addition of either resident peritoneal 
macrophages (Figure 11) or tumour -associated macrophages 
(Figure 12). 
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One of the major problems of tumour immunology is to 
arrive at an understanding of the various cellular interactions 
that may occur between T and B lymphocytes and accessory cells 
in the generation of an anti -tumour immune response. Part of 
the difficulty with this aspect of tumour immunology arises from 
the problems associated with the detection of specific responses 
to weak cellular antigens whose physico- chemical nature is 
largely unknown and maybe unique to individual tumours. 
Howie and McBride (1982b)have described a simple, sensitive 
and reproducible in vitro assay system based on those previously 
described for soluble hapten- carrier antigens which bypasses the 
need to measure anti -tumour responses directly. They demon- 
strated that tumour -specific TH cells obtained from the spleens 
of tumour -bearing animals could collaborate in vitro with 
hapten -primed B cells to generate an anti -hapten antibody 
response in the presence of haptenated- tumour. The TH responses 
thus generated followed the same rules as soluble hapten- carrier 
responses i.e. the responses show TH cell specificity for individ- 
ual tumours and require the hapten to be physically linked to 
the appropriate tumour cell carrier. 
The system developed by Howie and McBride (1982b)was used 
to investigate the accessory cell activity of tumour -associated 
macrophages in the expression of tumour -specific TH cell function. 
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Cultures containing 106 nylon wool -passed spleen cells from an 
animal bearing a day 14 FSA -R tumour, 5 x 106 whole normal 
spleen cells and 105 TNP -FSA -R generated a large anti -TNP PFC 
response (Figure 13). If accessory cells were removed by 
passage of the whole normal spleen cell suspension through 
a Sephadex G -10 column, the anti -TNP response was greatly 
depleted (Figure 13). This depleted response could however 
be reconstituted by the addition of accessory cells and tumour - 
associated macrophages could perform this accessory cell 
function (Figure 13). 
It is clear from the data so far discussed that macrophages 
only reconstitute Sephadex G -10 depleted PFC responses over a 
narrow range of concentrations. Optimal responses were normally 
found in cultures which received around 2% macrophages (resident 
peritoneal or tumour -associated) and if more than this number 
of cells were added, then the response generated was consider- 
ably reduced. This phenomenon can be seen most clearly in 
Figure 12. 
Niederhuber et al. (1979) proposed that the reduction in 
the PFC response generated in the presence of high concentrations 
of macrophages was the result of macrophage- mediated suppression. 
However, in the present study the addition of adherent resident 
peritoneal cells to cultures of whole normal spleen cells and 
CRBC did not significantly alter the magnitude of the anti -CRBC 
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PFC response generated even at the highest concentration 
examined (Figure 14). Furthermore, instead of suppressing 
the anti -CRBC PFC response of whole normal spleen cells, the 
addition of tumour -associated macrophages actually caused a 
dose -dependent increase in the magnitude of the response gener- 
ated (Figure 15). 
The enhancing cells present within the tumour -associated 
macrophage population were further characterized. It was 
found that although treatment with anti -Ia serum plus complement 
effectively depleted Ia- positive tumour -associated macrophages 
(Table XII), this procedure had no significant effect on the 
ability of these cells to enhance the primary anti -CRBC PFC 
response of whole normal spleen cells (Figure 16). It may 
be concluded therefore that only Ia- negative tumour -associated 
macrophages are involved in enhancement. This conclusion is 
supported by the finding that although macrophages obtained 
from tumours grown in nu /nu animals lacked detectable I -Ak 
antigen (Table IX) they were nevertheless as efficient as 
macrophages obtained from tumours grown in nu /+ animals at 
enhancing the primary anti -CRBC PFC response of whole normal 
spleen cells (Figure 17). 
Separation of enzymatically disaggregated tumour cells 
into populations of differing modal size by centrifugal elut- 
riation (Figure 19; Table XIII) enabled the physical character- 
istics of the enhancing macrophages to be defined. Correlation 
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of the degree of enhancement obtained, with the macrophage 
content of each fraction revealed that enhancement was primarily 
a function of large macrophages (Table XIII; Figure 20). 
Macrophages are known to secrete a number of soluble 
factors, (monokines), which may stimulate or inhibit lympho- 
cyte responses (reviewed by Unanue, 1981). The possibility 
was therefore considered that enhancement of the primary anti - 
CRBC PFC responses of whole normal spleen cells by tumour - 
associated macrophages was mediated by soluble factors. The 
results presented in Figure 21 show that culture supernatants 
conditioned by tumour -derived adherent cells for 24 or 48 hours 
were indeed highly efficient at enhancing the PFC response. 
At least four biochemically distinct antigen non -specific 
factors have been shown to enhance anti -heterologous- erythrocyte 
PFC responses. These factors are the T cell- derived lymphokines 
IL -2 and T cell- replacing factor (TRF), the macrophage- derived 
monokine IL -1, and CSF, which is produced by several diverse 
cell types including lymphocytes, macrophages and fibroblasts 
(reviewed by Farrar and Hilfiker, 1982). In addition, Howard 
et al. (1981) have suggested the existence of another distinct 
T cell- derived factor known as B cell growth factor (BCGF), 
although as yet there is no published biochemical data to dis- 
tinguish it from any of the other factors. 
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One of the first clear demonstrations that macrophage - 
derived soluble factors could enhance in vitro antibody responses 
came from the studies of Wood and co- workers (Wood and Gaul, 
1974; Wood and Cameron, 1975, 1976; Wood et al., 1976). In 
these studies, medium conditioned by endotoxin- stimulated human 
monocytes was found to significantly enhance the anti -CRBC PFC 
response of whole or T cell depleted murine spleen cells. The 
monocyte- derived factor responsible for enhancement had a mole- 
cular weight of approximately 15,000 daltons and was designated 
B cell- activating factor (BAF) (Wood and Cameron, 1976). Sub- 
sequent studies by Unanue et al. (1976) demonstrated that a 
functionally equivalent factor was also produced by murine peri- 
toneal macrophages. 
Although BAF was originally believed to be distinct from 
other monokines (Wood and Gaul, 1974) studies on the physical 
and biochemical properties of the factor (Wood, 1979a) revealed 
a striking similarity to the previously described thymocyte 
proliferative monokine known as lymphocyte- activating factor 
(LAF) (Gery et al., 1971, 1972; Cery and Waksman, 1972; Gery 
and Handschumacher, 1974; Blyden and Handschumacher, 1977) now 
designated IL -1 (Mizel and Farrar, 1979). This similarity 
suggests that these activities are either properties of a single 
molecule or of a number of closely related molecules. In support 
of the identity of BAF and IL -1, Koopman et al. (1978) and Wood 
(1979b) both found that BAF activity in the 12,000- 18,000 dalton 
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fraction of supernatants from unstimulated human monocytes could 
not be separated from the thymocyte mitogenic activity in the 
same fraction. Similarly, in chromatographic studies, murine 
macrophage- derived B cell stimulatory molecules were usually 
found in the same position as IL -1 (Calderon et al., 1975; 
Mannel et al., 1981). Finally, it is interesting to note that 
the same stimuli that induced peritoneal macrophages to secrete 
IL -1 also increased B cell stimulatory activity (Unanue et al., 
1976). 
Although little disagreement now exists concerning the 
identity of BAF, the nature of the target cell both in vivo 
and in vitro remains controversial. Two distinct, although 
not mutually exclusive views have been expressed. Several 
groups favour the view that IL -1 acts directly on B cells 
increasing their proliferation and /or differentiation (Wood and 
Cameron, 1976; Hoffman, 1979; Falkoff et al., 1983; Lipsky 
et al., 1983). However, by definition, IL -1 is also able to 
augment the proliferation of antigen- or mitogen- stimulated T 
lymphocytes (Mizel and Farrar, 1979) and this activity could 
lead indirectly to enhanced antibody responses. Thus in mixed 
cell cultures IL -1 could perhaps produce the same end result by 
acting on either T cells or B cells. However, Farrar and 
Koopman (1979) have recently shown that a partially purified 
preparation of human IL -1 (devoid of IL -2) was able to enhance 
the PFC response of nude mouse spleen cells only at concentrations 
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that were supraoptimal with regard to the induction of thymocyte 
proliferation. It was argued on the basis of these results that 
T cells express high affinity receptors for IL -1 and can thus be 
induced to proliferate by physiological concentrations of IL -1. 
B cells on the other hand were assumed to have low affinity 
receptors and proliferation could only be induced by very high 
concentrations of IL -1 which might never be realised in vivo 
(Farrar and Hilfiker, 1982). It is most likely therefore that 
the major target cell for IL -1 in the antibody response to thymus - 
dependent antigens is the T cell, although the possibility that 
B cells might also be stimulated directly cannot be excluded. 
CSF has also been shown to possess enhancing activity. 
Rubin (1979) demonstrated that a partially purified preparation 
of murine spleen cell- derived CSF could enhance the PFC response 
of B cell -enriched murine spleen cells. However this rather 
crude CSF preparation undoubtably contained various other factors 
and the importance of CSF is difficult to evaluate. Recently 
however, Moore et al. (1980, 1981) have demonstrated that prepar- 
ations of murine fibroblast -derived CSF which were apparently 
devoid of IL -1, IL -2 and TRF activity were able to enhance the 
anti -CRBC PFC response of normal murine spleen cells. 
A large body of evidence indicates that the primary target 
cell of CSF is the macrophage (reviewed by Moore et al., 1981). 
Thus CSF has been shown to be capable of inducing macrophages to 
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produce secondary mediators such as interferon (Hilfiker et al., 
1981), plasminogen activator (Lin and Gordon, 1979), prosta- 
glandins (Kurland et al., 1979) and IL -1 (Moore et al., 1980). 
The ability to augment the production of IL -1 probably explains 
the ability of CSF to enhance the PFC response of normal spleen 
cells. 
In the present study, the magnitude of the anti -CRBC PFC 
response, generated by whole normal spleen cells, was enhanced 
in a dose -dependent fashion by the addition of tumour -associated 
macrophages (Figure 15) or nylon wool -passed CRBC -primed spleen 
cells (Figure 8). The striking similarity in the dose -response 
curves obtained using these two distinct populations of cells, 
raised the possibility that tumour -associated macrophages might 
mediate their enhancing activity by effectively expanding the 
number of CRBC- specific TH cells present in the cultures. It 
was further argued that if this was the mechanism of macrophage - 
mediated enhancement, then in cultures where TH cells are in 
excess, addition of tumour -associated macrophages should have no 
further effect. If the macrophage- derived factor operated 
instead of augmenting B cell proliferation and /or differentiation 
then addition of tumour -associated macrophages would be expected 
to enhance the PFC response of cultures which contain excess TH 
cells. The results of such an experiment are shown in Figure Ja 
It is clear that while tumour -associated macrophages enhanced 
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the primary anti -CRBC PFC response of whole normal spleen cells, 
they had no significant effect on the response of cultures which 
also received excess nylon wool -passed CRBC -primed spleen cells. 
Thus it seems that the soluble enhancing factor produced by 
tumour -associated macrophages does not act directly on B cells. 
Instead, it is likely that this factor indirectly enhances anti- 
body responses by augmenting the proliferation and /or differ- 
entiation of antigen- stimulated T lymphocytes. 
Insufficient evidence is available at present to precisely 
define the nature of the tumour -associated macrophage- derived 
enhancing factor. However it is evident that although tumour - 
associated macrophages reconstituted the anti -CRBC PFC response 
of Sephadex G -10- passed spleen cells (Figure S ), the maximum 
response generated was not significantly higher than that obtained 
with whole normal spleen cells. This result suggests that the 
enhancing factor produced by tumour -associated macrophages does 
not act directly on T cells, instead it seems that a third cell 
type which is presumably removed by Sephadex G -10 is involved. 
Although further studies are clearly necessary it is possible that 
the enhancing factor could be CSF. CSF is produced in large 
amounts by "activated" macrophages (Chervenick and LoBuglio, 1972) 
and is known to indirectly augment T cell proliferation by inducing 
other macrophages to release IL -1 (Moore et al., 1980). In order 
to explain the lack of enhancement found in cultures of Sephadex 
G -10- passed spleen cells and tumour -associated macrophages it is 
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necessary to assume that tumour -associated macrophages are them- 
selves non -responsive to CSF. In this connection it is inter- 
esting to note that macrophages differ greatly in their expression 
of receptors for CSF (Chen and Lin, 1982). This model can also 
be used to explain the reduction in the PFC response generated 
by Sephadex G -10- passed spleen cells in the presence of high 
concentrations of tumour- associated macrophages (Figure 15). 
In addition to enhancing factors, macrophages may secrete mole- 
cules which inhibit lymphocyte responses (reviewed by Unanue, 
1981). Because Sephadex G -10 passed spleen cells lack the 
target cell for the macrophage- derived enhancing factors, the 
activity of inhibitory factors can be more readily seen. 
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Since the beginning of the century a vast amount of effort 
has gone into trying to elucidate the various diverse and complex 
interactions involved in the induction, expression and regulation 
of the immune response to neoplastic cells. Behind much of this 
work lay the belief that through a better understanding of these 
interactions, it would be possible to develop useful immuno- 
therapeutic approaches to the treatment of human cancer. However 
today immunological control of neoplasia through therapeutic 
intervention is still no more than an attractive and elusive 
goal. Tumour immunology remains by and large phenomenology. 
Many observations are made but the relationship between them 
is largely obscure. Clearly in situ tumour immunity is an 
important and often overlooked aspect of the tumour -host relation- 
ship. It cannot be emphasized too strongly that the eventual 
success of immunotherapy will largely depend upon a thorough 
understanding of all aspects of the tumour -host relationship 
including intratumoural events. 
Although the functional activity of tumour- associated 
macrophages is an area of fertile speculation, few studies have 
examined anything other than the cytotoxic activity of these 
cells (reviewed by Evans and Haskill, 1983). It was the aim 
of the present study to investigate the accessory cell activity 
of the macrophage population associated with the murine FSA -R 
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tumour. These cells were found to be fully capable of recon- 
stituting the primary anti -CRBC PFC response of Sephadex G -10 
passed spleen cells. This function required the presence of 
I -Ak positive cells, and macrophages treated with anti -Ia 
serum plus complement, or obtained from tumours grown in 
nu /nu hosts were inactive. However, several recent studies 
have demonstrated that it is not merely the presence or absence of 
Ia but also the number of Ia molecules expressed per cell that 
determines functional accessory cell activity (Matis et al., 
1982; Beller, 1984). Since tumour -associated macrophages are 
clearly heterogeneous with respect to the amount of I -Ak 
they express, it would be interesting to separate these cells 
into populations expressing differing amounts of I -Ak and 
investigate the ability of these various populations to recon- 
stitute the Sephadex G -10 depleted response. 
Tumour -associated macrophages were also able to supply 
the essential accessory cell activity required for cooperation 
between antigen -primed TH cells and normal B cells in the 
generation of PFC responses in vitro. However, the character- 
istics of the active accessory cell in this system were not 
further investigated. It would be interesting to determine 
whether I -Ak- positive cells were also required for this response. 
Finally, large I -Ak- negative tumour -associated macrophages 
were found to secrete a soluble factor(s) which could enhance 
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the primary anti -CRBC PFC response of whole normal spleen cells. 
The possibility that this factor could be CSF has already been 
discussed and certainly deserved further study. It would be 
relatively simple to test media conditioned by tumour -associated 
macrophages for their ability to induce bone marrow -derived 
macrophage precursors to form colonies in vitro. In addition, 
recently developed monoclonal antibodies against CSF could 
perhaps be used to deplete the enhancing activity from macro- 
phage conditioned medium or block its effect in vitro. 
From the results presented in this thesis it would seem that 
the intratumoural environment does not compromise the ability 
of macrophages to act as accessory cells in the generation of 
antibody responses in vitro. It should be noted however, that 
tumours generally contain relatively few B cells and it is 
unlikely that such a response could actually occur in situ. 
Perhaps future studies should utilize an in vitro assay system 
more relevant to the events which may occur within the tumour 
mass. The generation oflymphokine responses in vitro could 
perhaps constitute a suitable assay system. This response 
requires that macrophages present antigen to T cells in assoc- 
iation with Ia determinants (reviewed by Unanue, 1981). Lympho- 
kines produced as the result of an interaction between tumour - 
associated macrophages and T cells could attract macrophages to 
the tumour site and activate these cells to a cytotoxic state. 
Such events may have important implications with respect to tumour 




AASKOV, J.G. and ANTHONY, H.M. (1976) Assay of human 
lymphokines in vitro. Evidence for a migration stimulation 
factor (MstF) which interferes with the migration inhibition 
assay. Aust. J. Exp. Biol. Med. Sci., 54: 527 -529. 
ADAMS, D.O. (1980) Effector mechanisms of cytolytically- 
activated macrophages. I. Secretion of neutral protein - 
ases and effect of protease inhibitors. J. Immunol., 124: 
286 -292. 
ADAMS, D.O. (1982) Macrophage activation and secretion. 
Fed. Proc., 41: 2193 -2197. 
ADAMS, D.O. and MARINO, P.A. (1981) Evidence for a multi- 
step mechanism of cytolysis by BCG -activated macrophages: 
the interrelationship between the capacity for cytolysis, 
target binding and secretion of cytolytic factor. J. 
Immunol., 126: 981 -987. 
ADAMS, D.O. and SNYDERMAN, R. (1979) Do macrophages destroy 
nascent tumours? J. Natl. Cancer. Inst., 62: 1341 -1345. 
ADAMS, D.O., KAO, K.J., FARB, R. and PIZZO, S.V. (1980) 
Effector mechanisms of cytolytically- activated macrophages. 
II. Secretion of a cytolytic factor by activated macrophages 
and its relationship to secreted neutral proteases. J. 
Immunol., 124: 293 -300. 
ADAMS, D.O., JOHNSON, W.J. and MARINO, P.A. (1982) Mechanisms 
of target recognition and destruction in macrophage- mediated 
tumor cytotoxicity. Fed. Proc., 41: 2212 -2221. 
ADLER, W.H., TAKIGUCHI, T. and SMITH, R.T. (1971) Phyto- 
hemagglutinin unresponsiveness in mouse spleen cells 
induced by methylcholanthrene sarcomas. Cancer Res., 31: 
864 -867. 
ALEXANDER, P. (1976) The functions of the macrophage in 
malignant disease. Ann. Rev. Med., 27: 207 -224. 
ALEXANDER, P. and EVANS, R. (1971) Endotoxin and double 
stranded RNA render macrophages cytotoxic. Nature: 
New Biology, 232: 76 -78. 
ALEXANDER, P., ECCLES, S.A. and GAUCI, C.L. (1976) The 
significance of macrophages in human and experimental 
tumors. Ann. N.Y. Acad. Sci., 276: 124 -133. 
ANACLERIO, A., MORAS, M.L., CONTI, G., MISTRELLO, G., and 
SPREAFICO, F. (1978) Suppression of mitogen responses 
and graft- versus -host reaction by splenocytes from mice 
bearing Lewis lung carcinoma. J. Natl. Cancer Inst., 
61: 471 -475. 
14U 
ASKENASE, P.W. and HAYDEN, J.B. (1974) Cytophilic anti- 
bodies in mice contact -sensitized with oxazolone. Immuno- 
chemical characterisation and preferential binding to a 
trypsin- sensitive macrophage receptor. Immunology, 
27: 563 -576. 
AULT, K.A. and SPRINGER, T.A. (1981) Cross -reaction of a 
rat -anti -mouse phagocyte -specific monoclonal antibody 
(anti- Mac -1) with human monocytes and natural killer 
cells. J. Immunol., 126: 359 -364. 
BAIRD, L.G. and KAPLAN, A.M. (1977a) Macrophage regulation 
of mitogen- induced blastogenesis. I. Demonstration of 
inhibitory cells in the spleens and peritoneal exudates of 
mice. Cell Immunol., 28: 22 -35. 
BAIRD, L.G. and KAPLAN, A.M. (1977b) Macrophage regulation 
of mitogen induced blastogenesis. II. Mechanism of 
inhibition. Cell Immunol., 28: 36 -50. 
BALDWIN, R.W. (1981) Mechanisms of immunity in cancer. 
Pathobiol. Annu., 11: 155 -175. 
BAR -ELI, M., TERRITO, M.C. and CLINE, M.J. (1981) The 
progeny of a single progenitor cell can develop character- 
istics of either a tissue or an alveolar macrophage. 
Blood, 57: 95 -98. 
BASTEN, T., MILLER, J.F.A.P., WARNER, N.L., CHIA, E. and 
BAMBLE, J. (1975) A subpopulation of T cells bearing 
Fc receptors. J. Immunol., 115: 1159 -1165. 
BEHIN, R., MAUEL, J., BIROUM -NOERJASIN and ROWE, D.S. (1975) 
Mechanisms of protective immunity in experimental cutaneous 
leishmaniasis of the guinea pig. II. Selective destruction 
of different Leishmania species in activated guinea pig 
and mouse macrophages. Clin Exp. Immunol., 20: 351 -358. 
BELLER, D.I. (1984) Functional significance of the regulation 
of macrophage la expression. Eur. J. Immunol., 14: 138 -143. 
BELLER, D.I. and HO, K. (1982) Regulation of macrophage 
populations. V. Evaluation of the control of macrophage 
la expression in vitro. J. Immunol., 129: 971 -976. 
BELLER, D.I. and UNANUE, E.R. (1980) la antigens and antigen - 
presenting function of thymic macrophages. J. Immunol., 
124: 1433 -1440. 
241 
BELLER, D.I. and UNANUE, E.R. (1981) Regulation of macro- 
phage populations. U. Synthesis and expression of Ia 
antigens by peritoneal exudate macrophages is a transient 
event. J. Immunol., 126: 263 -269. 
BELLER, D.I.,SPRINGER, T.A. and SCHREIBER, R.D. (1982) 
Anti -Mac -1 selectively inhibits the mouse and human type 
three complement receptor. J. Exp. Med., 156: 1000- 
1009. 
BELNAPS, Le G -P., CLEVELAND, P.H., COLMERAUER, 
BARONE, R.H. and PILCH, Y.H. (1979) Immunogenicity of 
chemically- induced murine colon cancers. Cancer Res., 
39: 1174 -1179. 
BEN -SASSON, S.Z., SHEVACH, E.M., GREEN, I. and PAUL, W.E. (1974) 
Alloantiserum- induced inhibition of migration inhibition 
factor production in immune response gene -controlled immune 
systems. J. Exp. Med., 140: 383 -395. 
BEN -SASSON, S.Z., LIPSCOMB, M.F., TUCKER, T.F. and UHR, J.W. 
(1977) Specific binding of T lymphocytes to macrophages. 
U. Role of macrophage- associated antigen. J. Immunol., 
119, 1493 -1500. 
BERG, J.W. (1959) Inflamation and prognosis in breast cancer; 
a search for host resistance. Cancer, 12: 714 -720. 
BERKOWER, I., MATIS, L.A., LONGO, D.L., GURD, F.R.N. and 
BERZOTSKY, J.A. (1983) T cell clones to myoglobulin: 
I -A /I -E restriction correlated with epitope recognized, 
and monoclonal antibody to the same epitope blocks the 
response. Fed. Proc., 42: 1242, abstract 5566. 
BERLINGER, N.T. and GOOD, R.A. (1980) Suppressor cells in 
healthy relatives of patients with hereditary colon cancer. 
Cancer, 45: 1112 -1116. 
BERLINGER, N.T., LOPEZ, C. and GOOD, R.A. (1976) Facilitation 
or attenuation of mixed leukocyte culture responsiveness by 
adherent cells. Nature, 260: 145 -146. 
BERNSTEIN, I.D., ZBAR, B. and RAPP, H.J. (1972) Impaired 
inflammatory response in tumor -bearing guinea pigs. 
J. Natl. Cancer Inst., 49: 1641 -1647. 
BIANCO, C. and NUSSENZWEIG, V. (1977) Complement receptors. 
Contemp. Top. Molec. Immunol., 6: 145 -176. 
242 
BLOMGREN, H., BARAL, E., PETRINI, B. and WASSERMAN, J. (1976) 
Impaired lymphocyte responses to PPD- tuberculin in 
advanced breast carcinoma. Increased reactivity after 
depletion of phagocytic or adherent cells. Clin. Oncol., 
2: 379 -392. 
BLOOM, B.R., GAFFNEY, J. and JIMENEZ, L. (1972) Dissociation 
of MIF production and cell proliferation. J. Immunol., 
109: 1395 -1402. 
BLUESTEIN, H.G. and PIERCE, C.W. (1973a) Development of 
primary M,G, and A anti -TNP plaque- forming cell responses 
in vitro. J. Immunol., 111: 130 -136.. 
BLUESTEIN, H.G. and PIERCE, C.W. (1973b) Cellular require- 
ments for development of primary anti -hapten antibody 
responses in vitro. J. Immunol., 111: 137 -142. 
BLUSSE van OUD ALBLAS, A. and van FURTH, R. (1979) Origin, 
kinetics, and characteristics of pulmonary macrophages in 
the normal steady state. J. Exp. Med., 149: 1504 -1518. 
BLYDEN, G. and HANDSCHUMACHER, R.E. (1977) Purification and 
properties of human lymphocyte activating factor (LAF). 
J. Immunol., 118: 1631 -1638. 
BOETCHER, D.A. and LEONARD, E.J. (1974) Abnormal monocyte 
chemotaxis response in cancer patients. J. Natl. Cancer 
Inst., 52: 1091 -1099. 
BOL, S. and WILLIAMS, N. (1980) The maturation state of 
three types of granulocyte /macrophage progenitor cells 
from mouse bone marrow. J. Cell Physiol., 102: 233 -243. 
BOTTAZZI, B., POLENTANUTTI, N., BALSANI, A., BORASCHI, D., 
GHEZZI, P., SALMONA, M., and MANTOVANI, A. (1983) 
Chemotactic activity for mononuclear phagocytes of culture 
supernatants from murine and human tumor cells: evidence 
for a role in the regulation of the macrophage content 
of neoplastic tissues. Int. J. Cancer, 31: 55 -63. 
BRAATHEN, L.R. and THORSBY, E. (1980) Studies on human 
epidermal Langerhans cells. I. Allo- activating and 
antigen -presenting capacity. Scand. J. Immunol., 11: 
401 -408. 
BRITZ, J.S., ASKENASE, P.W., PTAK, W., STEINMAN, R.M. and 
GERSHON, R.K. (1982) Specialized antigen -presenting 
cells. Splenic dendritic cells and peritoneal- exudate 
cells induced by mycobacteria activate effector T cells 
that are resistant to suppression. J. Exp.Med., 155: 1344- 
1356. 
243 
BROOKS, C.G., KURIBAYASHI, K., SALE, G.E. and HENNEY, C.S. 
(1982) Characterization of five cloned murine cell lines 
showing high cytolytic activity against YAC -1 cells. 
J. Immunol., 128: 2326 -2335. 
BUHLES, W.C. Jnr. (1979) Studies on mononuclear phagocyte 
progenitor cells: morphology of cells and colonies in 
liquid culture of mouse bone marrow. J. Reticuloendothel. 
Soc., 25: 363 -378. 
BURG, G. and BRAUN -FALCO, 0. (1972) The cellular stromal 
reaction in malignant melanoma. A cytochemical investigation. 
Arch. Dermatol. Forsch., 245: 318 -333. 
BURMESTER, G.R., DIMITRIU -BORA, A., WATERS, S.J. and WINCHESTER, 
R.J. (1983) Identification of three major synovial 
lining cell populations by monoclonal antibodies directed 
to la antigens and antigens associated with monocytes/ 
macrophages and fibroblasts. Scand. J. Immunol., 17: 
69 -82. 
BURSUKER, I. and GOLDMAN, R. (1982) Distinct bone marrow 
precursors for mononuclear phagocytes expressing high 
and low 5'- nucleotidase activity. J. Cell Physiol., 
112: 237 -242. 
BURSUKER, I. and GOLDMAN, R. (1983) On the origin of macro- 
phage heterogeneity: a hypothesis. J. Reticuloendothel. 
Soc., 33: 207 -220. 
BURSUKER, I., RHODES, J.M. and GOLDMAN, R. (1982) B- galacto- 
sidase - an indicator of the maturation state of mouse and 
human mononuclear phagocytes. J. Cell Physiol., 112: 
385 -390. 
BYRNE, P., HEIT, W. and KUBANEK, B. (1977) The in vitro 
differentiation of density sub -populations of colony - 
forming cells under the influence of different types of 
colony- stimulating factor. Cell Tissue Kinet., 10: 341- 
351. 
CALDERON, J.J., KIELY, J. -M., LEFKO, J.L. and UNANUE, E. (1975) 
The modulation of lymphocyte functions by molecules secreted 
by macrophages. I. Description and partial biochemical 
analysis. J. Exp. Med., 142: 151 -159. 
CARR, I., UNDERWOOD, J.C.E., McGINTY, F. and WOOD, P. (1974) 
The ultrastructure of the local lymphoreticular response 
to an experimental neoplasm. J. Pathol., 113: 175 -182. 
244 
CHAMPION, H.R., WALLACE, I.W. and PRESCOTT, R.J. (1972) 
Histology in breast cancer prognosis. Br. J. Cancer, 26: 
129 -138. 
CHEN, D. -M. and LIN, H. -S. (1982) Interaction of murine colony 
stimulating factor (CSF -1) with alveolar mononuclear phago- 
cytes. Exp. Cell Res., 140: 323 -329. 
CHEN, D. -M., LIN, H. -S., STAHL, P. and STANLEY, E.R. (1979) 
Clonal growth in vitro by mouse Kupffer cells. Exp. Cell 
Res., 121: 103 -109. 
CHERVENIK, P.A. and LOBUGLIO, A.F. (1972) Human blood monocytes: 
stimulators of granulocyte and mononuclear colony formation 
in vitro. Science, 178: 164 -166. 
CHESNUT, R., COLON, S. and GREY, H.M. (1982) Antigen present- 
ation by normal B cells, B cell tumours, and macrophages: 
functional and biochemical comparison. J. Immunol., 128: 
1764 -1768. 
CHEUNG, H.T., CANTAROW, W.D. and SUNDHARADAS, G. (1979) 
Characteristics of a low molecular weight factor extracted 
from mouse tumors that affects in vitro properties of 
macrophages. Int. J. Cancer, 23: 344 -352. 
CIANCIOLO, G.J. and SNYDERMAN, R. (1982) Effects of neoplasms 
on mononuclear phagocytes. In: "Tumour Immunity in 
Prognosis. The role of mononuclear cell infiltration." 
(Haskill S. ed.), pp 151- 174,Marcel Dekker, Inc., New York 
and Basel. 
CIANCIOLO, G.J. and SNYDERMAN, R. (1983) Neoplasia and mono- 
nuclear phagocyte function. In: "The Reticuloendothelial 
System. A comprehensive treatise. Volume 5, Cancer." 
(Herberman, R.B. and Friedman, H., eds.), pp 193 -216, 
Plenum Press, New York and London. 
CIANCIOLO, G.J., HERBERMAN, R.B. and SNYDERMAN, R. (1980) 
Depression of murine macrophage accumulation by low - 
molecular- weight factors derived from spontaneous mammary 
carcinoma. J. Natl. Cancer Inst., 65: 829 -834. 
CIANCIOLO, G., HUNTER, J., SILVA, J., HASKILL, J.S. and 
SNYDERMAN, R. (1981) Inhibitors of monocyte responses 
to chemotaxins are present in human cancerous effusions 
and react with monoclonal antibodies to the P15 (E) structural 
protein of retroviruses. J. Clin. Invest.,68: 831 -844. 
245 
CLAESSON, M.H. and OLSSON, L. (1980) Autoreactive natural 
killer -like cells from agar- cloned murine bone marrow 
cells. Nature 283: 578 -580. 
CLARK, R.L. (1979) Systemic cancer and the metastatic process. 
Cancer, 43: 790 -797. 
COCHRAN, A.J. (1969) Histology and prognosis in malignant 
melanoma. J. Pathol., 97: 459 -468. 
CODINGTON, J.F., SANFORD, B.H. and JEANLOZ, R.W. (1972) 
Glycoprotein coat of the TA3 cell. Isolation and partial 
characterization of a sialic acid containing glycoprotein 
fraction. Biochemistry, 11: 2559 -2564. 
COHN, Z.A. (1978) The activation of mononuclear phagocytes: 
fact, fancy and future. J. Immunol., 121: 813 -816. 
CRUCHAUD, A., BERNEY, M. and BALANT, L. (1975) Catabolism 
physical and immunologic properties of endocytosed isologous 
and heterologous iota -globulins by mouse macrophages. 
J. Immunol., 114: 102 -109. 
CUNNINGHAM, A.J. (1965) A method of increased sensitivity for 
detecting single antibody- forming cells. Nature, 207: 
1106 -1107. 
CUNNINGHAM, A.J. and SZENBERG, A. (1968) Further improvements 
in the plaque technique for detecting single antibody - 
forming cells. Immunology, 14: 599 -600. 
CURRIE, C.A. (1978) Activated macrophages kill tumour cells 
by releasing arginase. Nature, 273: 758 -759. 
CURRIE, G. (1980) Immunotherapy of human cancer: prospect 
and retrospect. In: "Cancer and the immune response. ", 
pp 88 -115, Edward Arnold, London. 
DAEMS, W.T. (1980) Peritoneal macrophages. In: "The 
Reticuloendothelial System. A comprehensive Treatise. 
Volume 1, Morphology (Carr, I. and Daems, W.T., eds.), 
pp 57 -127, Plenum Press, New York. 
DAVEY, G.C., CURRIE, G.A. and ALEXANDER, P. (1979) Immunity 
as the predominant factor determining metastasis by murine 
lymphomas. Br. J. Cancer, 40: 590 -596. 
DAVID, J.R., REMOLD, H.G., LIU, D.Y., WEISER, W.Y. and DAVID, 
R.A. (1983) Lymphokines and macrophages. Cell Immunol., 
82: 75 -81. 
246 
DAVIES, P. and ALLISON, A.C. (1976) Secretion of macrophage 
enzymes in relation to the pathogenesis of chronic inflam- 
mation. In: "Immunobiology of the Macrophage ", (D.S. 
Nelson, ed.), pp 427 -461, Academic Press, New York. 
DAVIES, P. and BONNEY, R.J. (1979) Secretory products of 
mononuclear phagocytes: A brief review. J. Reticulo- 
endothel. Soc., 26: 37 -47. 
DAYER, J.H., STEPHENSON, M.L., SCHMIDT, E., KARGE, W. and 
KRANE, S.M. (1981) Purification of a factor from human 
blood monocyte- macrophages which stimulates the production 
of collagenase and prostaglandin E0 by cells cultured from 
rheumatoid synovial tissues. Fes Ltt., 124: 253 -256. 
DeBAKKER, J.H. and DAÉMS, W.Th. (1981) The heterogeneity of 
mouse peritoneal macrophages. In: "Heterogeneity of 
Mononuclear Phagocytes ", (Forster, O. and Landy, M. eds), 
pp 11 -13, Academic Press, Londong. 
DeLUSTO, F. and HASKILL, J.S. (1978) In situ cytotoxic cells 
in a methylcholanthrene- induced tumor. J. Immunol., 121: 
1007 -1009. 
DIENSTMAN, S.R. and DEFENDI, V. (1978) Necessary and sufficient 
conditions for recruitment of macrophages into the cell 
cycle. Exp. Cell Res., 115: 191 -199. 
DINARELLO, C.A., GOLDIN, N.P. and WOLFF, S.M. (1974) Demon- 
stration and characterization of two distinct human leuko- 
cytic pyrogens. J. Exp. Med., 139: 1369 -1381. 
DINARELLO, C.A., BENDTZEN, K. and WOLFF, S.M. (1982) Studies 
on the active site of human leukocytic pyrogen. 
Inflammation, 6: 63 -73. 
DIZON, Q. and SOUTHAM, C.M. (1963) Abnormal cellular response 
to skin abrasion in cancer patients. Cancer, 16: 1288- 
1292. 
DOUGHERTY, G.J. and McBRIDE, W.H. (1984) Macrophage hetero- 
geneity. J. Clin. Lab. Immunol., 14: 1 -11. 
DOUGLAS, S.D. (1980) Mononuclear phagocytes and tissue 
regulatory mechanisms. Dev. Comp. Immunol., 4: 7 -10. 
DUKE, O., PANAYI, G., JANOSSY, G. and POULTER, L.W. (1982) 
An immunological analysis of lymphocyte subpopulations and 
their microenvironment in the synovial membranes of patients 
with rheumatoid arthritis using monoclonal antibodies. 
Clin. Exp. Immunol., 49: 22 -30. 
247 
ECCLES, S.A. (1978) Macrophages and cancer. In: "Immuno- 
logical Aspects of Cancer. ", (Castro, J.E.ed.) MTP Press, 
Lancaster, England, pp 123 -154. 
ECCLES, S.A. (1980) Tumour metastasis in thymectomized an 
athymic rats. In: "Proceedings of the Medical Research 
Symposium on Immunodeficient animals in cancer research" 
(Sparrow, S., ed.) pp 167 -177, Macmillan, London. 
ECCLES, S.A. (1982) Host immune mechanisms in the control of 
tumor. metastasis. In: "Tumour immunity in prognosis. 
The role of mononuclear cell infiltration" (Haskill, S., 
ed.), pp 37 -74, Marcel Dekker Inc., New York and Basel. 
ECCLES, S.A. and ALEXANDER, P. (1974) Macrophage content 
of tumours in relation to metastatic spread and host immune 
reaction. Nature, 250: 667 -669. 
ECCLES, S.A., STYLES, J.M., HOBBS, S.M. and DEAN, C.J. (1979) 
Metastasis in the nude rat associated with the lack of 
immune response. Br. J. Cancer, 40: 802 -805. 
ECCLES, S.A., HECKFORD, S.E. and ALEXANDER, P. (1980) Effect 
of cyclosporin A on the growth and spontaneous metastasis 
of syngereic animal tumours. Br. J. Cancer, 42: 252 -259. 
ELLNER, J.J. and ROSENTHAL, A.S. (1975) Quantitative and 
immunologic aspects of the handling of 2,4, dinitrophenyl 
guinea pig albumin by macrophages. J. Immunol., 114: 
1563 -1569. 
ELLNER, J.J., LIPSKY, P.E. and ROSENTHAL, A.S. (1977) Antigen 
handling by guinea pig macrophages: further evidence for 
the sequestration of antigen relevant for activation of 
primed T lymphocytes. J. Immunol., 118: 2053 -2057. 
EPSTEIN, W.L., SAGEBEIL, R., SPITLER, L. et al., (1973) Halo 
nevi and melanoma. JAMA, 225: 373 -377. 
ERB, P and FELDMANN, M. (1975a) The role of macrophages in 
the generation of T- helper cells. II. The genetic control 
of the macrophage -T -cell interaction for helper cell induction 
with soluble antigens. J. Exp. Med., 142: 460 -472. 
ERB, P. and FELDMAN, M. (1975b) Role of macrophages in in 
vitro induction of T- helper cells. Nature, 254: 352 -354. 
EVANS, R. (1972) Macrophages in syngeneic animal tumours. 
Transplantation, 14: 468 -473. 
248 
EVANS, R. (1973) Macrophages and the tumour bearing host. 
Br. J. Cancer, 28: Supple. 1, 19 -25. 
EVANS, R. (1975) Macrophage- mediated cytotoxicity: its 
possible role in rheumatoid arthritis. Ann. N.Y. Aca. 
Sci., 256: 275 -287. 
EVANS, R. (1976) Tumour macrophages in host immunity to 
malignancies. In: "The Macrophage in Neoplasia", (Fink, 
M.A., ed.,), pp 27 -42, Academic Press, New York. 
EVANS, R. (1977) Macrophages in solid tumours. 'In: "The 
Macrophage and Cancer" (James, K., McBridge, B. and. Stuart, 
A., eds.), pp 321 -329, Published by the editors, Edinburgh. 
EVANS, R. (1978) Macrophage requirement for growth of a 
murine fibrosarcoma. Br. J.Cancer, 37: 1086 -1089. 
EVANS, R. (1979) Host cells in transplanted murine tumors 
and their possible relevance to tumor growth. J. 
Reticuloendothel. Soc., 26: 427 -437. 
EVANS, R. (1980) Macrophage accumulation in primary and 
transplanted tumors growing in C5- deficient B10.D2 /oSn 
mice. Int. J. Cancer, 26: 227 -229. 
EVANS, R. (1982) Macrophages and neoplasms: new insights 
and their implication in tumor immunobiology. Cancer 
Metastasis Rev., 1: 227 -239. 
EVANS, R. and ALEXANDER, R. (1976) Mechanisms of extra - 
cellular killing of nucleated mammalian cells by macrophages. 
In: "Immunobiology of the Macrophage ", (Nelson, D.S., ed), 
pp 536 -576, Academic Press, New York. 
EVANS, R. and EIDLEN, D.M. (1981) Macrophage accumulation 
in transplanted tumors is not dependent on host immune 
responsiveness or presence of tumor -associated rejection 
antigens. J. Reticuloendothel. Soc., 30: 425 -437. 
EVANS, R. and HASKILL, S. (1983) Activities of macrophages 
within and peripheral to the tumor mass. In: "The 
Reticuloendothelial System. A Comprehensive Treatise, 
Volume 5, Cancer ", (Herberman, R.B. and Friedman, H., eds.), 
pp 155 -176, Plenum Press, New York. 
EVANS, R. and LAWLER, E.M. (1980) Macrophage content and immuno- 
genicity of C57BL /6J and BALB /cByJ methylcholanthrene- 
induced sarcomas. Int. J. Cancer, 26: 831 -835. 
249 
EVANS, R., BOOTH, C.G. and SPENCER, F. (1978) Lack of 
correlation between in vivo rejection of syngeneic fibro- 
sarcomas and in vitro non -specific macrophage cytotoxicity. 
Br. J. Cancer, 38: 583 -590. 
EVANS, R., MADISON, L.D. and EIDLEN, D.M. (1980) Cyclo- 
phosphamide- induced changes in the cellular composition of 
a methylcholanthrene- induced tumor and their relation to 
bone marrow and blood leukocyte levels. Cancer Res., 40: 
395 -402. 
FALK, W., TOMASAWA, S., KLIMETZEK, V. and MELTZER,.M.S. (1981) 
Chemotactic activity of bone marrow -derived macrophages 
changes with time in culture. Infect. Immun., 33: 629- 
631. 
FALKOFF, R.J.M., MURAGUCHI, A., HONG, J. -X., BUTLER, J.L., 
DINARELLO, C.A. and FAUCI, A.S. (1983) The effects of 
interleukin 1 on human B cell activation and proliferation. 
J. Immunol., 131: 801 -805. 
FARAH, F.S., SAMRA, S.A. and NUWAYRI -SALTI, N. (1975) The 
role of the macrophage in cutaneous leishmaniasis. 
Immunology, 29: 755 -764. 
FARR, A.G., DORF, M.E. and UNANUE, E.R. (1977) Secretion 
of mediators following T lymphocyte- macrophage interaction 
is regulated by the major histocompatibility complex. 
Proc. Natl. Acad. Sci. USA., 74: 3542 -3546. 
FARR, A.G., WECHTER, W.J., KIELY, J.M. and UNANUE, E.R. (1979) 
Induction of cytocidal macrophages after in vitro inter- 
actions between immune T cells and macrophages - role of H -2. 
J. Immunol., 122: 2405 -2412. 
FARRAR, J.J. and HILFIKER, M.L. (1982) Antigen- nonspecific 
helper factors in the antibody response. Fed. Proc., 41: 
263 -268. 
FARRAR, J.J. and KOOPMAN, W.J. (1979) Characterization of 
mitogen factors and their effect on the antibody response 
in vitro. In: "Biology of the Lymphokines ", (Cohn, S., 
Pick, E. and Oppenheim, J.J., eds.), pp 325 -346, Academic 
Press, New. York. 
FATHMAN, C.G., WATSON, J.D., BACH, F.H., BONNARD, G.D., FITCH, 
F., GILLIS, S., KLINMAN, N., MAWAS, C., MELCHERS, F., 
NABHOLZ, M., PAUL, W., ROSENBERG, S.A., SCHWARTZ, R.H., 
SMITH, K. and TALMAGE, D.W. (1981) Cloning of 
250 
immunocompetent cells. In: "New Initiatives in 
Immunology ", NIAID Study Group report, pp 61 -97, NIH 
Publication No. 81 -2215, US Government Printing Office. 
FEARON, D.T. (1984) Cellular receptors for the third 
component of complement. Immunol. Today, 5: 105 -110. 
FEARON, D.T. and WONG, W.W. (1983) Complement ligand- 
receptor interactions that mediate biological responses. 
Ann. Rev. Immunol., 1: 243 -271. 
FELDMAN, D.G., EHRENREICH, T. and GROSS, L. (1974) Electron 
microscopic study of the growth and regression of leukemic 
intradermal tumors in guinea pigs. Cancer Res., 34: 
901 -914. 
FELDMANN, M. and BASTEN, A. (1972) Cell interactions in 
the immune response in vitro. III. Specific collaboration 
across a cell impermeable membrane. J. Exp. Med., 136: 
49 -67. 
FELDMANN, M. and BASTEN, A. (1972) Cell interactions in 
the immune response in vitro. IV. Comparison of the 
effects of antigen- specific and allogeneic thymus- derived 
cell factors. J. Exp. Med., 136: 722 -736. 
FELDMANN, M. and PALMER, J. (1971) The requirement for 
macrophages in the secondary immune response to antigens 
of small and large size in vitro. Immunology, 21: 685- 
699. 
FELDMANN, M., HOWIE, S., ERB, P., MAURER, P., NOZES, E. and 
HAMMERLING, V. (1978) In: "Ir genes and Ia antigens ", 
(McDevitt, H.D. ed.) p. 315, Academic Press, New York. 
FERLUGA, J., SCHORLEMMER, H.U., BAPTISTA, L.C. and ALLISON, A.C. 
(1976) Cytolytic effects of the complement cleavage 
product C3a. Br. J. Cancer, 34: 626 -634. 
FERNBACH, B.R., KITCHNER, H., BONNARD, G.D. and HERBERMAN, R.B. 
(1976) Suppression of mixed lymphocyte response in mice 
bearing primary tumors induced by murine sarcoma virus. 
Transplantation, 21: 381 -386. 
FIDLER, I.J. (1975) Activation in vitro of mouse macrophages 
by syngeneic, allogeneic or xenogeneic lymphocyte super- 
natants. J. Natl. Cancer Inst., 55: 1159 -1163. 
FIDLER, I.J. (1980) Therapy of spontaneous metastases by 
intravenous injection of liposomes containing lymphokines. 
Science, 208: 1469 -1471. 
251 
FIDLER, I.J. (1981) The in situ induction of tumoricidal 
activity in alveolar macrophages by lipsomes containing 
muramyl dipeptide is a thymus- independent process. j. 
Immunol., 127: 1719 -1720. 
FIDLER, I.J. and CIFONE, M.A. (1979) Properties of metastatic 
and nonmetastatic cloned subpopulations of an ultraviolet - 
light- induced murine fibrosarcoma of recent origin. Am. 
J. Pathol., 97: 633 -648. 
FIDLER, I.J. and POSTE, G. (1982) Macrophage- mediated 
destruction of malignant tumor cells and new strategies 
for the therapy of metastatic disease. Springer Semin. 
Immunopathol., 5: 161 -174. 
FIDLER, I.J. and RAZ, A. (1981) The induction of tumoricidal 
capacities in mouse and rat macrophages by lymphokines. 
In: "Lymphokines, Vol. 3 ", (Pick, E. ed.), p. 345, Academic 
Press, New York. 
FIDLER, I.J., GERSTEN, D.M. and KRIPKE, M.L. (1979) Influence 
of immune status on the metastasis of three murine fibro- 
sarcomas of different immunogenicities. Cancer Res., 39: 
3816 -3821. 
FIDLER, I.J., RAZ, A., FOGLER, W.E., KIRSCH, R., BUGELSKI, P. 
and POST, G. (1980) Design of liposomes to improve 
delivery of macrophage- augmenting agents to alveolar 
macrophages. Cancer Res., 40: 4460 -4466. 
FIDLER, I.J., SONE, S., FOGLER, W.E. and BAINES, Z.L. (1981) 
Eradication of spontaneous metastases and activation of 
alveolar macrophages by intravenous injection of liposomes 
containing muramyl dipeptide. Proc. Natl., Acad. Sci., 
USA., 78: 1680 -1684. 
FIDLER, I.J., BARNES, Z., FOGLER, W.E., KIRSH, R., BUGELSKI, 
P., and POSTE, G. (1982) Involvement of macrophages 
in the eradication of established metastases following 
intravenous injection of liposomes containing macrophage 
activators. Cancer Res., 42: 496 -501. 
FLOTTE, T., SPRINGER, T.A. and THORBECKE, G.J. (1983) 
Dendritic cell and macrophage staining by monoclonal 
antibodies in tissue sections and epidermal sheets. 
Am. J. Pathol., 111: 112 -124. 
FORNI, G., VARESIO, L., GIOVARELLI, M. and CAVALLS, G. (1979) 
Dynamic state of spontaneous immune reactivity towards a 
mammary adenocarcinoma. In: "Tumor Associated Antigens 
and their Specific Immune Response." (Spreafico, F. and 
Aron, R. eds.), pp. 167 -192, Academic Press, New York. 
252 
FORNI, G., GIOVARELLI, M., LANFRANCONE, L. and VARESIO, L. 
(1982) Suppressor macrophages in tumor -bearing mice. 
Inconsistency between in vivo and in vitro findings. 
Int. J. Cancer, 29: 695 -698. 
FORRE, O., EGELAND, T., DOBLOUG, J.H., KVIEN, T.K. and NATVIG, 
J.B. (1982) Autologous mixed lymphocyte reactions in 
patients with rheumatoid arthritis and juvenile rheumatoid 
arthritis. Both non -T and in vivo -activated T cells can 
act as stimulator cells. Scand. J. Immunol., 16: 173 -179. 
FRIEDMAN, S.M., KUHNS, J., IRIGOYEN, O. and CHESS, L. (1979) 
The induction of TNP -altered self -reactive human cytotoxic 
T cells by soluble factors: the role of la angiens. J. 
Immunol., 122: 1302 -1309. 
van FURTH, R. (1978) In: "Mononuclear Phagocytes in Inflam- 
mation", (Vane, J.R. and Fereira, J.R. eds.), pp 69 -108, 
Springer Verlay, Berlin -Heidelberg -New York. 
van FURTH, R. (1981) Development of mononuclear phagocytes. 
In: "Heterogeneity of Mononuclear Phagocytes ", (Forster, O. 
and Landy, M. eds.), pp. 3 -10, Academic Press, London. 
GABLZON, A., LEIBOVICH, S.J. and GOLDMAN, R. (1980) Constrast- 
ing effects of activated and nonactivated macrophages from 
tumor -bearing mice on tumor growth in vivo. J. Natl. Cancer 
Inst., 65: 913 -920. 
GANDOUR, D.M. and WALKER, W.S. (1983) Macrophage cell cycling: 
influence on Fc receptors and antibody dependent phagocytosis. 
J. Immunol., 130: 1108 -1112. 
GECZY, A., de WECK, A.L., SCHWARTZ, B.D. and SHEVACH, E.M. 
(1975) The major histocompatibility complex of the guinea 
pig. I. Serologic and genetic studies. J. Immunol., 115: 
1704 -1710. 
GEMSA, D., DEBATIN, K. -M., DRAMEN, W., KUBELKA, C., DEIMANN, W., 
KEES, U. and KRAMMER, P.H. (1983) Macrophage- activating 
factors from different T cell clones induce distinct macro- 
phage functions. J. Immunol., 131: 833 -844. 
GERSHON, R.K. (1974) T cell control of antibody production. 
Contemp. Topics Immunobiol., 3: 1 -140. 
GERY, I. and HANDSCHUMACHER, R.E. (1974) Potentiation of the 
T lymphocyte response to mitogens. III. Properties of the 
mediator(s) from adherent cells. Cell Immunol., 11: 162- 
169. 
GERY, I. and WAKSMAN, B.H. (1972) Potentiation of the T- 
lymphocyte response to mitogens. U. The cellular source 
of potentiating mediator(s). J. Exp. Med., 136: 143 -155. 
253 
GERY, I., GERSHON, R.K. and WAKSMAN, B.H. (1971) Potentiation 
of cultured mouse thymocyte responses by factors released 
by peripheral leucocytes. J. Immunol., 107: 1778 -1780. 
GERY, I., GERSHON, R.K. and WAKSMAN, B.H. (1972) Potentiation 
of the T- lymphocyte response to mitogens. I. The responding 
cell. J. Exp. Med., 136: 128 -142. 
GILLESPIE, G.Y. and RUSSELL, S.W. (1978) Development and 
persistence of cytolytic T lymphocytes in regressing or 
progressing Moloney sarcomas. Int. J. Cancer, 21: 94 -99. 
GILLESPIE, G.Y. and RUSSELL, S.W. (1980) Level of activation 
determines whether inflammatory peritoneal and intratumoral 
macrophages will promote or suppress in vitro development 
of cytolytic lymphocyte activity. J. Reticuloendothel. 
Soc., 27: 535 -545. 
GILLETTE, R.W. and BOONE, C.W. (1973) Changes in phytohemag- 
glutinin response due to presence of tumors. J. Natl. 
Cancer Inst., 50: 1391 -1393. 
GILLETTE, R.W. and BOONE, C.W. (1975) Changes in the mitogen 
response of lymphoid cells with progressive tumor growth. 
Cancer Res., 35: 3774 -3779. 
GINSBERG, A. (1970) The function of the delayed sensitivity 
reaction as revealed in the graft reaction culture. Adv. 
Cancer Res., 13: 63 -95. 
GISLER, R.H., STERN, A.C., ALKAN, S.S. and ERB, P. (1981) 
Characterization of bone marrow- derived macrophages for 
T helper cell induction in vitro. In: "Heterogeneity of 
Mononuclear Phagocytes ", (Forster, O. and Landy, M. eds.) 
pp. 201 -207, Academic Press, London. 
GLOBERSON, A. and FELDMAN, M. (1964) Antigenic specificity 
of benzo (a) pyrene- induced sarcomas. J- ..Natl. Cancer 
Inst., 32: 1229 -1243. 
GOODMAN, M.G., WEIGLE, W.O. and HUGLI, T.E. (1980) Inability 
of C3a anaphylatoxin to promote cellular lysis. Nature, 
283: 78 -80. 
GORELIK, E., WILTROUT, R.H., BRUNDA, M.J., HOLDEN, H.T. and 
HERBERMAN, R.B. (1982) Augmentation of metastasis 
formation by thioglycollate- elicited macrophages. Int. 
J. Cancer, 29: 575 -581. 
254 
GOUD, T.J.L.M. and van FURTH, R. (1975) Proliferative 
characteristics of monoblasts grown in vitro. J. Exp. 
Med., 142: 1200 -1217. 
GOUD, T.J.L.M., SCHOTTE, C. and van FURTH, R. (1975) 
Identification and characterization of the monoblast in 
mononuclear phagocyte colonies grown in vitro. J. Exp. 
Med., 142: 1180 -1199. 
GOWEN, H., WOOD, D.D., IHRIE, E.J., McGUIRE, H.K.B. and 
RUSSELL, R.G.G. (1983) An interleukin 1 like factor 
stimulates bone resorption in vitro. Nature, 306: 378- 
380. 
GRIFFIN, J.D., BEVERIDGE, R.P. and SCHLOSSMAN, S.F. (1982) 
Isolation of myeloid progenitor cells from peripheral 
blood of chronic myelogenous leukemia patients. Blood, 
60: 30 -37. 
GUYER, R.L., KOSHLAND, M.E. and KNOPH, P. (1976) Immuno- 
globulin binding by mouse epithelial cell receptors. 
J. Immunol., 117: 587 -593. 
HANDLEY, W.S. (1907) The pathology of melanotic growths in 
relation to their operative treatment. Lancet, 1: 927- 
953. 
HANNA, N. and FIDLER, I.J. (1980) Role of natural killer 
cells in the destruction of circulating tumor emboli. 
J. Natl. Cancer Inst., 65: 801 -809. 
HART, I.R., FOGLER, W.E., POSTE, G. and FIDLER, I.J. (1981) 
Toxicity studies of liposome- encapsulated immunomodulators 
administered intravenously to dogs and mice. Cancer 
Immunol. Immunother., 10: 157. 
HASKILL, J.S. (1982) Intratumor effector cells, clinical 
and experimental studies. In: "Tumor Immunity in Prognosis. 
The Role of Mononuclear Cell Infiltration." (Haskill, S. 
ed.), pp 309 -332, Narcel Dekker Inc., New York and Basel. 
HASKILL, J.S. and FETT, J.W. (1976) Possible evidence for 
antibody- dependent macrophage- mediated cytotoxicity directed 
against murine adenocarcinoma cells in vivo. J. Immunol., 
117: 1992 -1998. 
HASKILL, J.S., PROCTOR, J.W. and YAMAMURA, Y. (1975a) Host 
responses within solid tumors. I. Monocytic effector cells 
within rat sarcomas. J. Natl. Cancer Inst., 54: 387 -392. 
255 
HASKILL, J.S., YAMAMURA, Y. and RADOV, L. (1975b) Host 
responses within solid tumors: non -thymus- derived specific 
cytotoxic cells within a murine mammary adenocarcinoma. 
Int. J. Cancer, 16: 798 -809. 
HASKILL, J.S.HAYRY, P. and RADOV, L.A. (1978) Systemic and 
local immunity in allograft and cancer rejection. In: 
"Contemporary Topics in Immunobiology, Vol. 8 ", (Warner, 
N.L. and Cooper, M.D., eds.), pp. 107 -170, Plenum Press, 
New York. 
HASKILL, S., KOREN, H., BECKER, S. FOWLER, W. AND WALTON, L. 
(1982) Mononuclear -cell infiltration in ovarian cancer. 
III. Suppressor -cell and ADCC activity of macrophages 
from ascitic and solid ovarian tumours. Br . J. Cancer, 
45: 747 -753. 
HAUSMAN, M., BROSMAN, S., FAHEY, J.L. and SNYDERMAN, R. (1973) 
Defective mononuclear leukocyte chemotactic activity in 
patients with genitourinary carcinoma. Clin. Res., 21: 
646a. 
HAUSMAN, M., BROSMAN, S., SNYDERMAN, R., MICKEY, M.R. and 
FAHEY, J. (1975) Defective monocyte function in patients 
with genitourinary carcinoma. J. Natl. Cancer Inst., 55: 
-1054. 
HAYRY, P. and DEFENDI, V. (1970) Mixed lymphcyte cultures 
produce effector cells: An in vitro model for allograft 
rejection. Science, 168: 133 -135. 
HENNEY, C.S., GAFFNEY, J. and BLOOM, B.R. (1974) On the 
relation of products of activated lymphocytes to cell 
mediated cytolysis. J. Exp.Med., 140: 837 -852. 
HERBERMAN, R.B., HOLDEN, H.T., DJEU, J.Y., JERRELLS, T.R., 
VATESIO, L., TAGLIABUE, A., WHITE, S.L., OEHLER, J.R. and 
DEAN, J.H. (1980) Macrophages as regulators of immune 
responses against tumors. In: "Macrophages and Lymphocytes, 
Part B. ", (Escobar, M.R. and Friedman, H., eds.) pp. 361- 
379, Plenum Press, New York. 
HERCEND, T., REINHERZ, E.L., MEUER, S., SCHLOSSMAN, S.F. and 
RITZ, J. (1983) Phenotypic and functional heterogeneity 
of human cloned natural killer cell lines. Nature, 301: 
158 -160. 
HEWLETT, G., OPITZ, H. -G., SCHLUMBERGER, H.D. and LEMKE, H. (1977) 
Growth regulation of a murine lymphoma line by a 2- mercapto- 
ethanol or macrophage activated serum factor. Eur. J. 
Immunol., 7: 781 -785. 
256 
HIBBS, J.B., Jr. (1974a) Discriminating between neoplastic 
and nonneoplastic cells in vitro by activated macrophages. 
J . Natl. Cancer Inst., 53: 1487 -1492. 
HIBBS, J.B. (1974b) Heterocytolysis by macrophages activated 
by BCG: lysosome exocytosis into tumor cells. Science, 
184: 468 -471. 
HIBBS, J.B., Jr., TAINTOR, R., CHAPMAN, H.A., Jr., WEINBERG, 
J . (1977) Macrophage tumor killing: influence of the 
local environment. Science, 197: 279 -282. 
HIBBS, J.B., Jr., CHAPMAN, H.A., Jr. and WEINBERG, J.B. (1978) 
The macrophage as an antineoplastic surveillance: biological 
perspectives. J. Reticuloendothel. Soc., 24: 549 -570. 
HILFIKER, M.L., MOORE, R.N. and FARRAR, J.J. (1981) Bio- 
logical properties of chromatographically separated murine 
thymoma derived interleukin 2 colony stimulating factor. 
J . Immunol., 127: 1983 -1987. 
HIRSCHBERG, H., BERGH, O.J. and THORSBY, E. (1980) Antigen - 
presenting properties of human vascular endothelial cells. 
J . Exp. Med., 152: 249s -255s. 
HO, H.K. and SPRINGER, T.A. (1982) Mac -1 antigen: Quantit- 
ative expression in macrophage populations and tissues, 
and immunofluorescent localization in the spleen. J. 
Immunol., 128: 2281 -2286. 
HODES, R.J. and SINGER, A. (1977) Cellular and genetic 
control of antibody responses in vitro. I. Cellular 
requirements for the generation of genetically controlled 
primary IgM responses to soluble antigens. Eur. J. Immunol., 
7: 892 -897. 
HODES, R.J., AHMANN, G.B., HATHCOCK, K.S., DICKLER, H.B. and 
SINGER, A. (1978) Cellular and genetic control of 
antibody responses in vitro. IV. Expression of Ia antigens 
on accessory cells required for responses to soluble antigens 
including a response under Ir gene control. J. Immunol., 
121: 1501 -1509. 
HOFFMAN, M.K. (1979) Control of B -cell differentiation by 
macrophages. Ann. N.Y. Acad. Sci., 332: 557 -563. 
HOLDEN, H.T., HASKILL, J.S., KIRCHNER, H. and HERBERMAN, R.B. 
(1976) Two functionally distinct anti -tumor effector cells 
isolated from primary murine sarcoma virus -induced tumors. 
J . Immunol., 117: 440 -446. 
257 
HOLMBERG, L.A., SPRINGER, T.A., and AULT, K.A. (1981) 
Natural killer activity in the peritoneal exudates of mice 
infected with Listeria monocytogenes: Characterization 
of the natural killer cells by using a monoclonal rat anti - 
murine macrophage antibody (M1/70). J. Immunol., 127: 
1792 -1799. 
HOLMES, E.C., MORTON, D.L.,,EILBER, F.R., GOLUB, S.E. and 
SULIT, H.L. (1976) Immunotherapy in malignant melanoma. 
National Cancer Inst. Monograph 44: 85 -97. 
HOPF, U., MEYER, K.H. and DIERICH, M.P. (1976) Demonstration 
of binding sites for IgG Fc and the third component (C3) 
on isolated hepatocytes. J. Immunol., 117: 639 -645. 
HOPPER, K.E., WOOD, P.R. and NELSON, D.S. (1979) Macrophage 
heterogeneity. Vox. Sang., 36: 257 -274. 
HOWARD, M., KESSLER, S., CHUSED, T. and PAUL, W.E. (1981) 
Long -term culture of normal mouse B lymphocytes. Proc. 
Natl. Acad. Sci. USA., 78: 5488 -5792. 
HOWIE, S. and FELDMANN, M. (1978) Immune response (Ir) genes 
expressed at macrophage -B lymphocyte interactions. Nature, 
273: 664 -666. 
HOWIE, S. and McBRIDE, W.H. (1982a) Cellular interactions 
in thymus- dependent antibody responses. Immunol. Today, 
3: 273 
HOWIE, S. and McBRIDE, W.H. (1982b) Tumor -specific T- 
helper activity can be abrogated by two distinct suppressor 
cell mechanisms. Eur. J. Immunol., 12: 671 -675. 
HOWIE, S., McBRIDE, W.H. and JAMES, K. (1982) Distribution 
of IgM, IgA and IgG secreting cells in the tissues of normal 
and tumour -bearing mice. Immunology, 46: 43 -48. 
HUMPHREY, J.H. (1981) Differentiation of function among 
antigen -presenting cells. Ciba Found. Symp., 84: 302 -321. 
ILFELD, D., CARNAUD, C., COHEN, I.R. and TRIININ, N. (1973) 
In vitro cytotoxicity and in vivo tumor enhancement induced 
by mouse spleen cells autosensitized in vitro. Int. J. 
Cancer, 12: 213 -222. 
IOACHIM, H.L. (1976) The stromal reaction of tumors: an 
expression of immune surveillance. J. Natl. Cancer Inst., 
57: 465 -475. 
258 
ISHIZAKA, K. and ADACHI, T. (1976) Generation of specific 
helper cells and suppressor cells in vitro for IgE and 
IgG antibody responses. J. Immunol., 117: 40 -47. 
JAMES, K., MERRIMAN, J., MILNE, I., McBRIDE, W.H. and IHLE, 
J.N. (1978) Tumour -associated immunoglobulins, anti - 
tumour antibodies, and antiviral antibodies in C. parvum 
treated normal and tumour bearing mice. Cancer Immunol., 
Immunother., 5: 141. 
JAMES, K., BESSOS, Y.H.I. and MERRIMAN, J. (1979). Association 
of host immunoglobulins with solid tumours in vivo. 
Br. J. Cancer, 40: 689 -700. 
JANOSSAY, G., PANAYI, G., DUKE, 0., BOFILL, M., POULTER, L.W. 
and GOLDSTEIN, G. (1981) Rheumatoid arthritis: a 
disease of T lymphocyte /macrophage immunoregulation. 
Lancer, ii: 839 -842. 
JERNE, N.K. and NORDIN, A.A. (1963) Plaque formation in 
agar by single antibody -producing cells. Science, 140: 
405. 
JERNE, N.K., HENRY, C., NORDIN, A.A., FUJI, H., KOROS, A.M.C. 
and LEFKOVITS, I. (1974) Plque forming cells: methodology 
and theory. Transplant. Rev. 18: 130 -191. 
JERRELLS, T.R., DEAN, J.H., RICHARDSON, G.L., McCOY, J.L. and 
HERBERMAN, R.B. (1978) Role of suppressor cells in 
depression of in vitro lymphoproliferative responses of 
lung cancer and breast cancer patients. J. Natl. Cancer 
Inst., 61: 1001 -1009. 
JOHNSON, M.W., MAIBACH, H.I. and SALMON, S.E. (1971) Skin 
reactivity in patients with cancer. Impaired delayed 
hypersensitivity or faulty inflammatory response. N. Engl. 
J. Med., 284: 1255 -1257. 
JOHNSON, W.J., WHISNANT, C.C. and ADAMS, D.O. (1981) The 
binding of BCG- activated macrophages to tumor targets 
stimulates secretion of cytolytic factor. J. Immunol., 
127: 1787 -1792. 
JOHNSTON, R.B.Jr., GODZIK, C.A. and COHN, Z.A. (1978) Increased 
superoxide anion production by immunologically activated and 
chemically elicited macrophages. J. Exp. Med., 148: 115 -127. 
JONES, W.M., WILLIAMS, W.J., ROBERTS, M.M. and DAVIES, K. (1968) 
Malignant melanoma of the skin: prognostic value of 
259 
clinical features and the role of treatment in 111 cases. 
Br. J. Cancer, 22: 437 -441. 
JONES, J.T., McBRIDE, W.H. and WEIR, D.M. (1975) The in vitro 
killing of syngeneic cells by peritoneal cells from adjuvant - 
stimulated mice. Cell Immunol., 18: 375 -383. 
JULIUS, M.H., SIMPSON, E. and HERZENBERG, L.A. (1973) A 
rapid method for the isolation of functional thymus- derived 
murine lymphocytes. Eur. J. Immunol., 3: 645 -649. 
KAIZER, L. and LALA, P.K. (1977) Post -mitotic age of 
mononuclear cells migrating into TA -3(St) solid tumors. 
Cell Tissue Res., 10: 279 -288. 
KAPLAN, A.M., WALKER, P.M. and MORAHAN, P.S. (1977) Tumor 
cell cytotoxicity versus cytostasis of pyran activated 
macrophages. In: "Modulation of Host Immune Resistance ", 
(Chirigos, M., ed.), pp. 277 -286, Fogarty International 
Centre Proceedings, US. Goverment Printing Office, 
Washington D.C. 
KARNOVSKY, M.I. and LAZDINS, J.K. (1978) Biochemical criteria 
for activated macrophages. J. Immunol., 121: 809 -813. 
KARNOVSKY, M.L., SIMMONS, S., GLASS, E.A., SHAFER, A.W. and 
HART, P.D. (1970) Metabolism of macrophages. In: 
"Mononuclear Phagocytes ", (van Furth, R. ed.), pp 102 -117, 
Blackwell, Oxford. 
KATZ, D.H. and BENACERRAF, B. (1975) The function and inter- 
relationships of T -cell receptors, Ir genes and other 
histcompatibility gene products. Transpl. Rev., 22: 
175 -195. 
KATZ, D.H. and UNANUE, E.R. (1973) Critical role of deter- 
minant presentation in the induction of specific responses 
in immunocompetent lymphocytes. J. Exp. Med., 137: 
967 -990. 
KELLER, R. (1973) Cytostatic elimination of syngeneic rat 
tumor cells in vitro by nonspecifically activated macrophages. 
J. Exp. Med., 138: 625 -644. 
KELLER, R. (1976) Susceptibility of normal and transformed 
cell lines to cytostatic and cytocidal effects exerted by 
macrophages. J. Natl. Cancer Inst., 56: 369 -374. 
KELLER, A.R., KAPLAN, H.S., LUKES, R.J. and RAPPAPORT, H. (1968) 
Correlation of histopathology with other prognostic 
260 
indicators in Hodgkin's disease. Cancer, 22: 487 -499. 
KERBEL, R.S. (1976) Resistance of activated macrophages to 
H2- antibody- mediated cytotoxicity and Fc rosette inhibition. 
Nature 259: 226 -228. 
KERBEL, R.S. and DAVIES, A.J.S. (1974) The possible bio- 
logical significance of Fc receptors on mammalian lympho- 
cytes and tumor cells. Cell, 3: 105 -112. 
KERBEL, R.S. and PROSS, H.F. (1976) Fc receptor-bearing 
cells as a reliable marker for quantitation of host lympho- 
reticular cell infiltration of progressively growing solid 
tumors. Int. J. Cancer, 18: 432 -438. 
KERBEL, R.S., PROSS, H.F. and ELLIOTT, E.V. (1975) Origin 
and partial characterization of Fc receptor- bearing cells 
found within experimental carcinomas and sarcomas. Int. 
J. Cancer, 15: 918 -932. 
KEY, M.E. (1983) Macrophages in cancer metastasis and 
their relevance to metastatic growth. Cancer Metastasis 
Rev., 2: 165 -182. 
KEY, M. and HASKILL, J.S. (1981) Macrophage- mediated, anti- 
body- dependent destruction of tumor cells: in vitro 
identification of an in situ mechanism. J. Natl. Cancer 
Inst., 66: 102 -110. 
KIM, U. (1970) Metastasizing mammary carcinomas in rats: 
induction and study of their immunogenicity. Science, 
167: 72 -74. 
KING, D.P. and JONES, P.P. (1983) Induction of la and H -2 
antigens on a macrophage cell line by immune interferon. 
J. Immunol., 131: 315 -318. 
KIRCHNER, H. (1978) Suppressor cells of immune reactivity 
in malignancy. Eur. J. Cancer, 14: 453 -459. 
KIRCHNER, H., HERBERMAN, R.B., GLASER, M. and LAVRIN, D.H. 
(1974a) Suppression of in vitro lymphocyte stimulation 
in mice bearing primary Moloney sarcoma virus -induced tumors. 
Cell Immunol., 13: 32 -40. 
KIRCHNER, H., CHUSED, T.M., HERBERMAN, R.B., HOLDEN, H.T. and 
LAURIN, D.H. (1974b) Evidence of suppressor cell activity 
in the spleens of mice bearing primary tumors induced by 
Moloney sarcoma virus. J. Exp. Med., 139: 1473 -1487. 
261 
KIRCHNER, H., MUCHMORE, A.V., CHUSED, T.M., HOLDEN, H.T. and 
HERBERMAN, R.B. (1975a) Inhibition of proliferation 
of lymphoma cells and T lymphocytes by suppressor cells 
from spleens of tumor -bearing mice. J. Immunol., 114: 
206 -210. 
KIRCHNER, H., GLASER, M. and HERBERMAN, R.B. (1975b) 
Suppression of cell- mediated tumour immunity by Coryne- 
bacterium parvum. Nature, 251: 369 -398. 
KITAGAWA, S., TAKAKU, F. and SAKAMOTO, S. (1980) Evidence 
that proteases are involved in superoxide production by 
human polymorphonuclear leukocytes and monocytes. J. 
Clin. Invest., 65: 74 -81. 
KLARESKOG, L., FORSUM, U., MALMNAS -TJERNLUND, U.K., KABELITZ, 
D. and WIGREN, A. (1981) The appearance of anti- HLA -DR- 
reactive cells in normal and rheumatoid synovial tissue. 
Scand. J. Immunol., 14: 183 -192. 
KLAUS, G.G.B., HUMPHREY, J.H., KUNKL, A. and DONGWORTH, D.W. 
(1980) The follicular dendritic cell: its role in 
antigen presentation in the generation of immunological 
memory. Immunol. Rev., 53: 3 -28. 
KNIGHT, S.C., BALFOUR, B.M., O'BRIEN, J., BUTTIFANT, L., 
SUMERSKA, T. and CLARK, J. (1982) Role of vieled 
cells in lymphocyte activation. Eur. J. Immunol., 12: 
1057 -1060. 
KONEVAL, T., APPLEBAUM, E., POPOVIC, D., GILL, L., SISSON, G., 
WOOD, G.W. and ANDERSON (1977) Demonstration of 
immunoglobulin in tumor and marginal tissues of squamous 
cell carcinomas of the head and neck. J. Nati. Cancer 
Inst., 59: 1089 -1097. 
KOOPMAN, W.J., FARRAR, J.J. and FULLER -BONAR, J. (1978) 
Evidence for the identification of lymphocyte activating 
factor as the adherent cell- derived mediator responsible 
for enhanced antibody synthesis by nude mouse spleen cells. 
Cell Immunol., 35: 92 -98. 
KOREN, H.S. and HODES, P.J. (1977) Effect of tumor cells on 
the generation of cytoxic T lymphocytes in vitro. I. 
Accessory cell functions of mouse tumor cells in the 
generation of cytotoxic T lymphocytes in vitro: replacement 
of adherent phagocytic cells by tumor cells or 2- mercapto- 
ethanol. Eur. J. Immunol., 7: 394 -400. 
262 
KORN, J.H., HASKILL, J.S., HOLDEN, H.T., RADOV, L.A. and 
RITTER, F.L. (1978) In situ Fc receptor- bearing cells 
in two murine tumors. U. Role in tumor immunity. 
J. Natl. Cancer Inst., 60: 1391-1397. 
KOSTER, F. and McGREGOR, D.D. (1970) Rat thoracic duct 
lymphocytes: types that participate in inflammation. 
Science, 167: 1137 -1139. 
KRAHENBAHL, J.L., LAMBERT, L.H., Jr., and REMINGTON, J.S. (1976) 
Effect of Corynebacterium parvum treatment and Toxoplasma 
gondii infection on macrophage- mediated cytostasis of 
tumour target cells. Immunology, 31: 837 -846. 
KRENSKY, A.M., AULT, K.A., REISS, C.S., STROMINGER, J.L. and 
BURAKOFF, S.J. (1982) Generation of long -term human 
cytolytic cell lines with persistant natural killer 
activity. J. Immunol., 129: 1748 -1751. 
KURLAND, J.I., PELUS, L.M., RALPH, P., BOCKMAN, R.S. and 
MOORE, M.A.S. (1979) Induction of prostaglandin E 
synthesis in normal and neoplastic macrophages: role 
for colony- stimulating factor(s) distinct from myeloid 
progenitor cell proliferation. Proc. Natl., Acad. Sci. 
USA, 76: 2326 -2330. 
KURZINGER, K. and SPRINGER, T.A. (1982) Purification and 
structural characterization of LFA -1, a lymphocyte function - 
associated antigen, and Mac -1, a related macrophage differ- 
entiation antigen. J. Biol. Chem., 257: 12412 -12418. 
KURZINGER, K., HO, M.D. and SPRINGER, T.A. (1982) Structural 
homology of a macrophage differentiation antigen and an 
antigen involved in T -cell- mediated killing. Nature, 
296: 668 -670. 
L'AGE -STEHR, J. (1981) Priming of T helper cells by antigen - 
activated B cells. J. Exp. Med., 153: 1236 -1245. 
LAMB, J.R., ZANDERS, E.D., LAKE, P., WEBSTER, R.G., ECKELS, 
D.D., WOOLY, J.N., GREEN, N., LERNER, R.A. and FELDMANN, 
M. (1984) Inhibition of T cell proliferation by anti- 
bodies to synthetic peptides. Eur. J. Immunol., 14: 
153 -157. 
LANDOLFO, S., HERBERMAN, R.B. and HOLDEN, H.T. (1977) 
Stimulation of mouse migration inhibitory factor (MIF) 
production from MSV- immune lymphocytes by soluble tumor 
assoicated antigen: requirement for histocompatible macro- 
phages. J. Immunol., 118: 1244 -1248. 
263 
LANE, R.D., KAPLAN, A.M., SNODGROSS, M.J. and SZAKAL, A.K. 
(1982) Characterization of a macrophage chemokinetic 
factor in tumor cell culture media. J. Reticuloendothel. 
Soc., 31: 171 -184. 
LAUDER, I., AHERNE, W., STEWART, J. and SAINSBURY, R. (1977) 
Macrophage infiltration of breast tumours: a prospective 
study. J. Clin. Pathol., 30: 563 -468. 
LEDBETTER, J.A. and HERZENBERG, L.A. (1979) Xenogeneic 
monoclonal antibodies to mouse lymphoid differentiation 
antigens. Immunol. Rev., 47: 63 -89. 
LEE, K. -C. (1980) On the origin and mode of action of 
functionally distinct macrophage subpopulations. Mol. 
Cell Biochem., 30: 39 -55. 
LEE, K. -C. and BERRY,D. (1977) Functional heterogeneity in 
macrophages activated by Corynebacterium parvum: character- 
ization of subpopulations with different activities in 
promoting immune responses and suppressing tumor cell growth. 
J. Immunol., 118: 1530 -1540. 
LEE, K. -C., KAY, J. and WONG, M. (1979) Separation of 
functionally distinct subpopulations of Corynebacterium 
parvum - activated macrophages with predominantly stimul- 
atory or suppressive effect on cell mediated cytotoxic 
T cell response. Cell Immunol., 42: 28 -41. 
LEE, K. -C., WONG, M. and McINTYRE, D. (1981) Characterization 
of macrophage subpopulations responsive to activation by 
endotoxin and lymphokines. J. Immunol., 126: 2474 -2479. 
LEE, K. -C., WONG, M. and SPITZER, D. (1982) Chloroquine 
as a probe for antigen processing by accessory cells. 
Transplantation, 34: 150 -153. 
LERNER, E.A., MATIS, L.A., JANEWAY, C.A., JONES, P.P., 
SCHWARTZ, R.H. and MURPHY, D.B. (1980) Monoclonal 
antibody against an Ir gene product. J. Exp. Med., 152: 
1085 -1101. 
LEWIS, M.G., PROCTOR, J.W., THOMSON, D.M.P., ROWDEN, G. and 
PHILLIPS, T.M. (1976) Cellular localization of immuno- 
globulin within human malignant melanomata. Br. J. Cancer, 
33: 260 -266. 
LIKHITE, V.V. (1974) Rejection of tumors and metastases in 
Fischer 344 rats following intratumors administration of 
killed Corynebacterium parvum. Int. J. Cancer, 14: 684- 
690. 
264 
LIN, H. -S. (1977) Colony formation in vitro by mouse blood 
monocytes. Blood, 49: 593 -598. 
LIN, H. -S. and GORDON, S. (1979) Secretion of plasminogen 
activator by bone marrow -derived mononuclear phagocytes 
and its enhancement by colony -stimulating factor. J. Exp. 
Med., 150: 231 -245. 
LIN, H. -S., KUHN, C. and KUP, T. (1975) Clonal growth of 
hamster free alveolar cells in soft agar. J. Exp. Med., 
142: 877 -886. 
LIPSKY, P.E. and KETTMAN, J.R. (1982) Accessory cells unre- 
lated to mononuclear phagocytes and not of bone marrow 
origin. Immunology Today, 3: 36 -42. 
LIPSKY, P.E., THOMPSON, P.A., ROSENWASSER, L.J. and DINARELLO, 
C.A. (1983) The role of interleukin 1 in human B cell 
activation: inhibition of B cell proliferation and gener- 
ation of immunoglobulin- secreting cells by antibody against 
human leukocyte pyrogen. J. Immunol. 130: 2708 -2714. 
LOHMANN- MATTHES, M. -L., SUN, D.M. and ZAHRINGER, M. (1981) 
Maturation of macrophages and macrophage mediated cyto- 
toxicity. In: "Heterogeneity of Mononuclear Phagocytes ", 
(Forster, O. and Landy, M., eds.), pp. 486 -495, Academic 
Press, London. 
LONAI, P. and FELDMANN, M. (1971) Studies on the effect of 
macrophages in an in vitro graft reaction system. Immunology, 
21: 861 -867. 
LOVELESS, S.E. and HEPPNER, G.H. (1983) Tumor -associated 
macrophages of mouse mammary tumors. I. Differential cyto- 
toxicity of macrophages from metastatic and non -metastatic 
tumors. J. Immunol., 131: 2074 -2078. 
LOWRY, A., TOMINAGA, A., DREBIN, J., TAKAOKI, M., BENACERRAF, 
B. and GREENE, M.I. (1983) Identification of an I -J+ 
antigen -presenting cell required for third order suppressor 
cell. J. Exp. Med., 157: 353 -358. 
LOWRY, A., DREBIN, J.A., MONROE, J.G., GRANSTEIN, R.D. and 
GREENE, M.I. (1984) Genetically restricted antigen 
presentation for immunological tolerance and suppression. 
Nature, 308: 373 -375. 
LU, C.Y., PETERS, E. and UNANUE, E.R. (1981) Ia- bearing 
macrophages in athymic mice: antigen presentation and 
regulation. J. Immunol., 126: 2496 -2498. 
265 
LU, C.Y., CHANGELIAN, P.S. and UNANUE, E.R. (1984) Alpha - 
fetoprotein inhibits macrophage expression of la antigens. 
J . Immunol., 132: 1722 -1727. 
LY, I.A. and MISHELL, R.I. (1974) Separation of mouse spleen 
cells by passage through columns of Sephadex G -10. J. 
Immunol. Meth., 5: 239 -247. 
MacCARRY, W.C. (1922) Factors which influence longevity in 
cancer. Ann. Surg., 76: 9. 
MacCARTY, W.C. and MAHLE, A.E. (1921) Relation of differ- 
entiation and lymphocytic infiltration to postoperative 
longevity in gastric carcinoma. J. Lab. Clin.Med., 6: 
473 -480. 
MACKANESS, G.B. (1962) Cellular resistance to infection. 
J . Exp. Med., 116: 381 -406. 
MACKANESS, G.B. (1964) The immunological basis for acquired 
cellular resistance. J. Exp. Med., 120: 105 -120. 
MACKANESS, G.B. (1970) The monocyte in cellular immunity. 
Seminars in Haematology, 7: 172 -184. 
MACANESS, G.B. (1971) Resistance to intracellular infection. 
J . Infect. Dis., 123: 439 -445. 
MacVITTIE, T.J. and McCARTHY, K.F. (1977) The detection of 
in vitro monocyte- macrophage colony- forming cells in mouse 
thymus and lymph nodes. J. Cell Physiol., 92: 203 -208. 
MacVITTIE, T.J. and PORVAZNIK, M. (1978) Detection of in 
vitro macrophage colony- forming cells (M -CFC) in mouse 
bone marrow, spleen and peripheral blood. J. Cell Physiol., 
97: 305 -313. 
MANNEL, D.N., FARRAR, J.J. and MERGENHAGEN, S.E. (1981) 
Separation of a serum -derived tumoricidal factor from a 
helper factor for plaque- forming cells. J. Immunol., 
124: 1106 -1110. 
MANTOVANI, A. (1978) Effects of in vitro tumor growth of 
murine macrophages isolated from sarcoma lines differing 
in immunogenicity and metastasizing capacity. Int. J. 
Cancer, 22: 741 -746. 
MANTOVANI, A. (1981) In vitro effects on tumor cells of 
macrophages isolated from an early -passage chemically- 
266 
induced murine sarcoma and from its spontaneous metastases. 
Int. J. Cancer, 27: 221 -228. 
MARBROOK, J. (1967) Primary immune response in cultures of 
spleen cells. Lancet, ii: 1279 -1281. 
MARINO, P.A. and ADAMS, D.O. (1980a) Interaction of Bacillus 
Calmette -Gverin- activated macrophages and neoplastic cells 
in vitro. I. Conditions of binding and its selectivity. 
Cell Immunol., 54: 11 -25. 
MARINO, P.A. and ADAMS, D.O. (1980b) Interaction of Bacillus 
Calmette- Gverin- activated macrophages and neoplastic cells 
in vitro. U. The relationship of selective binding 
to cytolysis. Cell Immunol., 54: 26 -35. 
MARINO, P.A., WHISNANT, C. and ADAMS, D.O. (1981) Binding 
of BCG -activated macrophages to tumor targets. Selective 
inhibition by membrane preparations from homologous and 
heterologous neoplastic cells. J. Exp. Med., 154: 77 -87. 
MATIS, L.A., JONES, P.P., MURPHY, D.B., HEDRICK, S.M., LERNER, 
E.A., JANEWAY, C.A., McNICHOLAS, J.M. and SCHWARTZ, R.H. 
(1982) Immune response gene function correlates with the 
expression of an Ia antigen. U. A quantitative deficiency 
in Ae:E alpha complex expression causes a corresponding 
defect in antigen -presenting cell function. J. Exp. Med. 
155: 508 -523. 
McBRIDE, W.H., PETERS, L.J., MASON, K.A. and BARROW, G. (1980) 
The effect of Corynebacterium parvum on T cell dependent 
tumor regression. J. Reticuloendothel. Soc., 27: 151 -158. 
McBRIDE, W.H., WOODRUFF, M.F.A., FORBES, G.M. and MOORE, K. 
(1982) Effect of C.parvum on the number and activity of 
macrophages in primary and transplanted murine fibrosarcomas. 
Br. J. Cancer, 46: 448 -451. 
McCARTHY, K.F. and McVITTIE, T.J. (1978) Velocity sedemen- 
tation studies on monocyte- macrophage colony- forming cells 
from marrow, spleen, blood and peritoneal exudate. J. 
Reticuloendothel. Sco., 24: 263 -269. 
McGOVERN, V.J., MIHM, M.C., Jr., BAILLY, C., BOOTH, J.C., 
CLARK, W.H., Jr., COCHRAN, A.J., HARDY, E.G., HICKS, H.D., 
LEVENE, A., LEWIS, M.G., LITTLE, J.H. and MILTON, G.W. 
(1973) The classification of malignant melanoma and its 
histologic reporting. Cancer, 32: 1446 -1457. 
267 
MEHRA, V., MASON, L.H., FIELDS, J.P. and BLOOM, B.R. (1979) 
Lepromin- induced suppressor cells in patients with leprosy. 
J. Immunol., 123: 1813 -1817. 
MELLMAN, I.S., STEINMAN, R.M., UNKELESS, J.C. and COHN, Z.A. 
(1980) Selective iodination and polypeptide composition 
of pinocytic vesicles. J. Cell Biol., 86: 712 -722. 
MELTZER, M.S. (1981) Tumor cytotoxicity by lymphokine - 
activated macrophages: development of macrophage tumor - 
icidal activity requires a sequence of reactions. 
Lymphokines, 3: 319 -332. 
MELTZER, M.S., TUCKER, R.W. and BREUER, A.C. (1975) Inter- 
action of BOG- activated macrophages with neoplastic and 
nonneoplastic cell lines in vitro: cinemicrographic 
analysis. Cell Immunol., 17: 30 -42. 
MELTZER, M.S., STEVENSON, M.M. and LEONARD, E.J. (1977) 
Characterization of macrophage chemotaxins in tumor cell 
cultures and comparison with lymphocyte- derived chemo- 
tactic factors. Cancer Res., 37: 721 -725. 
MELTZER, M.S., RUCO, L.P. and LEONARD, E.J. (1980) Macro- 
phage activation for tumor cytotoxicity: mechanisms of 
macrophage activation by lymphokines. Adv. Exp. Med. 
Biol., 121: 381 -398. 
MELTZER, M.S., OCCHIONERO, M. and RUCO, L.P. (1982) Macro- 
phage activation for tumor cytotoxicity: regulatory 
mechanisms for induction and control of cytotoxic activity. 
Fed. Proc., 41: 2198 -2205. 
MENARD, S., COLNAGHI, M.I. and DELLA -PORTA, G. (1973) 
In vitro demonstration of tumor- specific common antigens 
and embryonal antigens in murine fibrosarcomas induced 
by 7 ,12- dimethyl -benz(a)anthracene. Cancer Res., 33: 
478 -481. 
MERRIMAN, C.R., PULLIAM, L.A. and KAMPSCHMIDT, R.F. (1977) 
Comparison of leukocyte pyrogen and leukocyte endogenous 
mediator. Proc. Soc. Exp. Biol. Med., 154: 224 -227. 
METCALF, D. (1982) Regulation of macrophage production. 
Adv. Exp. Med. Biol., 155: 33 -48. 
METCALF, D. and McDONALD, H.R. (1975) Heterogeneity of 
in vitro colony- and cluster -forming cells in the mouse 
marrow: segregation by velocity sedimentation. J. Cell 
Physiol., 85: 643 -653. 
268 
METCALF, D., JOHNSON, G.R. and BURGESS, A.W. (1980) Direct 
stimulation by purified GM -CSF of the proliferation of 
multipotential and erythroid precursors. Blood 55: 
138 -147. 
MICHL, J., PIECZONKA, M.M., UNKELESS, J.C. and SILVERSTEIN, 
S.C. (1979) Effects of immobilized immune complexes on 
Fc- and complement- receptor function in resident and 
thioglycollate- elicited mouse peritoneal macrophages. 
J. Exp. Med., 150: 607 -621. 
MIKI, K. and MACKANESS, G.B. (1964) The passive transfer 
of acquired resistance to Listeria monocytogenes. J. Exp. 
Med., 120: 93 -104. 
MILAS, L., HUNTER, N., BASIC, I. and WITHERS, H.R. (1974) 
Complete regression of an established murine fibrosarcoma 
induced by systemic application of Corynebacterium 
granulosum. Cancer Res., 34: 2470 -2475. 
MILAS, L., FAYKUS, M.H., Jr., McBRIDE, W.H., HUNTER, N. and 
PETERS, L.T. (1984) Concomitant development of 
granulocytosis and enhancement of metastases formation 
in tumor -bearing mice. Clin. Exp. Metastasis, Submitted 
for publication. 
MILLER, J.F.A.P., VADAS, M.A., WHITLAW, A. and GAMBLE, J. 
(1976) Role of major histocompatibility complex gene 
products in delayed -type hypersensitivity. Proc. Nat. 
Acad. Sci. USA, 73: 2486 -2490. 
MILLER, J.F.A.P., VADAS, M.A., WHITELAW, A., GAMBLE, J. and 
BERNARD, C. (1977) Histocompatibility linked immune 
responsiveness and restrictions imposed on sensitized 
lymphocytes. J. Exp. Med., 145: 1623 -1628. 
MILLER, S.D., SY, M.S. and CLAMAN, H.N. (1978) Genetic 
restrictions for the induction of suppressor T cells by 
hapten- modified lymphoid cells in tolerance to 1- Fluoro- 
2,4-dinitrobenzene contact sensitivity. Role of H -2D 
region of the major histocompatibility complex. J. Exp. 
Med., 147: 789 -799. 
MILNER, J. (1978) Is protein synthesis necessary for the 
committment of lymphocyte transformation? Nature, 272: 
628 -629. 
MINAMI, M., HONJI, N. and DORF, M.E. (1982) Mechanism res- 
ponsible for the induction of I -J restriction on TS3 
suppressor cells. J. Exp. Med., 156: 1502 -1515. 
269 
MISHELL, R.I. and DUTTON, R.W. (1966) Immunization of normal 
mouse spleen cell suspensions in vitro. Science, 153: 
1004 -1006. 
MISHELL, R.I. and DUTTON, R.W. (1967) Immunization of 
dissociated spleen cell cultures from normal mice. J. 
Exp. Med., 126: 423 -442. 
MISHRA, B.B., POULTER, L.W., JANOSSY, G. and JAMES, D.G. (1983) 
The distribution of lymphoid and macrophage -like cell 
subsets of sarcoid and Kveim granulomata: possible mech- 
anism of negative PPD reaction in sarcoidosis.' Clin. Exp. 
Immunol., 54: 705 -715. 
MIYAZAKI, H. and OSAWA, T. (1983) Accessory functions and 
mutual cooperation of murine macrophages and dendritic 
cells. Eur. J. Immunol., 13: 984 -989. 
MIZEL, S.B. and FARRAR, J.J. (1979) Revised nomenclature 
for antigen- nonspecific T -cell proliferation and helper 
factors. Cell Immunol., 48: 433 -436. 
MOORE, 0.S. and FOOTE, F.W., Jr. (1949) The relatively 
favorable prognosis of medullary carcinoma of the breast. 
Cancer, 2: 635 -642. 
MOORE, K. and McBRIDE, W.H. (1980) The activation state of 
macrophage subpopulations from a murine fibrosarcoma. 
Int. J. Cancer, 26: 609 -615. 
MOORE, K. and McBRIDE, W.H. (1983) Enhanced Fc receptor 
expression by a sub -population of murine intra- tumour 
macrophages following intravenous Corynebacterium parvum 
therapy. Br. J. Cancer, 47: 797 -802. 
MOORE, K. and MOORE, E.M. (1977a) Intra- tumour host cells 
of transplanted rat noeplasms of different immunogenicities. 
Int. J. Cancer, 19: 802 -813. 
MOORE, M. and MOORE, K. (1977b) Kinetics of macrophage infil- 
tration of experimental rat neoplasms. In: "The Macrophage 
and Cancer ", (James, K., McBride, B. and Stuart, A. eds.), 
pp 330 -339. Published by the editors, Edinburgh. 
MOORE, R.N., OPPENHEIM, J.J., FARRAR, J.J., CARTER, C.S., 
WAHEED, A. and SHADDUCK, R.K. (1980) Production of 
lymphocyte- activating factor (interleukin 1) by macrophages 
activated with colony -stimulating factors. J. Immunol., 
125: 1302 -1305. 
270 
MOORE, R.N., HOFFELD, J.T., FARRAR, J.J., MERGENHAGEN, S.E., 
OPPENHEIM, J.J. and SHADDUCK, R.K. (1981) Role of 
colony- stimulating factors as primary stimulators of 
macrophage functions. In: "Lymphokines Vol. 3 ", (Pick,E., 
ed.), pp. 119 -148, Academic Press, New York. 
MORANTZ, R.A., WOOD, G.W., FOSTER, M., CLARK, M. and GOLLAHON, 
K. (1979) Macrophages in experimental and human brain 
tumors. Part 1: Studies of the macrophage content of 
experimental rat brain tumors of varying immunogenicity. 
J. Neurosurg., 50. 298 -304. 
MORRISON, A.S., BLACK, M.M. and LOWE, C.R. (1973) Some 
international differences in histology and survival in 
breast cancer. J. Cancer, 2: 261 -267. 
MORTON, D.L., EILBER, F.R., MALMGREN, R.A. and WOOD, W.C. 
(1970) Immunologic factors which influence response 
to immunotherapy in malignant melanoma. Surgery, 68: 
158 -164. 
MORTON, D.L., EILBER, F.R., HOLMES, E.C., HUNT, J.S., KETCHAM, 
A.S., SILVERSTEIN, M.J. and SPARKS, F.C. (1974) BCG 
immunotherapy of malignant melanoma: summary of a seven - 
year experience. Ann. Surg., 180: 635 -643. 
MJSIER, D.E. (1967) A requirement for two cell types for 
antibody formation in vitro. Science, 158: 1573 -1575. 
MOS IER, D.E. (1981) Separation of murine macrophages by 
adherence to solid substrates. In: "Methods for Studying 
Mononuclear Phagocytes ", (Adams, D.O., Edelson, P.J. and 
Koren, H., eds.), pp. 179 -186, Academic Press, New York. 
MOZES, G. and HAIMOVICH, J. (1979) Antigen -specific T -cell 
helper factor cross reacts idiotypically with antibodies 
of the same specificity. Nature, 278: 56. 
NAMBA, Y. and HANAOKA, M. (1972) Immunocytology of cultured 
IgM- forming cells in the mouse. I. Requirement of phagocytic 
cell factor for the growth of IgM- forming tumor cells in 
tissue culture. J. Immunol., 109: 1193 -1200. 
NASH, J.R.G., PRICE, J.E. and TARIN, D. (1981) Macrophage 
content and colony- forming potential in mouse mammary 
carcinomas. Br. J. Cancer, 39: 478 -485. 
NATHAN, C. and COHN, Z. (1980) Role of oxygen dependent 
mechanisms in antibody- induced lysis of tumor cells by 
activated macrophages. J. Exp. Med., 152: 198 -208. 
271 
NATHAN, C.F. and TERRY, W.D. (1975) Differential stimulation 
of murine lymphoma growth in vitro by normal and BCG 
activated macrophages. J. Exp. Med., 142: 887 -902. 
NATHAN, C.F., BRUKNER, L.H., SILVERSTEIN, S.C. and COHN, Z.A. 
(1979a) Extracellular cytolysis by activated macrophages 
and granulocytes. I. Pharmacologic triggering of effector 
cell and the release of hydrogen peroxide. J. Exp. Med., 
149: 84 -99. 
NATHAN, C.F., SILVERSTEIN, S.C., BRUKNER, L.H. and COHN, Z.A. 
(1979b) Extracellular cytolysis by activated macrophages 
and granulocytes. U. Hydrogen peroxide as a mediator of 
cytotoxicity. J. Exp. Med., 149: 100 -113. 
NATHAN, C.F., MURRAY, H.W. and COHN, Z.A. (1980) The macro- 
phage as an effector cell. N. Eng. J. Med., 303: 622 -626. 
NELSON, M. and NELSON, D.S. (1978) Macrophages and resistance 
to tumours. I. Inhibition of delayed -type hypersensitivity 
reactions by tumour cells and by soluble products affecting 
macrophages. Immunology, 34: 277 -290. 
NELSON, M. and NELSON, D.S. (1980) Macrophages and resistance 
to tumors. IV. The influence of age on the susceptibility 
of mice to the antiinflammatory and antimacrophage effects 
of tumor cell products. J. Natl. Cancer Inst., 65: 781- 
789. 
NEUMANN, C. and SORG, C. (1981) Differential induction of 
plasminogen activator and interferon production in murine 
macrophages. In: "Heterogeneity of Mononuclear Phagocytes ", 
(Forster, 0. and Landy, M., eds), pp. 368 -376. 
NICOLA, N.A., BURGESS, A.W., JOHNSON, G.R., METCALF, D. and 
BATTYE, F.L. (1980) Differential expression of lectin 
receptors during hemopoietic differentiation: enrichment 
for granulocyte- macrophage progenitor cells. J. Cell Physiol., 
103: 217 -237. 
NIEDERHUBER, J.E. (1978) The role of I region gene products 
in macrophage -T lymphocyte interaction. Immunol. Rev., 
40: 28 -52. 
NIEDERHUBER, J.E. and ALLEN, R. (1980) Role of I- region gene 
products in macrophage induction of an antibody response. 
M. Restriction at the level of T cell in recognition of 
I -J- subregion macrophage determinants. J. Exp. Med., 151: 
1103 -1113. 
272 
NIEDERHUBER, J.E., ALLEN, P. and MAYO, L. (1979) The expression 
of la antigenic determinants on macrophages required for 
the in vitro antibody response. J. Immunol., 122: 1342- 
1349. 
NOAR, D. (1979) Suppressor cells: permitters and promoters 
of malignancy? Adv. Cancer Res., 29: 45 -125. 
NOGVEIRA, N., GORDON, S. and COHN, Z. (1977) Trypanosome 
cruzi: modification of macrophage function during infection. 
J. Exp. Med., 146: 157 -171. 
NOLTENIUS, H.W. (1981) Fc and complement receptors on 
malignant tumor cells. Cancer, 48(8): 1761 -1767. 
NORMANN, S.J. (1978) Tumor cell threshold required for 
suppression of macrophage inflammation. J. Natl. Cancer 
Inst., 60: 1091 -1096. 
NORMANN, S.J. and CORNELIUS, J. (1978) Concurrent depression 
of tumor macrophage infiltration and systemic inflammation 
by progressive cancer growth. Cancer Res., 38: 3453 -3459. 
NORMANN, S.J. and CORNELIUS, J. (1982) Characterization of 
anti -inflammatory factors produced by murine tumor cells in 
culture. J. Natl. Cancer Inst., 69: 1321 -1327. 
NORMANN, S.J. and SORKIN, E. (1976) Cell- specific defect in 
monocyte function during tumor growth. J. Natl. Cancer 
Inst., 57: 135 -140. 
NORMANN, S.J. and SORKIN, E. (1977) Inhibition of macrophage 
chemotaxis by neoplastic and other rapidly proliferating 
cells in vitro. Cancer Res., 37: 705 -711. 
NORMANN, S.J., SCHARDT, M. and SORKIN, E. (1979a) Anti - 
inflammatory effect of spontaneous lymphoma in SJL /J mice. 
J. Natl. Cancer Inst., 63: 825 -833. 
NORMANN, S.J., SCHARDT, M. and SORKIN, E. (1979b) Cancer 
progression and monocyte inflammatory dysfunction: Relation- 
ship to tumour excision and metastasis. Int. J. Cancer, 
23: 110 -113. 
NUSSENZWEIG, M.C., STEINMAN, R.M., GUTCHINOV, B. and COHN, Z.A. 
(1980) Dendritic cells are accessory cells for the develop- 
ment of anti -trinitrophenyl cytotoxic T lymphocytes. J. 
Exp. Med., 152: 1070 -1084. 
273 
OBRIST, R. and SANDBERG, A.L. (1983) Enhancement of macro- 
phage invasion of tumors by administration of chemotactic 
factor -antitumor antibody conjugates. Cell Immunol., 81(1): 
169 -174. 
OEHLER, J.R., HERBERMAN, R.B. and HOLDEN, H.T. (1978) Modul- 
ation of immunity by macrophages. Pharmacol. Ther. A., 2: 
551 -593. 
OGMUNDSDOTTIR, H.M. and WEIR, D.M. (1980) Mechanisms of 
macrophage activation. Clin. Exp. Immunol., 110: 223 -234. 
OHISHI, M. and ONOUE, K. (1975) Functional activation of 
immune lymphocytes by antigenic stimulation in cell mediated 
immunity. I. Requirement for macrophages in antigen - 
induced MIF production by guinea pig immune lymphocytes 
in vitro. Cell Immunol., 18: 220 -232. 
OI, V.T., JONES, P.P., GODING, J.W., HERZENBERG, L.A. and 
HERZENBERG, L.A. (1978) Proterties of monoclonal anti- 
bodies to mouse Ig allotypes, H -2 and la antigens. Curr. 
Top. Microbiol. Immunol., 81: 115 -120. 
OKUDA, K., TANI, K., ISHIGATSUBA, Y., YOKOTA, S. and DAVID, 
C.S. (1980) Antigen -pulsed neutrophils bearing Ia antigens 
can induce T lymphocyte proliferative response to the syn- 
geneic or semisyngeneic antigen -primed T- lymphocytes. 
Transplantation, 30: 368 -372. 
OLIVOTTO, M. and BOMFORD, R. (1974) In vitro inhibition of 
tumor growth and DNA synthesis by peritoneal and lung 
macrophages from mice injected with Corynebacterium parvum. 
Int. J. Cancer, 13: 478 -488. 
ONOZAKI, K., AKAGAWA, K.S., HAGA, S., MIURA, K., HASHIMOTO, T. 
and TOKUNAGA, T. (1983) Role of lymphokines in regulation 
of macrophage differentiation. Cell Immunol., 76: 129 -136. 
OPPENHEIM, J.J. and GERY, I. (1982) Interleukin 1 is more than 
an interleuken. Immunol. Today, 3: 113 -119. 
OREN, R.A., FARNHAM, A., SAITO, K., MILOFSKY, E. and KARNOVSKY, 
M.L. (1963) Metabolic patterns in three types of 
phagocytozing cells. J. Cell Biol., 17: 487 -501. 
ORTALDO, J.R., SHARROW, S.O., TIMONEN, T. and HERBERMAN, R.B. 
(1981) Determination of surface antigens on highly purified 
human NK cells by flow cytometry with monoclonal antibodies. 
J. Immunol., 2401 -2409. 
2 74. 
PARTHENAIS, E. and HASKILL, J.S. (1979) Immunity to the 
T1699 murine mammary tumor. U. Thymic influence on the 
in situ inflammatory response, metastatic growth and 
invasiveness. J. Immunol., 123: 1334 -1338. 
PAUL, W.E., SHEVACH, E.M., PICKERAL, S., THOMAS, D.W. and 
ROSENTHAL, A.S. (1977) Independent populations of 
primed F1 guinea pig T lymphocytes respond to antigen - 
pulsed peritoneal exudate cells. J. Exp. Med., 145: 
618 -630. 
PELOUZE, G. and BONENFANT, J. -L. (1979) Signification possible 
de la presence de cellales epitheliodes dans le cancer 
de l'estromae. Union. Med. Can., 108: 348 -353. 
PERI, G., BIONDI, A., BOTTAZZI, B., POLENTARUTTI, N., BORDIGNON, 
C. and MANTOVANI, A. (1982) Tumoricidal and immuno- 
regulating activity of macrophages from human ovarian 
carcinomas. Adv. Exp. Med. Biol., 155: 737 -743. 
PERLMANN, H., PERLMANN, P., SCHREIBER, R.D. and MULLER -EBERHARD, 
H.J. (1981) Interaction of target cell -bound Cibi and 
Cad with human lymphocyte receptors. Enhancement of 
antibody- mediated cellular cytotoxicity. J. Exp. Med., 
153: 1592 -1603. 
PERRY, L.L., DORF, M.E., BENACERRAF, B. and GREENE, M.I. (1978) 
Regulation of immune response to tumor antigen: interference 
with syngeneic tumor immunity by anti I -A alloantisera. 
Proc. Natl. Acad. Sci. USA, 76: 920 -924. 
PERRY, L.L., DORF, M.E., BACH, B.A., BENACERRAF, B. and GREENE, 
M.I. (1980) Mechanisms of regulation of cell mediated 
immunity: anti -I -A alloantisera interfere with induction 
and expression of T- cell -mediated immunity to cell -bound 
antigen in vivo. Clin. Immunol. Immunopathol., 15: 279- 
292. 
PETERS, L.J., McBRIDE, W.H., MASON, K.A. and MILAS, L. (1978) 
A role for T lymphocytes in tumor inhibition and enhancement 
caused by systemic administration of Corynebacterium parvum. 
J. Reticuloendothel. Soc., 24: 9 -18. 
PETTINELLI, C.B., AHMANN, G.B. and SHEARER, G.M. (1980) 
Expression of both I -A and I -E /C subregion antigens on access - 
orycells required for in vitro generation of cytotoxic T 
lymphocytes against alloantigens or TNBS- modified syngeneic 
cells. J. Immunol., 124: 1911 -1916. 
275 
PHILLIPS, J.M. and WALDMANN, H. (1977) Monogamous T helper 
cell. Nature, 268: 641 -642. 
PICKEL, K. and HOFFMAN, M.K. (1977) Suppressor T cells 
arising in mice undergoing graft- versus -host response. 
J. Immunol., 118: 653 -656. 
PIERCE, C.W. (1969) Immune responses in vitro. I. Cellular 
requirements for the immune response by nonprimed and primed 
spleen cells in vitro. J. Exp. Med., 130: 345 -364. 
PIERCE, C.W., KAPP, J.A., WOOD, D.D. and BENACERRAF, B. (1974) 
Immune responses in vitro. X. Functions of macrophages. 
J. Immunol.., 112: 1181 -1189. 
PIERRES, M. and GERMAIN, R.N. (1978) Antigen- specific T 
cell- mediated suppression. IV. Role of macrophages in 
the generation of L- glutamic and L- alanine -L- tyrosine 
(GAT)- specific suppressor T cells in responder mouse strains. 
J. Immunol., 121: 1306 -1314. 
PIESSENS, W.F. (1978) Increased binding of tumor cells by 
macrophages activated in vitro with lymphocyte mediators. 
Cell Immunol., 35: 303 -317. 
PIKE, M.C. and SNYDERMAN, R. (1976) Depression of macrophage 
function by a factor produced by neoplasms: a mechanism 
for abrogation of immune surveillance. J. Immunol., 117: 
1243 -1249. 
PIMM, M.V. and BANDWIN, R.W. (1978) Immunology and immuno- 
therapy of experimental and clinical metastasis. In: 
"The Secondary Spread of Cancer ", (Baldwin, R.W. ed.), 
pp. 163 -209, Academic Press, New York. 
POLLACK, S.B., NELSON, K. and GRAUSZ, J.O. (1976) Separation 
of effector cells mediating antibody- dependent cellular 
cytotoxicity (ADC) to erythrocyte targets from those 
mediating ADC to tumor targets. J. Immunol., 116: 944- 
946. 
POPE, B.L., WHITNEY, R.B., LEVY, J.G. and KILBURN, D.G. (1976) 
Suppressor cells in spleens of tumor -bearing mice: 
enrichment by centrifugation on hypaque -ficoll and character- 
ization of the suppressor population. J. Immunol., 116: 
1342 -1346. 
POSTE, G., BUCANA, C., RAZ, A., BUGELSKI, P., KIRSH, R. and 
FIDLER, I.J. (1982) Analysis of the fate of systemically 
administered liposomes and implications for their use in 
drug delivery. Cancer Res., 42: 1412 -1422. 
2 76 
POULTER, L.W. (1983) Antigen presenting cells in situ: 
their identification and involvement in immunopathology. 
Clin. Exp. Immunol., 53: 513 -520. 
POULTER, L.W., DUKE, O., HOBBS, S., JANOSSY, G. and PANAYI, 
G.S. (1982) Histochemical discrimination of HLA -DR 
positive cell populations in normal and arthritic synovial 
lining. Clin. Exp. Immunol., 48: 381 -388. 
PREHN, R.T. (1976) Do tumors grow because of the immune 
response of the host? Transplant. Rev., 28: 34 -42. 
PREHN, R.T. (1977) Immunostimulation of the lymphodependent 
phase of neoplastic growth. J. Natl. Cancer Inst., 59: 
1043 -1049. 
PREHN, R.T. (1982) Immunological surveillance versus 
immunological stimulation of oncogenesis - a formal proof 
of the stimulation hypothesis. Adv. Exp. Med. Biol., 155: 
77 -85. 
PREHN, R.T. and MAIN, J.M. (1957) Immunity to methylcholan- 
threne- induced sarcomas. J. Natl. Cancer Inst., 18: 
769 -778. 
PROSS, H.F. and KERBEL, R.S. (1976) An assessment of intra- 
tumor phagocytic and surface marker bearing cells in a 
series of autochthonous and early passaged chemically 
induced murine sarcomas. J. Natl. Cancer Inst., 57: 1157 -1167. 
PURI, J. and LONAI, P. (1980) Mechanism of antigen binding 
by T cells. H- 2(I -A)- restricted binding of antigen plus 
Ia by helper cells. Eur. J. Immunol., 10: 273 -281. 
RABINOVITCH, M. (1969) Phagocytosis of modified erythrocytes 
by macrophages and L2 cells. Exp. Cell Res., 56: 326 -332. 
RABINOVITCH, M. and DeSTEFANO, M.J. (1973) Macrophage 
spreading in vitro. I. Inducers of spreading. Exp. 
Cell Res., 77: 323 -334. 
RALPH, P., HO, M.K., LITCOFSKY, P.B. and SPRINGER, T.A. (1983) 
Expression and induction in vitro of macrophage differentiation 
antigens on murine cell lines. J. Immunol., 130: 108 -114. 
RAMILA, G., STUDER, S., MISCHLER, S. and ERB, P. (1983) 
Evaluation of Ia tumor cell lines and peritoneal exudate 
macrophages as accessory cells; differential requirements 
for the activation of certain T cell functions. J. Immunol., 
131: 2714 -2718. 
277 
REMINGTON, J.S., KRAHENBUHL, J.L. and MENDENHALL, J.W. (1972) 
A role for activated macrophages in resistance to infection 
with toxoplasma. Infect. Immun., 6: 829 -834. 
RICHMAN, L.K., STROBER, W. and BERZOFSKY, J.A. (1980) Genetic 
control of the immune response to myoglobulin. III. 
Determinant -specific, two Ir gene phenotype is regulated 
by the genotype of reconstituting Kupffer cells. I. 
Immunol., 124: 619 -625. 
RIGLAR, C. and CHEERS, C. (1980) Macrophage activation during 
experimental murine brucellosis. II. Inhibition of in 
vitro lymphocyte proliferation by brucella- activated macro- 
phages. Cell Immunol., 49: 154 -167. 
RIISGAARD, S., RHODES, J.M. and BENNEDSEN, J. (1978) Macro- 
phage activation by lymphokines and after direct contact 
with sensitized lymphocytes: histocompatibility requirements 
and the effect of inhibitors. Scand. J. Immunol., 7: 
209 -213. 
ROCK, K.L. and BENACERRAF, B. (1983a) Inhibition of antigen - 
specific T lymphocyte activation by structurally related 
Ir gene -controlled polymers. Evidence of specific com- 
petition for accessory cell antigen -presentation. J. Exp. 
Med., 157: 1618 -1634. 
ROCK, K.L. and BENACERRAF, B. (1983b) MHC- restricted T cell 
activation: analysis with T cell hybridomas. Immunol. 
Rev., 76: 29. 
ROCK, K.L. and BENACERRAF, B. (1984) Selective modification 
of a private I -A allostimulating determinant(s) upon 
association of antigen with an antigen -presenting cell. 
J. Exp. Med., 159: 1238 -1252. 
RODDA, S.J. and WHITE, D.O. (1976) Cytotoxic macrophages - 
a rapid non -specific response to viral infection. J. 
Immunol., 117: 2067 -2072. 
ROSEMAN, J. (1969) X -ray resistant cell required for the 
induction of in vitro antibody formation. Science, 165: 
1125 -1127. 
ROSENTHAL, A.S. and SHEVACH, E.M. (1973) The function of 
macrophages in antigen recognition by guinea pig T lympho- 
cytes. I. Requirement for histocompatible macrophages and 
lymphocytes. J. Exp. Med., 138: 1194 -1212. 
278 
ROSENWASSER, L.J. and ROSENTHAL, A.S. (1979) Adherent cell 
function in murine T lymphocyte antigen recognition. III. 
A macrophage- mediated immune response gene function in the 
mouse. J. Immunol., 123: 1141 -1144. 
ROSS, G.D. (1980) Analysis of the different types of 
leukocyte membrane complement receptors and their inter- 
action with the complement system. J. Immunol. Methods, 
37: 197 -211. 
RUBIN, A.S. (1979) Antagonistic interactions between enhancing 
and suppressor factors that regulate the humoral immune 
response. Immunology, 36: 629 -641. 
RUBIN, B. and HERTEL -WULFF, B. (1975) Biological significance 
of Fc receptor- bearing cells among activated T lymphocytes. 
Scand. J. Immunol., 4: 451 -462. 
RUBIN, R.H., COSIMI, A.B. and GOETZL, E.J. (1976) Defective 
human mononuclear leukocyte chemotaxis as an index of host 
resistance to malignant melanoma. Clin. Immunol. Immuno- 
pathol., 6: 376 -388. 
RUCO, L.P. and MELTZER, M.S. (1977) Macrophage activation 
for tumor cytotoxicity: induction of tumoricidal macrophages 
by supernatants of PPD- stimulated Bacillus- Calmette- 
Guerin -immune spleen cell cultures. J. Immunol., 119: 
889 -896. 
RUCO, L.P. and MELTZER, M.S. (1978) Macrophage activation 
for tumor cytotoxicity: development of macrophage cyto- 
toxic activity requires completion of a sequence of short 
lived intermediary reactions. J. Immunol., 121: 2035- 
2042. 
RUSKIN, J., McINTOSH, M. and REMINGTON, J.S. (1969) Studies 
on the mechanisms of resistance to phylogenetically diverse 
organisms. J. Immunol., 103: 252 -259. 
RUSSELL, S.W. and COCHRANE, C.G. (1974) The cellular events 
associated with regression and progression of murine 
(Moloney) sarcomas. Int. J. Cancer, 13: 54 -63. 
RUSSELL, S.W. and McINTOSH, A.T. (1977) Macrophages isolated 
from regressing Moloney sarcomas are more cytotoxic than 
those recovered from progressing sarcomas. Nature, 268: 
69 -71. 
279 
RUSSELL, S.W., DOE, W.F. and McINTOSH, A.T. (1977) Functional 
characterization of a stable, noncytolytic stage of macro- 
phage activation in tumors. J. Exp. Med., 146: 1511 -1520. 
SABIN, F.R., DOAN, C.A. and CUNNINGHAM, B.S. (1925) Discrim- 
ination of two types of phagocytic cells in the connective 
tissues by the supravital technique. Contrib. Embryol., 
16: 125 -162. 
SADLER, T.E., JONES, P.D.E. and CASTRO, J.E. (1977) Effect 
of altered phagocytic activity on the growth of primary 
and metastatic tumour. In: "The Macrophage and Cancer ", 
(James, K., McBride, B. and Stuart, A. eds.), pp. 155 -162, 
Published by the editors, Edinburgh. 
SALMON, S.E. and HAMBURGER, A.W. (1978) Immunoproliferation 
and cancer: a common macrophage- derived promoter substance. 
Lancet, i: 1289 -1290. 
SANCHEZ- MADRID, F., NAGY, J.A., ROBBINS, E., SIMON, P. and 
SPRINGER, T.A. (1983) A human leukocyte differentiation 
antigen family with distinct alpha- subunits and a common B 
subunit: the lymphocyte function associated antigen (LFA -1), 
the cab. complement receptor (OKM1 /Mac -1), and the p 150, 
95 molecule. J. Exp. Med., 158: 1785 -1803. 
SCHER, M.G., BELLER, D.I. and UNANUE, E.R. (1980) Demonstration 
of a soluble mediator that induces exudates rich in Ia- 
positive macrophages. J. Exp. Med., 152: 1684 -1698. 
SCHER, M.G., UNANUE, E.R. and BELLER, D.I. (1982) Regulation 
of macrophage populations. III. The immunologic induction 
of exudates rich in Ia- bearing macrophages is a radiosen- 
sitive process. J. Immunol., 138: 447 -450. 
SCHIRRMACHER, V., SHANTZ, G., CLAUER, K., KOMITOWSKI, D., 
ZIMMERMANN, H. -P. and LOHMANN- MATTHES, M. -L. (1979) 
Tumor metastasis and cell -mediated immunity in a model 
system in DBA /2 mice. I. Tumor invasiveness in vitro and 
metastasis formation in vivo. Int. J. Cancer, 23: 233- 
244. 
SCHMIDTKE, J.R. and UNANUE, E.R. (1971) Interaction of macro- 
phages and lymphocytes with surface immunoglobulin. 
Nature (New Biology), 233: 84. 
SCHOORL, R., De la RIVIERE, A.B., von dem BORNE, A.E.G.Kr. and 
FELTKAMP -VROOM, T.M. (1976) Identification of T and 
B lymphocytes in human breast cancer with immunohistochemical 
techniques. Am. J. Pathol., 84: 529 -544. 
2 80 
SCHULLER, G.B., SNODGRASS, M.J. and KAPLAN, A.M. (1978) 
Macrophage motility and chemotaxis in response to culture 
fluids from tumor cell lines. Fed. Proc., 37: 1578, 
Abstract 1697. 
SCHWARTZ, R.H. (1984) The role of gene products of the 
major histocompatability complex in T cell activation 
and cellular interactions. In: "Fundamental Immunology ", 
(Paul, W.E. ed.), pp. 379 -438, Raven Press, New York. 
SCHWARTZ, B.D., PAUL, W.R. and SHEVACH, E.M. (1976) Guinea 
pig Ia antigens: functional significance and chemical 
characterization. Transplant Rev., 30: 174 -196. 
SCHWARTZ, R.H., YANO, A. and PAUL, W.E. (1978) Interaction 
between antigen presenting cells and primed T lymphocytes. 
Immunol. Rev., 40: 153 -180. 
SCHWARTZ, R.H., YANO, A., STIMPFLING, J.H. and PAUL, W.E. 
(1979) Gene complementation in the T- lymphocyte pro- 
liferative response to poly(G1u55Lys36Phe9) . A demon- 
stration that both gene products must be expressed by the 
same antigen -presenting cell. J. Exp. Med., 149: 40- 57. 
SELA, M. (1969) Antigenicity: some molecular aspects. 
Science, 166: 1365 -1374. 
SELBY, W.S., JANOSSY, G., GOLDSTEIN, G. and JEWELL, D.P. (1981) 
T lymphocyte subsets in human interstitial mucosa: the 
distribution and relationship to MHC- derived antigens. 
Clin. Exp. Immunol., 44: 453 -458. 
SELBY, W.S., POULTER, L.W., HOBBS, S., JEWELL, D.P. and 
JANOSSY, G. (1983) Heterogeneity of HLA- DR -+ve histo- 
cytes in human interstinial lamina propria. A combined 
histochemical and immunohistological analysis. J. Clin. 
Path. (Suppl.), 36: 379 -384. 
SHARMA, B. and TERASAKI, P.I. (1974) In vitro immunization 
to cultured human tumor cells. Cancer Res., 34: 115 -118. 
SHEEHY, M.J., QUINTIERI, F.B., LEUNG, D.Y.M., GEHA, R.S., 
DUBEY, D.P., LIMMER, C.E. and UNIS, E.J. (1983) A human 
large granular lymphocyte clone with natural killer -like 
acitivity and T cell -like surface markers. J. Immunol., 
130: 524 -526. 
SHEVACH, E.M. (1976) The function of macrophages in antigen 
recognition by guinea pig T lymphocytes. III. Genetic 
281 
analysis of the antigens mediating macrophage -T lymphocyte 
interaction. J. Immunol., 116: 1482 -1489. 
SHEVACH, E.M. and ROSENTHAL, A.S. (1973) Function of macro- 
phages in antigen recognition by guinea pig T lymphocytes. 
U. Role of the macrophage in the regulation of genetic 
control of the immune response. J. Exp. Med., 138: 1213- 
1229. 
SHIMONOKEVITZ, R., KAPPLER, J., MANRACK, P. and GREY, H. (1983) 
Antigen recognition by H -2- restricted T cells., I. Cell - 
free antigen processing. J. Exp. Med., 158: 303 -316. 
SHIOZAWA, C., SINGH, B., RUBENSTEIN, S. and DEINER, E. (1977) 
Molecular control-of B cell triggering by antigen- specific 
T cell- derived helper factor. J. Immunol., 118: 2199- 
2205. 
SHORTMAN, K., DIENER, E., RUSSELL, P. and ARMSTRONG, W.D. (1970) 
The role of nonlymphoid accessory cells in the immune response 
to different antigens. J. Exp. Med., 131: 461 -482. 
SILBERBERG- SINAKIN, I., THORBECKE, G.J., BAER, R.L., ROSENTHAL, 
S.A. and BEREZOWSKY, V. (1976) Antigen bearing Langerhans 
cells in the skin, dermal lymphatics and in lymph nodes. 
Cell Immunol., 25: 137 -151. 
SILVERSTEIN, S.C. (1982) Membrane receptors and the regul- 
ation of mononuclear phagocyte effector functions. Adv. 
Exp. Med. Biol., 155: 21 -31. 
SIMONS, L.M., ROBIN, E.D., PHILLIPS, J.R., ACEVEDO, J., AXLINE, 
S.G. and THEODORE, J. (1977) Enzymatic basis for bio- 
energetic differences of alveolar versus peritoneal macro- 
phages and enzyme regulation by molecular 02. J. Clin. 
Invest., 59: 443 -448. 
SINGER, A., COWING, C., HATHCOCK, K.A., DICKLER, H.B. and 
HODES, J.J. (1978) Cellular and genetic control of 
antibody responses in vitro. III. Immune response gene 
regulation of accessory cell function. J. Exp. Med., 147: 
1611 -1620. 
SJOBERG, O., ANDERSSON, J. and MOLLER, G. (1972) Requirement 
for adherent cells in the primary and secondary immune 
response in vitro. Eur. J. Immunol., 2: 123 -126. 
SLAYTER, H.S. and CODINGTON, J.F. (1973) Size and configur- 
ation of glycoprotein fragments cleaved from tumour cells 
by proteolysis. J. Biol. Chem., 248: 3405 -3410. 
282 
SMALL, M. and TRAININ, N. (1975) Inhibition of syngeneic 
fibrosarcoma growth by lymphocytes sensitized on tumor - 
cell monolayers in the presence of thymic humoral factor. 
Int. J. Cancer, 15: 962 -972. 
SMITH, K.A. and RUSCETTI, F.W. (1981) T -cell growth factor 
and the culture of cloned functional T cells. Adv. 
Immunol., 31: 137 -175. 
SMITH, F.I., MOTTRAM, P.L. and MILLER, J.F.A.P. (1979) 
I- region -coded products expressed on both macrophages and 
thymus epithelium influence T -cell activities. Scand. J. 
Immunol., 10: 343 -347. 
SNODGRASS, M.J. and HANNA, M.G. (1973) Ultrastructural 
studies of histiocyte -tumor cell interactions during tumor 
regression after intralesional injection of Mycobacterium 
bovis. Cancer Res., 33: 701 -716. 
SNODGRASS, M.J., KAPLAN, A.M. and HARRIS, T.M. (1976) Macro- 
phage mobility in response to carcinoma cells and their 
soluble by- products. J. Reticuloendothel. Soc., 20: 
57a, Abstract 113. 
SNODGRASS, M.J., HARRIS, T.M., GEERAETS, R. and KAPLAN, A.M. 
(1977) Mobility and cytotoxicity of activated macrophages 
in the presence of carcinoma cells. J. Reticuloendothel. 
Soc., 22: 149 -157. 
SNODGRASS, M.J., HARRIS, T.M. and KAPLAN, A.M. (1978) 
Chemokinetic response of activated macrophages to soluble 
products of neoplastic cells. Cancer Res., 38: 2925- 
2929. 
SNYDER, D.S., BELLER, D.I. and UNANUE, E.R. (1982) Posta - 
glandins modulate macrophage la expression. Nature, 229: 
163 -165. 
SNYDERMAN, R. and GIANCIOLO, G.J. (1979) Further studies of 
a macrophage chemotaxis inhibitor (MCI) produced by neoplasms: 
Murine tumors free of lactic dehydrogenase virus produce 
MCI. J. Reticuloendothel. Sco., 26: 453 -458. 
SNYDERMAN, R. and PIKE, M.C. (1976) An inhibitor of macrophage 
chemotaxis produced by neoplasms. Science, 192: 370 -372. 
SNYDERMAN, R., PIKE, M.C., BLAYLOCK, B.L. and WEINSTEIN, P. (1976) 
Effect of neoplasms on inflammation: depression of macrophage 
accumulation after tumor implantation. J. Immunol., 116: 
585 -589. 
283 
SNYDERMAN, R., SEIGLER, H.F. and MEADOWS, L. (1977) 
Abnormalities of monocyte chemotaxis in patients with 
melanoma: effects of immunotherapy and tumor removal. 
J. Natl. Cancer Inst., 58: 37 -41. 
SYNDERMAN, R., MEADOWS, L., HOLDER, W. and WELLS, S.,Jr. 
(1978) Abnormal monocyte chemotaxis in patients with 
breast cancer: evidence for a tumor -mediated effect. 
J . Natl. Cancer Inst., 60: 737 -740. 
SONE, S. and FIDLER, I.J. (1980) Synergistic activation 
by lymphokines and muramyl dipeptide of tumoricidal pro- 
perties in rat alveolar macrophages. J. Immunol., 125: 
2454 -2460. 
SOUTHAM, C.M. (1968) The immunologic status of patients with 
non -lymphomatous cancer. Cancer Res., 28: 1433 -1440. 
SPRENT, J. (1978a) Restricted helper function of F hybrid 
T cells positively selected to heterologous erytftrocytes in 
irradiated parental strain mice. II. Evidence for 
restrictions affecting helper cell induction and T -B coll- 
aboration, both mapping to the K -end of the H -2 complex. 
J . Exp. Med., 147: 1159 -1174. 
SPRENT, J. (1978b) Role of H -2 gene products in the function 
of T helper cells from normal and chimeric mice in vivo. 
Immunol. Rev., 42: 108 -137. 
SPRINGER, T., GALFRE, G., SECHER, D.S. and MILSTEIN, C. (1979) 
Mac -1: A macrophage differentiation antigen identified by 
monoclonal antibody. Eur. J. Immunol., 9: 301 -306. 
SPRINGER, T.A., DAVIGNON, D., HO, M.K., KURZINGER, K., MARTZ, E. 
and SANCHEZ- MADRID, F. (1982) LFA -1 and Lyt -2,3, mole- 
cules associated with T lymphocyte- mediated killing; and 
Mac -1, an LFA -1 homologue associated with complement receptor 
function. Immunol. Rev., 68: 111 -135. 
STEDNI, B. and SCHWARTZ, R.H. (1981) Antigen- specific, pro- 
liferating T cell clones. Methodology, specificity, MHC 
restriction and alloreactivity. Immunol. Rev., 54: 187- 
224. 
STADECKER, M.J., CALDERON, J., KARNOUSKY, M.L. and UNANUE, E.R. 
(1977) Synthesis and release of thymidine by macrophages. 
J . Immunol., 119; 1738 -1743. 
284 
STADECKER, M.J., WYLER, D.J. and WRIGHT, J.A. (1982) 
Ia antigen expression and antigen -presenting function by 
macrophages isolated from hypersensitivity granulomas. 
J. Immunol., 128: 2739 -2744. 
STAHL, P., SCHLESINGER, P.H., SIGARDSON, E., RODMAN, J.S. 
and LEE, Y.C. (1980) Receptor- mediated pinocytosis 
of mannose glycoconjugates by macrophages: characterization 
and evidence for receptor recycling. Cell, 19: 207 -215. 
STEEG, P.S., MOORE, R. and OPPENHEIM, J.J. (1980) Regulation 
of macrophage Ia antigen expression by products of activated 
spleen cells. J. Immunol., 152: 1734 -1744. 
STEEG, P.S., MOORE, R.N., JOHNSON, H.M. and OPPENHEIM, J.J. 
(1982) Regulation of murine macrophage Ia antigen expression 
by a lymphokine with immune interferon activity. J. Exp. 
Med., 156: 1780 -1793. 
STEIGBIGEL, R.T., LAMBERT, L.H. and REMINGTON, J.S. (1974) 
Phagocytic and bactericidal properties of normal human 
monocytes. J. Clin. Invest., 53: 131 -142. 
STEINMAN, R.M., NOGUEIRA, N., WITMER, M.D., TYDINGS, J.D. 
and MELLMAN, I.S. (1980) Lymphokine enhances the 
expression and synthesis of la antigens on cultured mouse 
peritoneal macrophages. J. Exp. Med., 152 1248 -1261. 
STEINMAN, R.N., NUSSENZWEIG, M.C., WITMER, M.D., NOGUEIRA, N. 
and COHN, Z.A. (1981) A comparison of dendritic cells 
and macrophages. In: "Heterogeneity of Mononuclear 
Phagocytes ", (Forster, O. and Landy, M. eds.) pp. 189- 
194, Academic Press, London. 
STEVENS, T.C., CURRIE, G.A. and PEACOCK. J.H. (1978) 
Repopulation of X- irradiated Lewis lung carcinoma by 
malignant cells and host -macrophage progenitors. Br. J. 
Cancer, 38: 573 -582. 
STINGL, G., KATZ, S.I., CLEMENT, L., GREEN, I. and SHEVACH, 
E.M. (1978) Immunologic functions of Ia- bearing 
epidermal Langerhans cells. J. Immunol., 121: 2005 -2013. 
STUTMAN, 0. (1975) Delayed tumour appearance and absence 
of regression in nude mice infected with murine sarcoma 
virus. Nature, 253: 141 -144. 
SUGARBAKER, E.V. (1979) Cancer metastasis: a product of 
tumor -host interactions. Curr. Probl. Cancer, 3: 1 -59. 
285 
SUIT, H.D. and KASTELAN, A. (1970) Immunologic status of 
host and response of a methylcholanthrene -induced sarcoma 
to local X- irradiation. Cancer, 26: 232 -238. 
SVENNEVIG, J.L. and ANDERSSON, T.R. (1982) Cells bearing 
Fc receptors in human malignant solid tumours. Br. J. 
Cancer, 45: 201 -208. 
SVENNEVIG, J.L. and SVARR, H. (1979) Content and distribution 
of macrophages and lymphocytes in solid malignant human 
tumors. Int. J. Cancer, 24: 754 -758. 
SZYMANIEC, S. and JAMES, K. (1976) Studies on the Fc receptor 
bearing cells in a transplanted methylcholanthrene induced 
mouse fibrosarcoma. Br. J. Cancer, 33: 36 -50. 
TADA, T., TANIGUCHI, M. and DAVID, C.S. (1977) Suppressive 
and enhancing T -cell factors as I- region gene products: 
properties and the subregion assignment. Cold Spring 
Harbor Symp. Quant. Biol., 41: 119 -127. 
TALMADGE, J.E., KEY, M. and FIDLER, I.J. (1981) Macrophage 
content of metastatic and nonmetastatic rodent neoplasms. 
J. Immunol., 126: 2245 -2248. 
TANIYAMA, T. and HOLDEN, H.T. (1979) Requirement for histo- 
compatible macrophages for the induction of a secondary 
cytotoxic response to syngeneic tumor cells in vitro. 
J. Immunol., 123: 43 -49. 
TARAMELLI, D. and VARESIO, L. (1981) Activation of murine 
macrophages. I. Different pattern of activation by poly 
1:C than by lymphokine or LPS. J. Immunol., 127: 58 -63. 
TAUSSIG, M.J. (1974) T cell factor which can replace T 
cells in vivo. Nature, 248: 234 -236. 
THE, T.H., EINBERGEN, R., BAMBERTS, H.B. et al. (1972) 
Immune phagocytosis in vivo of human malignant melanoma 
cells. Acta. Med. Scand., 192: 141 -144. 
THOMAS, D.W. and SHEVACH, E.M. (1978) Nature of the antigenic 
complex recognized by T lymphocytes. VI. The effect of 
anti -TNP antibody on T cell responses to TNP -conjugated 
macrophages. J. Immunol., 121: 1145 -1151. 
THOMAS, D.W., CLEMENT, I. and SHEVACH, E.M. (1978) T lympho- 
cyte stimulation by hapten- conjugated macrophages: a 
model system for the study of immunocompetent cell inter- 
actions. Immunol. Rev., 40: 181 -204. 
286 
TILNEY, N.L., STROM, T.B., McPHERSON, J.G. and CARPENTER, C.B. 
(1975) Surface properties and functional characteristics 
of infiltrating cells harvested from acutely rejecting cardiac 
allografts in inbred rats. Transplantation, 20: 323 -330. 
TREVES, A.J., SCHECHTER, B., COHEN, I.R. and FELDMAN, M. 
(1976) Sensitization of T lymphocytes in vitro by 
syngeneic macrophages fed with tumor antigens. J. Immunol., 
116: 1059 -1064. 
UNANUE, E.R. (1972) The regulatory role of macrophages in 
antigenic stimulation. Adv. Immunol., 15: 95 -165. 
UNANUE, E.R. (1981) The regulatory role of macrophages in 
antigenic stimulation. II. Symbiotic relationship 
between lymphocytes and macrophages. Adv. Immunol., 31: 
1 -136. 
UNANUE, E.R. and ASKONAS, B.A. (1968) Persistence of immuno- 
genicity of antigen after uptake by macrophages. J. Exp. 
Med., 127: 915 -926. 
UNANUE, E.R. and CERROTTINI, J. -C. (1970) The immunogenicity 
of antigen bound to the plasma membrane of macrophages. 
J. Exp. Med., 131: 711 -725. 
UNANUE, E.R., KIELY, J. -M. and CALDERON, J. (1976) The 
modulation of lymphocyte functions by molecules secreted by 
macrophages. H. Conditions leading to increased secretion. 
J. Exp. Med., 144: 155 -166. 
UNANUE, E.R., BELLER, D.I., LU, C.Y. and ALLEN, P.M. (1984) 
Antigen presentation: comments on its regulation and 
mechanism. J. Immunol., 132: 1 -5. 
UNDERWOOD, J.C.W. (1974) Lymphoreticular infiltration of 
human tumours: prognostic and biological implications: 
a review. Br. J. Cancer, 30: 538 -542. 
UNKELESS, J.C. (1977) The presence of two Fc receptors on 
mouse macrophages: evidence from a varient cell line and 
differential trypsin sensitivity. J. Exp. Med., 145: 
931 -945. 
UNKELESS, J.C. and SPRINGER, T.A. (1984) Macrophages. In: 
"Handbook of Experimental Immunology, 4th Edition ", (Weir, 
D.M., Herzenberg, L.A., Blackwell, C.C. and Herzenberg, L.A. 
eds.), Blackwell Scientific Publications, Edinburgh, (In 
Press). 
287 
VADAS, M.A., MILLER, J.F.A.P., WHITLAW, A.M. and GAMBLE, J.R. 
(1977) Regulation by the H -2 gene complex of delayed 
type hypersensitivity. Immunogenetics, 4: 137 -153. 
VARESIO, L. (1983) Suppressor cells and cancer: inhibition 
of immune functions by macrophages. In: "The Reticulo- 
endothelial System. A Comprehensive Treatise. Volume 5, 
Cancer ", (Herberman, R.B. and Friedman, H., eds.), pp. 
217 -252, Plenum Press, New York. 
VARESIO, L. and HOLDEN, H.T. (1980a) Regulation of lympho 
cyte activation: macrophage dependent suppression of T 
lymphocyte protein synthesis. J. Immunol., 125: 1694- 
1701. 
VARESIO, L. and HOLDEN, H.T. (1980b) Suppression of lympho- 
kine production. I. Macrophage- mediated inhibition of 
MIF production. Cell Immunol., 56: 16 -28. 
VARESIO, L., GIOVARELLI, M., LANDOLFO, S. and FORNI, G. (1979a) 
Suppression of proliferative response and lymphokine pro- 
duction during the progression of a spontaneous tumour. 
Cancer Res., 39: 4983 -4988. 
VARESIO, L., HERBERMAN, R.B., GERSON, J.M. and HOLDEN, H.T. 
(1979b) Suppression of lymphokine production by macro- 
phages infiltrating murine virus -induced tumors. Int. 
J. Cancer, 24: 97 -102. 
VISCHER, T.L., BRETZ, U. and BAGGIOLINI, M. (1976) In vitro 
stimulation of lymphocytes by neutral proteinases from 
human polymorphonuclear leukocyte granules. J. Exp. Med., 
144: 863 -872. 
WAGNER, H., FELDMANN, M., BOYLE, W. and SCHRADER, J.W. (1972) 
Cell -mediated immune response in vitro. 3. The requirement 
for macrophages in cytotoxic reactions against cell -bound 
and subcellular alloantigens. J. Exp. Med., 136: 331 -343. 
WAHL, S.M., WILTON, J.M., ROSENSTREICH, D.L. and OPPENHEIM, J.J. 
(1975) The role of macrophages in the production of 
lymphokines by T and B lymphocytes. J. Immunol., 114: 
1296 -1301. 
WALKER, W.S. (1976) Functional heterogeneity of macrophages. 
In: "Immunobiology of the Macrophage ", (Nelson, D.S. ed.), 
pp. 91 -110, Academic Press, New York. 
WALKER, W.S. (1982) Macrophage heterogeneity. Adv. Exp. 
Med. Biol., 155: 435 -443. 
28ß 
WANNENMACHER, R.W., Jr., PEKAREK, R.S., THOMPSON, W.L. (1975) 
A protein from polymorphonuclear leukocytes (LEM) which 
affects the rate of hepatic amino acid transport and 
synthesis of actue -phase globulins. Endocrinology, 96: 
651 -661. 
WATSON, J.D. and PRESTIDGE, R.L. (1983) Interleukin 3 and 
colony- stimulating factors. Immunol. Today, 4: 278 -280. 
WEILAND, E. and MUSSGAY, M. (1977) Presence of splenic 
suppressor cells in mice bearing regressively growing 
Moloney sarcomas and their absence in progressor mice. 
Eur. J. Cancer, 13: 705 -711. 
WEINBERG, J.B., CHAPMAN, H.A. Jr., and HIBBS, J.B., Jr. (1978) 
Characterization of the effects of endotoxin on macrophage 
tumor cell killing. J. Immunol., 121: 72 -80. 
WEISBART, R.H., BLUESTONE, R., GOLDBERG, L.S. and PEARSON, 
C.M. (1974) Migration enhancement factor: a new 
lymphokine. Proc. Natl. Acad. Sci. USA, 71: 875 -879. 
WHICHER, J. and CHAMBERS, R. (1984) Mechanisms in chronic 
inflammation. Immunol. Today, 5: 3 -4. 
WHITE, D.J.G.; CLANE, R.Y. and PLUMB, A.M. (1979) Mode of 
action of Cyclosporin A, a new immunosuppressive agent. 
Transplant. Proc. II, 855 -859. 
WHITNEY, R.B., KELLY, B.S. and LEVY, J.G. (1978) Immuno- 
suppression in mice bearing primary tumors. Eur. J. 
Cancer, 14: 699 -705. 
WINCHESTER, R.J. and BURMESTER, G.R. (1981) Demonstration 
of Ia antigens on certain dendritic cells and on a 
novel elongate cell found in human synovial tissue. 
Scand. J. Immunol., 14: 439 -444. 
WING, E.J., GARDNER, J.D., RYNING, F.W. and REMINGTON, J.S. 
(1977) Dissociation of effector functions in populations 
of activated macrophages. Nature, 268: 642 -644. 
WITZ, I.P. (1977) Tumor -bound immunoglobulins: in situ 
expression of humoral immunity. Adv. Cancer Res. 25: 
95 -148. 
WONG, D.M. and HERCOWITZ, H.B. (1979) Immune activation by 
T- independent antigens: lack of effect of macrophage 
depletion on the immune response to TNP -LPS, PVP and 
dextran. Immunology, 37: 765 -775. 
289 
WOOD, D.D. (1979a) Purification and properties of human 
B cell- activating factor. J. Immunol., 123: 2395 -2399. 
WOOD, D.D. (1979b) Mechanism of action of hum an B cell - 
activating factor. I. Comparison of the plaque- stimulating 
activity with thymocyte stimulating activity. J. Immunol., 
123: 2400 -2407. 
WOOD, D.D. and CAMERON, P.M. (1975) Studies on the mechanism 
of stimulation of the humoral response of murine spleen 
cultures by culture fluids from human monocytes. J. 
Immunol., 114: 1094 -1100. 
WOOD, D.D. and.CAMERON, P.M. (1976) Stimulation of the 
release of a B cell- activating factor from human monocytes. 
Cell Immunol., 21 :' 133 -141. 
WOOD, D.D. and GAUL, S.L. (1974) Enhancement of the humoral 
response of T cell- depleted murine spleens by a factor 
derived from human monocytes in vitro. J. Immunol., 113: 
925 -932. 
WOOD, G.W. and MORANTZ, R.A. (1979) Immunohistologic eval- 
uation of the lymphoreticular infiltrate of human central 
nervous system tumors. J. Natl. Cancer Inst., 62: 485- 
491. 
WOOD, D.D., CAMERON, P.M., POE, M.T. and MORRIS, C.A. (1976) 
Resolution of a factor that enhances the antibody response 
of T cell -depleted murine splenocytes from several other 
monocyte products. Cell Immunol., 21: 88 -96. 
WOOD, G.W., TILZER, S.A., GOLLAHON, K.A. and LINDSAY, J.M. 
(1979) Association between immunoglobulins and macrophages 
in primary methylcholanthrene- induced sarcomas. Cancer 
Res., 39: 4588 -4593. 
WOODWARD, J.G. and DAYNES, R.A. (1979) Cell- mediated immune 
response to syngeneic UV- induced tumours. IV. The 
presence of I -A and I -E subregion -coded antigens on the 
accessory cell required for the in vitro differentiation 
of cytotoxic T lymphocytes. J. Immunol., 123: 1227 -1231. 
WOODWARD, J.G., FERNANDEZ, P.A. and DAYNES, R.A. (1979) 
Cell- mediated immune response to syngeneic UV- induced tumors 
III. Requirement for an Ia + macrophage in the in vitro 
differentiation of cytotoxic T lymphocytes. J. Immunol., 
122: 1196 -1202. 
290 
YAMASHITA, U. and HAMAOKA, T. (1979) The requirement for 
Ia- positive accessory cells for the induction of hapten- 
reactive cytotoxic T lymphocytes in vitro. J. Immunol., 
123: 2637 -2643. 
YANO, A., SCHWARTZ, R.H. and PAUL, W.E. (1977) Antigen 
presentation in the murine T lymphocyte proliferative 
response. I. Requrement for genetic identity at the 
major histocompatibility complex. J. Exp. Med., 146: 
828 -843. 
YANG, A., SCHWARTZ, R.H. and PAUL, W.E. (1978) Antigen 
presentation in the murine T lymphocyte proliferative 
response. II. Ir -GAT controlled T lymphocyte responses 
require antigen presenting cells from a high responder 
donor. Eur. J. Immunol., 8: 344 -347. 
YUNG, Y.P. and CUDKOWICZ, G. (1978) Suppression of cytotoxic 
T lymphocytes by carrageenan- activated macrophage -like cells. 
J. Immunol., 121: 1990 -1997. 
ZÁRLING J.M., CLOUSE, K.A., BIDDISON, W.E. and KUNG, P.C. 
(1981) Phenotypes of human natural killer cell populations 
detected with monoclonal antibodies. J. Immunol., 127: 
2575 -2580. 
ZBAR, B., BERNSTEIN, I.D., BARTLETT, G.L., HANNA, M.G., and 
RAPP, H.T. (1972) Immunotherpay of cancer: regression 
of intradermal tumors and prevention of growth of lymph 
node metastases after intralesional injection of living 
Mycobacterium bovin. J. Natl. Cancer Inst., 49: 119 -130. 
ZEMBALA, M., MYTAR, B., POPIELA, T. and SHERSON, G.L. (1977) 
Depressed in vitro peripheral blood lymphocyte response to 
mitogens in cancer patients: the role of suppressor cells. 
Int. J. Cancer, 19: 605 -613. 
ZEMBALA, M., ASHERSON, G. and COLIZZI, V. (1982) Hapten- 
specific T suppressor factor recognizes both hapten and 
I -J region products on haptenized spleen cells. Nature, 
297: 411 -413. 
ZIEGLER, K. and UNANUE, E.R. (1980) In: "macrophage 
Regulation of Immunity ", (Unanue, E.R. and Rosenthal, A.S., 
eds.), p. 245, Academic Press, New York. 
291 
ZIEGLER, K. and UNANUE, E.R. (1981) Identification of 
a macrophage antigen -processing event required for I- region- 
restricted antigen presentation to T lymphocytes. J. 
Immunol., 127: 1869 -1875. 
ZIEGLER, K. and UNANUE, E.R. (1982) Decrease in macrophage 
antigen catabolism by ammonia and chloroquine is associated 
with inhibition of antigen presentation to T cells. Proc. 
Natl. Acad. Sci. USA, 79: 175 -178. 
ZOLER, M.L. (1983) Marshaling macrophages against metastases. 
J.A.M.A., 249: 1690 -1695. 
van ZWET, T.L., THOMSON, J. and van FURTH, R. (1975) Effect 
of glucacorticosteroids on the phagocytosis and intracellular 
killing by peritoneal macrophages. Infet. Immun., 12: 
699 -705. 
